Report Cdsco Spurious Drugs

Samples Collected from all over India
INDEX
S.No.
Subject
Page No.
I.
Preface
1.0
Executive Summary
2.0
Background
3.0
Details of Sampling (Table 3)
4.0
Further processing after collection
5.0
Details of Drug Samples which were not accepted by the respective manufacturer
as genuine product (Table 5)
6.0
Photographs of Spurious Products
12
7.0
Drug samples from each of the brand collected at random from the stocks which
were accepted by the respective manufacturer as genuine products (Table-6)
23
8.0
Further Sampling from the residual stock
48
9.0
Recent studies on Spurious Drugs
51
10.0
Comparison of present study with the study conducted by SEARPharm
52
11.0
Observations
53
12.0
Conclusions
53
13.0
Future Study Design
54
14.0
Future Administrative Control
54
15.0
Annexure-I (Copy of Gazette Notification)
57
16.0
Annexure-II (Determination of Sample Size and Samples for Estimation of

Counterfeit Drugs)
69
17.0
Annexure-III (list of consumer associations / N.G.Os zone wise thorugh which all the
drugs samples have been collected.)
79
18.0
Annexure-IV (Format for recording the details of samples drawn)
83
19.0
Annexure-V (Format for recording the details of samples drawn) - CDSCO
87
20.0
Annexure-VI (details of the samples drawn from the residual stock which has
been accepted as their product by the respective manufacturing firms for further
laboratory analysis)
91
21.0
Acknowledgement
153
PREFACE
The Report on Countrywide Survey for Spurious Drugs is published by CDSCO on behalf of
Directorate General of Health Services, Ministry of Health & Family Welfare, Govt. of India. The survey
report is produced to fulfill the requirements prescribed in the Drugs & Cosmetics Rules-1945 for standards of
drugs produced and /or marketed in India and contributes in control of quality of the medicinal products.
The quality of Drug formulations has been a prime concern at National as well as International level.
Circulation of spurious drug can lead to grave & adverse consequences on both consumers (patients) and
genuine manufacturers. According to the report received from various State Drug Controllers, the extent of
circulation of spurious drug in Indian retail market is about 0.3%. However, media often magnifies it, in a sensational manner, between 10-25% which is mostly unverified. Indian Pharma Industry expressed displeasure
over the repeated projection of Indian Pharma Industry as major producers of spurious drugs in the world.
Due to dire consequences on public health in view of various projections regarding circulation of spurious
drug, a systematic study was necessary to assess the actual extent of spurious drug circulation in the community at large.
Report on Countrywide Survey for Spurious Drugs would, no doubt, provide relevant information about the
flow of Spurious drugs in National market and bring awareness among the community. Perhaps this is the
first time in world history such a scientific study has been carried out by collecting huge number of samples
involving consumer associations and other NGOs. It is expected that people at large will be immensely
benefited through this report and their belief in availability of quality medicines in India will be assured &
strengthened.
The sample collection and its verification was a mammoth task and involved strenuous day and night work
on part of NGOs, CDSCO Officials & Laboratories over a period of 7 Months. The team work to bring out
the actual figures on extent of problem of spurious drugs in the country is appreciable.
The survey report covers summary of sampling, results, interpretation and gives information about present
scenario of circulation of spurious drugs all over India. Detailed information on determination of sample size
for estimation of counterfeit drugs, format for recording the details of sample drawn and amendments done
in Drugs & Cosmetics Act-1940 are annexed.
************
1.0
Executive Summary
1.1
Background: Circulation of spurious drug can lead to grave, adverse consequences on both consumers (patients)
and genuine manufacturers. According to State Drug Controller, the extent of circulation of spurious drug is about 0.3%.
However, media often magnifies it, in a sensational manner, between 10%-25% which is mostly unverified. Due to dire
consequences on public health in view of circulation of spurious drug, a systematic study was necessary to assess actual
extent of spurious drug circulation in the community at large.
1.2
Methods : Samples of popular brands of oral solid dosage (OSD) formulations, belonging to 9 therapeutic
categories (anti-infective, anti-malarial, anti-T.B.Drugs, steroids, antihistaminic, cardiovascular drugs, anti-diabetics, NSAIDs,
and multivitamin preparations), were collected between November & December 2008. Samples of 61 popular brands of
the above mentioned class were collected. Collection of samples of each brand were made from retail pharmacy outlet
(25 each from metros, big cities, district head quarters, towns and villages) in each zone of CDSCO (East, West, North and
South) with the help of NGOs and consumer associations, who in turn, collected drug without prescription from retail shop
by acting as surrogate patients. Details of the sample (name of drug, brand name, expiry date, batch number, address of
retail pharmacy outlet, etc.) were recorded as per preset format and samples were stored as per required storage conditions.
Samples collected were handed over to authorized quality assurance person of the respective manufacturer for identification
by physical examination so as to establish the authenticity and were asked to return the samples with comments for
undertaking further chemical analysis.
From the samples which were accepted by the manufacturers as genuine product (24,125), five drug samples of each
brand were randomly selected and were subjected to further chemical analysis in Government testing laboratory (Indian
Pharmacopoeia Commission) and Private Testing laboratory (M/s Arbro Laboratory, New Delhi).
Later, on the direction of Ministry of Health & FW, an additional 2,671 samples were also sent for chemical analysis
(11.072 % of the collected samples which were accepted by the manufacturer as genuine i.e. 24,125).
1.3
Findings : Most of the pharmacy retail shops in metro cities refused to sale the scheduled drug without prescription
and in towns and district head quarters there was tendency to replace one brand with other brand. Though most of the drugs
were not available in retail pharmacy outlets, located in villages, availability of all selected brands was uniform throughout
the country. Most of the retail shop did not provide cash memo without request and at times even with request. A total of
24,780 samples were collected by visiting around 40,000 pharmacy outlets, of which 644 samples were of SALA (Sound
Alike and Look Alike). Of remaining 24,136 samples, only 11 samples were not accepted by manufacturers as their genuine
product by physical examination. These unaccepted samples were mainly from Bihar, West Bengal, UP and Gujarat states
accounting five, three, two and one sample respectively. However, none of these samples failed in identification test.
Of 305 samples subjected to chemical analysis, only 3 were found to be substandard with respect to the content of the
active ingredient mentioned on the label (reported results are 86.0, 89.3 and 84.8%). Additional 2,671 samples, which were
subjected to testing on the direction of Ministry of Health & FW, showed 100% conformity with respect to identification and
assay as reported by the government analyst at various central government testing laboratories.
1.4
Interpretation: The extent of spurious drug in retail pharmacy is much below the projections made by various
media, WHO, SEARO, and other studies i.e. only 0.046 % (11 samples out of 24,136 samples).
1.5
Funding: Ministry of Health & FW, Govt. of India
2.0 Background
The term Spurious Drug has been defined under Section
17-B of the Drugs and Cosmetics Act, 1940, as amended by
the Drugs and Cosmetics (Amendment) Act, 1982. In brief,
a drug shall be deemed to be spurious if it is manufactured
under a name which belongs to another drug, if it is an
imitation of another drug or if it has been substituted
wholly or partly by another drug or if it wrongly claims
to be the product of another manufacturer. A stringent
penalty for manufacture and sale of spurious drugs has
also been prescribed under the Act. Counterfeiting of
commercial products, including medicines, is a global issue
and is reported in many countries. The Govt. is aware of
the problem of movement of spurious drugs in the market
and has taken serious note of it.
Manufacture and sale of spurious drugs is primarily a

clandestine activity. To this extent, it is difficult to detect
the manufacture or movement of spurious drugs. Any
effective action against this activity would require continuous
surveillance by the regulators and active co-operation from
the Law and Order Enforcement machinery in the States.
However, unverified and unsupported figures are being
reported in the media as to large-scale production and
trading of spurious drugs in India.
Being a clandestine activity, it is difficult to assess the actual
quantum of spurious drugs. A study of samples of drugs
tested all over the country during the last 10 years reveals
that about 0.2% to 0.4% of around 40,000 samples fall within
the category of spurious drugs. However, this may not
project exact situation and would depend upon the intensity
of surveillance over the clandestine activity. It is pertinent to
mention that the aforesaid data is related to only the spurious
drugs which are defined under section 17B(d), not to other
sub sections of 17 B. As per Mashelker Committees report
the following results, shown in Table-1, are obtained during
the period 1995-2003.
Under the provisions of Drugs and Cosmetics Act and Rules

there under, it is the joint responsibility of Central and
State Governments through their respective Drug Control
organizations to regulate manufacture and sale of drugs
as well as to keep surveillance over possible movement of
spurious drugs .
Table: 1
Year
Tested
Not of sub-standard
quality
Spurious
Not of Sub-standard
Quality %
Spurious %
1995-1996
32770
3490
100
10.64
0.30
1996-1997
38936
3189
94
8.19
0.24
1997-1998
32936
2979
157
9.04
0.47
1998-1999
38936
3189
94
8.19
0.24
1999-2000
35570
3666
115
10.31
0.32
2000-2001
36947
3088
112
8.36
0.30
2001-2002
38824
3458
96
8.96
0.25
2002-2003
36314
3395
125
9.34
0.34
As per the feed back available from the State Drugs Controllers following is the statement, showing in
Table-2, indicating the number of samples tested & found sub. standard/ spurious during the period 2003-2008
Table-2
Year
Tested
Not of sub-standard
quality
Spurious
Not of Sub-standard
Quality %
Spurious %
2003-2004
38313
2402
67
6.3
0.3
2004-2005
49287
3695
144
7.5
0.29
2005-2006
41494
3017
145
7.3
0.35
2006-2007
42354
2718
66
6.4
0.16
2007-2008
(upto Jan. 08)
38313
2402
67
6.3
0.17
The media had been projecting the problem of spurious

drugs in the country in a manner which do not provide
a balanced picture and has, therefore, caused serious
apprehension. The figures quoted by media range from
10% to 25% of drugs in the country being spurious drugs.
These are totally unsubstantiated reports. For example, on
the basis of an alleged WHO report, the media frequently
reports that 35% of fake drugs produced in the world come
from India. However, when enquired, WHO has neither
confirmed its authenticity nor did hint the source of such
figures. WHO Representative in India has clarified that
there is no actual study by WHO concluding that 35% of the
World spurious drugs are produced in India. He has also
regretted that occasionally some individuals in the media
and the organizations use WHO references incorrectly and
even irresponsibly.
The issue of spurious drugs gets debated with a lot more
emotive content than factual understanding of situation. It
is always possible that the quoted facts, stories and statistics
feed on each other and result in distorted and exaggerated
projections. Trading in counterfeit product, including drugs,
is reported world over. However, keeping in view the serious
implications of spurious drugs on public health as well as
the loss to genuine industry, the Govt. has taken various
measures to combat this menace.
On account of apprehensions about the availability of
safe and genuine medicines in India, it is in a way causing
concern to the consumers within the country, on the other
affecting the credibility of drug products from India. Hence,
the Government had set up an Expert Committee under
the Chairmanship of Dr. R.A. Mashelkar, DG (CSIR) in
February, 2003 to recommend measures for strengthening
the drug regulatory system in the country as well as tackling
the problem of spurious drugs.
The Committee had submitted its report in November,
2003. In part (B) of the Report, the Committee had
recommended several changes in the penal provisions of the
Drugs & Cosmetics Act. The main recommendations of the
Committee are as follows:i)
Enhancement of penalty, for sale and manufacturing of
spurious drugs that cause grievous hurt or death, from life
imprisonment to death.
ii)
Sale and manufacture of spurious drugs, which are not
likely to cause consequences as stated in (i) above, be made

cognizable and non-bailable.
iii) There should be a penalty for those who are unable to
produce documents in support of their purchase.
iv) There should be a provision for compounding of minor
offences so that these should be disposed of expeditiously
while prosecution is able to concentrate on serious cases in
the appropriate courts.
v)
Authorization of the police to file prosecution.
vi) Constitution of special courts for trial of offence under

the Drugs & Cosmetics Act so that judicial proceedings can
be expedited.
vii)
Enhancement of prison terms and fines for different
offences, including the concept of damages.
In the tune of recommendations given by the Mashelkar
Committee a bill was passed in both the houses of Parliament
and the bill has been notified as The Drugs and Cosmetics
(Amendment) Act No.26 of 2008 dated 5th December 08
(copy enclosed as Annexure-1).
A recent survey on the extent of spurious (counterfeit)
medicines in India was carried out by SEAR Pharm Forum
in Association with SEARO, WHO and according to their
report, extent of counterfeit suspects were to the tune of 3.1
per cent. However, from the laboratory analysis, only 0.3
per cent did not meet the pharmacopoeia standards in terms
of label claim.
To find out the exact extent / magnitude of the issue, the
Office of Drugs Controller General (India) consulted Indian
Statistical Institute, Hyderabad and requested ISI to furnish
a sampling model based on rational statistical method. Later,
the Institute submitted its report to the Drugs controller
General (India) explaining the statistical methodology of
determining the sample size of retail pharmacy outlet, to be
surveyed, which is enclosed as Annexure-2.
The following aspects were considered while determining
the sample size (the number of retail pharmacy outlets to be
surveyed):
(i)
The possible range of the chance of getting a spurious
drug is in between 0.3% to 30% as suspected by different
sources such as Mashelkar Committee Report, media, press
reports, etc.
(ii)
There are about 400,000 retail pharmacy outlets in
the country.
(iii)
Sample size is determined for one brand of one
generic drug of one therapeutic category.
Based on the report submitted by Indian Statistical Institute,
Hyderabad, it was decided that:
The following therapeutic categories of drugs will be

considered for the survey:
a.
Anti-infective
b.
Steroids
c.
Antihistaminic
d.
Cardiovascular Drugs
e.
Anti-diabetics
f.
Anti-malarial
g.
NSAIDs
h.
Anti-T.B.Drugs
i.
Multivitamin preparations
Sixty one (61) popular brands of drugs belonging

to the aforesaid therapeutic category would be collected.
The drug samples from each brand under this survey

would be drawn from 500 retail pharmacy outlets, 100
from each stratum (metros, big cities, District HQs, Towns
and Villages).
The drug samples under this survey would be

collected within a period of not more than 60 days.
The drugs would be collected without prescription.
The drugs would be collected by the members of

Consumers Association / NGOs as surrogate patient
On the basis of aforesaid decision and subsequent approval
received from the Ministry of Health, Govt. of India, the
present study was started with the objective to collect
Sixty One (61) popular brands of drugs belonging to nine
therapeutic categories and manufactured by thirty (30)
Manufacturing Company from different one hundred (100)
retail sales outlets, located in each stratum (metros, big cities,
district HQs, towns, and villages) throughout the country,
covering all four zones. A quantity of smallest pack available
would be purchased from each pharmacy outlet at a time.
be maintained accordingly.
Each brand would be collected from twenty five (25) retail
pharmacy outlets of each of the five strata (i.e. Metro City, Big
Cities, District HQs, Towns and Villages) under each zone.
The respective zonal officer (i.e. Deputy Drugs Controllers
of East, West, South and North Zones of CDSCO) should
make a strategy for collection of samples from different
retail sales outlets, keeping in view the aforesaid strata ,after
discussion with the local NGOs / Consumers Association so
that a uniform distribution of retail outlets could be selected
at random for each brand.
All the zonal officers called the representatives of the said
Consumers Association/ NGOs in respective zonal offices
and explained in detail the modalities of the survey and
handed over the list of drugs to be collected along with the
Format through which the collected drugs were to be sent to
the zonal office.
As per the aforesaid model, a total number of Twenty
Four Thousand One Hundred Thirty Six (24,136) Samples
belonging to nine (9) therapeutic categories, containing sixty
one (61) fast moving brands, were collected by the members
of the Consumers Association/ NGOs during OctoberNovember08 from all corners of India covering Metro
cities, Big Cities, District Head Quarters, Town and Village
as detailed in Table-3
All CDSCO zonal officers were directed by the Drugs

Controller General (India) to coordinate with the Consumer
Action Forums and other local NGOs for collection of
samples from retail pharmacy outlets through their members
as surrogate patient within a span of not more than 60 days.
The cash memo for purchased drug sample would be asked
for but if refused, without further insistence, record should
3.0 Detail of sampling

Table-3
Therapeutic
Category
Generic
Name
Anti- infective
Brand
Name
Manufactured
By
No. of samples collected

MC
BC
DHQ
Vil Total
Cifran
Ranbaxy
Laboratories Ltd
104
80
128
133
68
513
All samples are

stated to be genuine
by the respective
manufacturer on
the basis of physical
verification
Ciplox
Cipla Ltd
119
86
140
126
80
551
Do
Ciprobid
Cadila Health
Care Ltd
90
78
113
101
54
436
Do
Mox
Ranbaxy
Laboratories Ltd
116
79
134
114
68
511
Do
Novamox
Cipla Ltd
136
83
113
125
76
533
Do
Septran
Glaxo Smith Kline

Pharm Ltd. (GSK)
123
77
128
140
97
565
Do
Ciplin
Cipla Ltd
19
33
33
20
113
Do
Bactrim
Nicholas Piramal
(I) Ltd
123
78
113
122
69
505
Do
Dexona
Cadila Health
Care Ltd.
98
69
111
163
81
522
Do
Decdan
Wockhardt Ltd
103
70
91
138
72
474
Do
Decdac ST
Nax Par Lab (p)

Ltd.
20
19
16
11
73
Do
Wysolone
Wyeth Ltd
111
91
133
154
94
583
Do
Omnacortil
Macleods
Pharmaceuticals
Ltd
86
88
119
134
79
506
Do
Medrol
Pharmacia Italia/
Pfizer Products
India
82
73
96
96
47
394
Do
Betnisol
GSK Ltd
102
92
123
140
80
537
Do
Betnilan
GSK Ltd
84
80
101
110
68
443
Do
Neoloridin
Cadila Health
Care Ltd.
44
40
44
38
10
176
Do
Lorfast
Cadila
Pharmaceuticals
64
65
86
84
41
340
Do
Claridine
Morepen
Laboratories Ltd
26
33
16
11
93
Do
Cetzine
Emcure
Pharmaceuticals
75
58
86
120
68
407
7 samples are
stated to be
spurious and rest
are genuine by
the respective
manufacturer
on the basis
of physical
verification
Cetrizet
Sun Pharma Ltd
13
30
All samples are stated

to be genuine by the
respective manufacturer
on the basis of physical
verification
Ciprofloxacin
Tablets
Amoxycillin
Capsules
Sulphamethoxazole & Trimethoprim Tablets
Dexamethasone
Tablets
Steroids
Prednisolone
Tablets
Betamethasone
Tablets
Loratidine
Tablets
Antihistaminic
Cetirizine
Tablets
Remark
Zyncet
Unichem
Laboratories Ltd
49
62
81
68
43
303
Do
Pheniramine
Maleate Tablets
Avil
Aventis Pharma
Ltd.
101
76
135
134
104
550
Do
Amlodipin
Tablets
Amlosafe
Tablet
Aristo
pharmaceuticals
91
73
83
95
54
396
Do
Amlopress
tablet
Cipla Ltd.
129
80
109
117
62
497
Do
Amdepine
Tablet
Cadila
Pharmaceuticals
39
49
49
31
22
190
Do
Tenolol
Tablet
IPCA Lab. Ltd
131
80
115
120
55
501
Do
Aten-50
Tablet
Cadila Health
Care Ltd.
135
86
124
132
70
547
Do
Ziblok-50
Tablet
FDC Ltd.
43
56
71
56
28
254
Do
Zivast-10
Tablet
FDC Ltd
69
68
64
63
27
291
Do
Atherochek10 Tablet
Indoco Remidies
Ltd
29
33
35
38
14
149
Do
Storvas-10
Tablet
Ranbaxy
Laboratories Ltd
99
81
99
103
53
435
Do
Glyciphage
Tablet
Franco Indian
Pharma (P) Ltd
101
78
110
122
70
481
Do
Glycomet
Tablet
USV Ltd
109
88
106
122
65
490
Do
Gluformin
Tablet
Nicholas Piramal
(India) Ltd
81
70
86
81
48
366
Do
Glizid-80
Tablet
Panacea Biotech
Ltd
95
77
91
100
51
414
Do
Glycigon-80
Tablet
Aristo
Pharmaceuticals
Ltd
62
65
80
77
45
329
Do
Reclide-80
Tablet
Dr. Reddys Lab.

Ltd.
60
74
77
101
43
355
Do
Glimiprex
Tablet
Aristo
Pharmaceuticals
Ltd
51
64
70
77
31
293
Do
Amaryl
Tablet
Aventis Pharma
Ltd
87
88
109
93
58
435
Do
Glyree
Tablet
IPCA Lab. Ltd.
76
52
47
68
36
279
Do
Chloroquine
Tablets
Lariago
IPCA Lab Ltd
113
78
108
127
73
499
Do
Anti-malarial
Pyramithamine
+ Sulphodoxin
Tablets
Reziz
Medibios Labs
(P) Ltd
61
51
75
67
36
290
Do
NSAIDS
Nimesulide
Tablet
Nimulid
Panacea Biotech
Ltd
103
82
104
109
61
459
Do
Nicip
Cipla Ltd
105
88
131
112
71
507
Do
Cardiovascular
Atenolol Tablets
Atorvastatin
Tablets
Metformin
Tablets
Anti-diabetic
Gliclazide
Tablets
Glimepride
Tablets
Nise
Dr. Reddys Labs

Ltd
135
87
131
144
83
580
4 samples are
stated to be
spurious and rest
are genuine by
the respective
manufacturer
on the basis
of physical
verification
Crocin
GSK Ltd.
160
91
139
166
108
664
All samples are

stated to be genuine
by the respective
manufacturer on
the basis of physical
verification
Pacimol
IPCA Lab. Ltd.
62
73
81
87
32
335
Do
Paracip
Cipla Ltd.
29
52
71
67
38
257
Do
Calpol
Remidex Pharma
149
84
151
166
112
662
Do
Brufen
Briocia Pharma (I)

Pvt Ltd
118
99
111
157
100
585
Do
Ibugesic
Cipla Ltd
58
64
69
65
36
292
Do
Rifampicin +
Isoniazide
R-Cinex
Lupin Limited
74
103
101
91
76
445
Do
Rimactazid
Novartis India Ltd
62
56
71
65
31
285
Do
Ethambutol
+ INH + PYZ
+Rifampicin
AKT-4
Lupin Ltd
148
84
114
128
73
547
Do
Pyrazinamide
Tablets
PZA-CIBA
Novertis India
Ltd.
79
78
72
72
32
333
Do
Pzide-750
Cadila
Pharmaceuticals
Ltd
41
57
35
15
155
Do
Revital
Capsules
Ranbaxy
Laboratories Ltd.
108
88
140
134
76
546
Do
Becadexamine Capsules
GSK Pharma Ltd.
71
67
101
94
54
387
Do
DSN
Capsules
Marketed by
Sheria Life
Sciences Pvt. Ltd
62
73
76
49
30
290
Do
Zeva
Tablets
Pamax Labs (P)

Ltd
31
41
45
29
12
158
Do
Paracetamol
Tablets
Ibuprofen
Tablets
Anti-TB
Multivitamins
&
Minerals
Vitamins &
Minerals
Detail of sampling Zone wise:

Table-4
Zone
MC
DHQ
Vill
Total
East
2073
BC
733
1368
1872
989
7035
South
1100
1063
868
1840
1219
6090
North
841
1213
1720
1345
546
5665
West
1064
1242
1681
800
559
5346
Total
5078
4251
5637
5857
3313
24136
4.0 Further Processing after Collection:

All the samples were collected through the members of Consumer Associations/NGOs (few drug samples
were collected by the Drug samplers of CDSCO from such places where local NGOs did not cooperate) as
surrogate patient (list of Consumers Association / NGOs are enclosed in Annexure-3), After such collections
were sent to the respective zonal offices of CDSCO, details of drug samples (i.e., name of drug, brand name,
name of manufacturer, mfg. date, expiry date, batch no., address of the retail pharmacy outlet from where the drug
sample is purchased, sample number etc.) were recorded. The formats used for this purpose are enclosed as
Annex- 4 & 5.
All the samples from different zones were centrally processed at CDSCO North Zone office at Ghaziabad and were handed
over to the authorized designated QA persons of respective manufacturer with a request to identify the product by physical
examination and return back all the samples with comment for further chemical analysis. Accordingly, eleven (11) samples,
as cited in table-5, had not been accepted by the original manufacturers as genuine on physical examination due to the
reason stated in the respective column. However, rests of the samples (24,125) were accepted by the manufacturer as their
genuine product and copy of Certificate of Analysis (COA) for these entire products were also furnished by the respective
firm.
5.0 Details of Drug Samples which were not accepted by the respective manufacturer as genuine
product:
Table-5
S.No.
Name
of the
Brand
Generic
Name
Batch
No.
Sample
No.
Manufactured by
Name & Addr

ess of the
Shop
Remarks
Nise
Nimesulide
Tablets
100mg
V80167,
D/MApril,08,
D/EMarch,
2011
EZ/WB/
Burdwan/
T/47/1024
M/s Dr. Reddys Laboratories Limited,

Khol, Baddi,
Distt. S olan.
M/s Rupam
Medicine Centre,
Khosbagan,
Burdwan, West
Bengal.
Spurious. Foil not matching (not coated with

protective overcoat). Text matter difference (no
dot after physician & children). Not matching
with dot elimination system of Dr.Reddys.
As per CDL, Kolkata Test Report No. 32-3/2009SS/SZS-6/1064 dated 04.06.2009 identification
positive, assay 69.4%
Nise
Nimesulide
Tablets
100mg
V80167,
D/MApril,08,
D/EMarch,
2011
EZ/BR/Hajipur/47/620

Khol, Baddi,
Distt. Solan.
M/s Anupama
Medical Hall,
Subash Chowk,
Hajipur, Bihar.
Spurious.
a) Foil is of poor quality.
b) Kangaroo symbol is not matching.
c) Font size of NISE on PVC side is not
matching. &
d) Font size of text matter on foil not
matching.
Nise
Nimesulide
Tablets
100mg
V70539,
D/MAug.-07,
D/EJuly,2010
WZ/Gujarat/
Himmatnagar/Vil/47/10

Khol, Baddi,
Distt. Solan.
M/s Bhawani
medical &
Provision Stores,
Near Old Bus
stand, Dhansura383001.
Spurious sample.
A) Kangaroo symbol not matching.
B) Font size of text matter is small.
C) NISE on PVC film is not ok. Poor
quality of foil (not coated with protective
overcoat)
Nise
Nimesulide
Tablets
100mg
V80167,
D/MApril,08,
D/EMarch,
2011
EZ/WB/Kol/
MC/47/1598

Khol, Baddi,
Distt. Solan.
M/s Gupta
Medical Stores,
1/A, Akrur Dutta
Lane,Opp. Hind
Cinema, Kolkata,
West Bengal.
Spurious sample.
A) Kangaroo symbol not matching.
B) Font size of text matter is small.
C) NISE on PVC film is not ok. Poor
quality of foil (not coated with protective
overcoat)
positive, assay 56%
Cetzine
Cetirizine
Hydrochloride
Tablets
L-346, D/
M-June,
07, D/EMay,2010
EZ/BR/
Bhagalpur/
DHQ/21/187
M/s Emcure
Pharmaceuticals Limited, C-10/121,
functional
Electronic
Estate, MIDC,
Bhosari, Pune.
M/s Sharada
Medical Agency,
MPD Road,
Bhagalpur (Bihar)
812002
1. Covert feature dot after Mfg. is missing

in spurious sample.
2. Font of letters C/Z on tablets and break
line of spurious sample not matching with
control sample.
3. Strip colour not matching with control
sample.
4. Stereos of batch details on strip not
matching with control sample.
5. Font size of letters on spurious sample
strip is slight larger than control sample
strips.
6. Repeat length of spurious sample strip not
As per CDL, Kolkata Test Report No. 323/2009-SS/SZS-13/1078 dated 04.06.2009
identification positive, assay 76%
Cetzine
Cetirizine
Hydrochloride
Tablets
L-408, D/
M-Feb.-8,
D/E-Jan.2011 L346, D/MJune, 07,
D/E-May,
2010
EZ/BR/Ara/
DHQ/21/418
M/s Emcure
functional
Electronic
Estate, MIDC,
Bhosari, Pune.
M/s Ojha
Medical Hall,
Hospital Road,
Ara, Bihar.

in spurious sample.
2. Font letters C/Z on tablets and break
control sample.
sample.
strips.
6. Repeat length of spurious sample strip
not matching with control sample.
As per CDL, Kolkata Test Report No.
32-3/2009-SS/SZS-9/1070 dated 04.06.2009
identification positive, assay 83.8%
Cetzine
Cetirizine
Hydrochloride
Tablets
L346,
D/MJune,07,
D/EMay,2010
L-409
D/MFeb.08
D/E-Jan.08
EZ/BR/
Hajpur/
DHQ/21/640
M/s Emcure
Pharmaceuticals Limited,
C-10/121,
functional
Electronic Estate, MIDC,
Bhosari,
Pune.
M/s Sneha
Medical Hall,
Subhash Chowk,
Hajipur, Bihar.

in spurious sample.
2. Font letters C/Z on tablets and break
line of spurious sample not matching
with control sample.
sample.
strips.
6. Repeat length of spurious sample strip
not matching with control sample.
Cetzine
Cetirizine
Hydrochloride
Tablets
L-384, D/
M-Dec.07, D/
E- Nov.2010
NZ/UP/Phulpur/Village/21/312
M/s Emcure
functional
Electronic
Estate, MIDC,
Bhosari, Pune.
M/s Shankar
Medical Store,
Lochanganj,
Phulpur,
Allahabad.
1. Covert feature dot after batch number

is missing in spurious sample.
line of spurious sample not matching
with control sample.
sample.
strips.
10
Cetzine
Cetirizine
Hydrochloride
Tablets
L-384, D/
M-Dec.07, D/
E- Nov.2010
EZ/WB/
Singur/
Vil/21/2040
M/s Emcure
functional
Electronic
Estate, MIDC,
Bhosari, Pune.
M/s Life Line

Pharmacy, P.O.
Singur, Hooghly,
Singur, West
Bengal.

control sample.
sample.
strips.
10
Cetzine
Cetirizine
Hydrochloride
Tablets
L-384, D/
M-Dec.07, D/
E- Nov.2010
NZ/UP/Behta
Hazipur/
Vil/21/927
M/s Emcure
functional
Electronic
Estate, MIDC,
Bhosari, Pune.
M/s Mohit
Medical Store,
Chemist &
Druggist, Pipe
Line Road, Near
Railway Crossing,
Sainy Market,
Behta Hajipur,
Dist. Ghaziabad.

control sample.
sample.
strips.
11
Cetzine
Cetirizine
Hydrochloride
Tablets
L-346, D/
M-June,
07, D/EMay,2010
EZ/BR/Siwan/
DHQ/21/739
M/s Emcure
functional
Electronic
Estate, MIDC,
Bhosari, Pune.
M/s Sree Ram

Medical Hall,
Pakrimore,
Siwan, Bihar.

in spurious sample.
control sample.
sample.
strips.
11
6.0 Photographs of these Spurious Products:
12
13
14
15
16
17
18
19
20
21
22
7.0 Five drug samples from each of the brand collected at random (i.e. 5x61=305 samples) from
the stocks which were accepted by the respective manufacturer as genuine products are
shown in Table-6
Table-6
DETAILS OF THE SAMPLES DRAWN AT RANDOM FROM THE SAMPLES WHICH HAS BEEN ACCEPTED
AS THEIR PRODUCT BY THE RESPECTIVE MANUFACTURING FIRMS FOR FURTHER LABORATORY
ANALYSIS
S.
NO.
Name
of the
Brand
Cifran
Generic Name
Batch No. D/
M & D/E
Sample No.
Cifran
9001935, 02/2008,
SZ/Kerala/Village/
Ranbaxy Labora-
Conforms to claim with
Hydrochloride Tab-
01/2011
Vil/01/5656
tories Limited, Sir-
respect to Identification &
mour, HP.
Assay
Ciprofloxacin
9002107, 04/2008,
WZ/Maharashtra/
Ranbaxy Labora-
Hydrochloride Tab-
03/2011
Mumbai/ MC/01/863
mour, HP.
Assay
lets IP
3
Cifran
Ciprofloxacin
9001494, 06/2007,
NZ/Haryana/Panipat/
Ranbaxy Labora-
Hydrochloride Tab-
05/2010
DHQ/01/432
mour, HP.
Assay
lets IP
4
Cifran
Ciprofloxacin
1865673, 02/2008,
EZ/WB/Uttarpara/
Ranbaxy Labora-
Hydrochloride Tab-
01/2011
T/01/2030
mour, HP.
Assay
lets IP
5
Cifran
Ciprofloxacin
9001969, 02/2008,
NZ/Haryana/Rohtak/
Ranbaxy Labora-
Hydrochloride Tab-
01/2011
BC/01/428
mour, HP.
Assay
Cipla Ltd, Solan
lets IP.
6
Ciplox
Ciprofloxacin
D72550, 11/2007,
SZ/Tamilnadu/Village/
Hydrochloride Tab-
10/2010
Vil/02/4725
lets IP
7
Ciplox
Assay
Ciprofloxacin
D8006, 01/2008,
SZ/Tamilnadu/
Hydrochloride Tab-
12/2010
Chennai(F)/
MC/02/1261
Assay
lets IP
8
Ciplox
Ciplox
Ciplox
D82256, 03/2008,
NZ/Himachal
Hydrochloride Tab-
02/2011
Pradesh/Kasauli/
T/02/83
Assay
Cipla Ltd, Solan
Ciprofloxacin
A80543, 08/2007,
WZ/Madhya
Hydrochloride Tab-
07/2011
Pradesh/Chhindwara/
DHQ/02/115
Assay
lets IP
10
Cipla Ltd, Solan
Ciprofloxacin
lets IP
Remarks
Ciprofloxacin
lets IP
Manufactured
by
Ciprofloxacin
D71638, 07/2007,
EZ/BR/Patna/
Hydrochloride Tab-
06/2010
BC/02/461
lets IP
Cipla Ltd, Sikkim
Cipla Ltd, Solan

Assay
23
11
Ciprobid
Ciprofloxacin
LG 1326, 09/2007,
EZ/OR/
Cadila Health Care
Tablets IP
08/2010
Burlalvil/03/755
Ltd., Ahmedabad

Assay
12
Ciprobid
Ciprofloxacin
ZHG1149, 11/2007,
WZ/Gujarat/Jamnagar/
Zydus Health Care,
Tablets IP
10/2010
T/03/37
Sikkim

Assay
13
Ciprobid
Ciprofloxacin
LG1081, 02/2007,
SZ/Karnataka/Lolar/
Cadila Healthcare
Tablets IP
01/2010
DHQ/03/4124
Ltd, Ahmedabad

Assay
14
Ciprobid
Ciprofloxacin
ZHH 1554, 06/2008,
NZ/Haryana/Rohtak/
Zydus Health Care,
Tablets IP
05/2011
BC/03/337
Sikkim

Assay
15
Ciprobid
Ciprofloxacin
LG1249, 06/2007,
WZ/Maharashtra/
Cadila Healthcare
Tablets IP
05/2010
Mumbai/MC/03/331
Ltd, Ahmedabad

Assay
16
Mox
Amoxycillin
S02008, 06/2008,
SZ/Andhara Pradesh/
Ranbaxy Laborato-
Trihydrate
05/2010
Rajahmundry/
ries Limited, Baddi,
BC/04/3804
HP.
Assay
Capsules IP
17
Mox
Amoxycillin
9091760, 03/2008,
WZ/Maharashtra/
Ranbaxy Laborato-
Trihydrate
02/2010
Nandurbar/
DHQ/4/14
HP.
Assay
Capsules IP
18
Mox
Amoxycillin
505708, 08/2008,
EZ/WB/Hasnabad/
Ranbaxy Laborato-
Trihydrate
07/2010
Vil/4/3046/4
HP.
Assay
Capsules IP
19
Mox
Amoxycillin
S03108, 06/2008,
NZ/J&K/Katra/
Ranbaxy Laborato-
Trihydrate
05/2010
T/04/160
HP.
Assay
Capsules IP
20
Mox
Amoxycillin
S04608, 07/2008,
EZ/WB/Kol/
Ranbaxy Laborato-
Trihydrate
06/2010
MC/4/1582
HP.
Assay
Cipla Ltd, H.P.
Capsules IP
21
Novamox
Amoxycillin
MA8036 Jan 2008,
EZ/WB/Kolkata/
Trihydrate
Dec 2009
MC/05/1639
Capsules IP
22
Novamox
Assay
Amoxycillin
MA7254 12/2007,
NZ/UP/Gyanpur/
Trihydrate
11/2009
Town/05/249
Cipla Ltd, H.P.

Dispersible
Assay
Tablets IP
23
Novamox
Amoxycillin
MA8107, 02/2008,
SZ/Tamilnadu/Theni/
Trihydrate
01/2010
DHQ/05/427
Capsules IP
24
Cipla Ltd, H.P.

Assay
24
Novamox
Amoxycillin
MA7211 10/2007,
WZ/Maharashtra/
Trihydrate
09/2009
Nasik/Vil/05/17
Cipla Ltd, H.P.

Dispersible
Assay
Tablets IP
25
Novamox
Amoxycillin
MW8014 09/2008,
NZ/Punjab/Jalandhar/
Trihydrate
08/2010
BC/05/367
Cipla Ltd, H.P.
Capsules IP
26
Septran

Assay
Cotrimoxazole Tab-
N780, Sept-2008,
NZ/Delhi/Delhi/
Glaxo Smithkline
lets IP
Aug. 2011
MC/07/89
Pharmaceuticals
Ltd., Kothur, Maha-
Assay
boobnagar
27
Septran
Cotrimoxazole Tab-
N747, Jul-2008, Jun-
WZ/Maharashtra/
Glaxo Smithkline
lets IP
2011
Chandrapur/T/07/16
Pharmaceuticals
Ltd., Kothur, Maha-
Assay
boobnagar
28
Septran
Cotrimoxazole Tab-
N692, May-2008,
SZ/Tamilnadu/Salem/
Glaxo Smithkline
lets IP
Apr-2011.
BC/07/06
Pharmaceuticals
Ltd., Kothur, Maha-
Assay
boobnagar
29
Septran
Cotrimoxazole Tab-
N699, May08,
EZ/BR/Shahebgangu/
Glaxo Smithkline
lets IP
Apr11
Vill/07/373
Pharmaceuticals
Ltd., Kothur, Maha-
Assay
boobnagar
30
Septran
Cotrimoxazole Tab-
N 691, May08,
NZ/Haryana/Sonepat/
Glaxo Smithkline
lets IP
Apr11
DHQ/07/228
Pharmaceuticals
Ltd., Kothur, Maha-
Assay
boobnagar
31
Ciplin DS
Co-trimoxazole Tab-
DJ6366, 12/2006,
EZ/Manipur/Imphal/
lets IP
11/2009
BC/08/14
Cipla Ltd, Daman.

Assay
32
Ciplin DS
Co-trimoxazole Tab-
DJ8644 07/2008,
NZ/NCT Delhi/Delhi/
lets IP
06/2011
MC/08/341
Cipla Ltd, Daman.

Assay
33
Ciplin DS
Co-trimoxazole Tab-
DG8089, 02/2008,
SZ/Karnataka/
lets IP
01/2011
Tumkur/DHQ/08/4263
Cipla Ltd, Daman.

Assay
34
Ciplin DS
Co-trimoxazole Tab-
DG8070 02/2008,
SZ/Andhra Pradesh/
lets IP
01/2011
Ludara/T/08/3415
Cipla Ltd, Daman.

Assay
35
Ciplin DS
Co-trimoxazole Tab-
DJ8050, 01/2008,
WZ/Maharashtra/
lets IP
12/2010
Nasik/Vil/08/18
Cipla Ltd, Daman.

Assay
25
36
Bactrim-ds
Trimethoprim &
MH0044, Apr08,
SZ/Tamilnadu/
Nicholas Piramal
Sulphamethoxazole
Mar12
Pattlkotjai &
India Limited, Ma-
Mannargudi/T/09/5234
harashtra.
Assay
Tablets IP
37
Bactrim-ds
Trimethoprim &
MH0092, Sep08,
NZ/J&K/Jammu/
Nicholas Piramal
Sulphamethoxazole
Aug12
BC/09/90
India Limited, Ma-
harashtra.
Assay
Tablets IP
38
Bactrim-ds
Trimethoprim &
MH0073, Jul08,
WZ/Gujrat/Godhra/
Nicholas Piramal
Sulphamethoxazole
Jun12
Vil/09/05
India Limited, Ma-
harashtra.
Assay
Tablets IP
39
Bactrim-ds
Trimethoprim &
MH0041, Mar08,
WZ/Madhya Pradesh/
Nicholas Piramal
Sulphamethoxazole
Feb12
Ujjain/DHQ/09/15
India Limited, Ma-
harashtra.
Assay
Tablets IP
40
Bactrim-ds
Trimethoprim &
MH0086, Aug08,
EZ/WB/Kolkata/
Nicholas Piramal
Sulphamethoxazole
Jul12
MC/09/495
India Limited, Ma-
harashtra.
Assay
Tablets IP
41
Dexona
Dexamethasone
LH1114, 06/2008,
NZ/Punjab/Rajpura/
Cadila Healthcare
Tablets IP
05/2011
T/10/470
Ltd, Ahmedabad

Assay
42
Dexona
Dexamethasone
LH1150, 07/2008,
WZ/Maharashtra/
Cadila Healthcare
Tablets IP
06/2011
Amravati/DHQ/10/06
Ltd, Ahmedabad

Assay
43
Dexona
Dexamethasone
LH1254, 10/2008,
WZ/Gujarat/
Cadila Healthcare
Tablets IP
09/2011
Ahmedabad/
Ltd, Ahmedabad
BC/10/154
44
Dexona
Assay
Dexamethasone
LH1053, 03/2008,
SZ/Tamilnadu/
Cadila Healthcare
Tablets IP
02/2011
Chennai(V)/
Ltd, Ahmedabad

Assay
MC/10/5414
45
Dexona
Dexamethasone
LH1084, 04/2008,
EZ/WB/Vluberia/
Cadila Healthcare
Tablets IP
03/2011
Vil/10/1370
Ltd, Ahmedabad

Assay
46
Decdan
Dexamethasone
11G0003, 02/2007,
SZ/Kerala/Village/
Wockhardt Limited,
Tablets IP
01/2010
Vil/11/2403
Mumbai.

Assay
47
Decdan
Dexamethasone
WAP 8042, Oct08,
NZ/UP/Modinagar/
Wockhardt Limited,
Tablets IP
Sep11
T/11/1255
Mumbai.

Assay
48
Decdan
Dexamethasone
07H0158, Jun08,
WZ/Madhya Pradesh/
Wockhardt Limited,
Tablets IP
May11
Satna/DHQ/11/92
Mumbai.

Assay
26
49
Decdan
Dexamethasone
07H0138, May08,
SZ/Tamilnadu/Salem/
Wockhardt Limited,
Tablets IP
Apr11
BC/11/10
Mumbai.

Assay
50
Decdan
Dexamethasone
WAP 8016, Jun08,
EZ/WB/Kolkata/
Wockhardt Limited,
Tablets IP
May11
MC/11/518
Mumbai.

Assay
51
Decdak ST
Dexamethasone
TNA7052, 10/2007,
EZ/WB/Kolkata/
Naxpar Labs Pvt.
Sodium Phosphate
09/2009
MC/12/603
Ltd., Silvassa
Tablets
52
Decdak ST
Assay
Dexamethasone
TNA8001, 03/2008,
SZ/Karnataka/
Naxpar Labs Pvt.
Sodium Phosphate
02/2010
Mangalore/
Ltd., Silvassa
Tablets
53
Decdak ST
BC/12/4183
Dexamethasone
TNA 7048, Sep07,
EZ/WB/
Naxpar Labs Pvt.
Sodium Phosphate
Aug09
Chandamnagar/
Ltd., Silvassa
Tablets
54
Decdak ST
T/12/3001
Decdak ST
Assay
Dexamethasone
TNA7052, Oct07,
WZ/Maharashtra/
Naxpar Labs Pvt.
Sodium Phosphate
Sep09
Chandarpur/
Ltd., Silvassa
Tablets
55
Assay
DHQ/12/10
Assay
Dexamethasone
TNA7051, Oct
WZ/Goa/Mangao/
Naxpar Labs Pvt.
Sodium Phosphate
2007, Sept 2009
T/12/23
Ltd., Silvassa
Tablets
56
Wysolone
Assay
Prednisolone
07446, 04/2008,
NZ/Haryana/Hisar/
Wyeth Limited,
Tablets IP
03/2011
BC/13/41
Verna Goa.

Assay
57
Wysolone
Prednisolone Tab-
07386, 09/2007,
WZ/Maharashtra/
Wyeth Limited,
lets IP
08/2010
Mumbai/MC/13/258
Verna Goa.

Assay
58
Wysolone
Prednisolone Tab-
07450, 05/2008,
SZ/Tamilnadu/
Wyeth Limited,
lets IP
04/2011
Cuddalore/
Verna Goa.
DHQ/13/350
59
Wysolone
Assay
Prednisolone Tab-
08336, 09/2008,
NZ/UP/Modinagar/
Wyeth Limited,
lets IP
08/2011
T/13/77
Verna Goa.

Assay
60
Wysolone
Prednisolone Tab-
08246 & 08288,
EZ/BR/Nautoor/
Wyeth Limited,
lets IP
08/2007, 07/2010 &
Vil/13/800
Verna Goa.
03/2008, 02/2011
61
Omnacortil
Assay
Prednisolone
K05-855, Sep08,
NZ/NCT Delhi/Delhi/
Macleods Pharma-
Dispersible Tablets
Aug11
MC/14/611
ceuticals Ltd., Da-
man.
Assay
27
62
63
64
Omnacortil
Omnacortil
Omnacortil
Prednisolone
K05-846, Aug08,
EZ/WB/Kalikapur/
Macleods Pharma-
Dispersible Tablets
Jul11
Vil/14/2371
ceuticals Ltd., Da-
man.
Assay
Prednisolone
K010-834, Sep08,
WZ/Madhya Pradesh/
Macleods Pharma-
Dispersible Tablets
Aug11
Ujjain/T/14/44
ceuticals Ltd., Da-
man.
Assay
Prednisolone
K05-776, Sep07,
NZ/UP/Meerut/
Macleods Pharma-
Dispersible Tablets
Aug10 & K05-815,
BC/14/705
ceuticals Ltd., Da-
man.
Assay
Feb08, Jan11
65
66
Omnacortil
Medrol
Prednisolone
K05-826, May08,
SZ/Tamilnadu/
Macleods Pharma-
Dispersible Tablets
Apr11
Kanchipuram/DHQ/
ceuticals Ltd., Da-
14/257
man.
Assay
Methylprednisolone
MD0587, 03/2005,
EZ/WB/Kolkata/
Pharmacia Ita-
Tablets USP
02/2010 & MH0480,
MC/15/70
lia S.p.A. Tronto.
Mktd. by Pfizer,
Assay
06/2005, 05/2010
Mumbai.
67
Medrol
Methylprednisolone
G902C, 01/2008,
NZ/J&K/Jammu/
Pharmacia Ita-
Tablets USP
01/2013
BC/15/88
lia S.p.A. Tronto.
Mktd. by Pfizer,
Assay
Mumbai.
68
Medrol
Methylprednisolone
H426A, 04/2008,
WZ/Chhattisgarh/
Pharmacia Ita-
Tablets USP
04/2013
Ambikapur/T/15/24
lia S.p.A. Tronto.
Mktd. by Pfizer,
Assay
Mumbai.
69
Medrol
Methylprednisolone
G933A, 01/2008,
EZ/NE/Jirania/
Pharmacia Ita-
Tablets USP
01/2013
Vill/15/141
lia S.p.A. Tronto.
Mktd. by Pfizer,
Assay
Mumbai.
70
Medrol
Methylprednisolone
H107A, 02/2008,
SZ/Karnataka/Kolar/
Pharmacia Ita-
Tablets USP
02/2013
DHQ/15/4133
lia S.p.A. Tronto.
Mktd. by Pfizer,
Assay
Mumbai.
71
Betnesol
Betamethasone
NH 124, May08,
NZ/Uttrakhand/
GSK Pharmaceuti-
Sodium Phosphate
Apr10
Haridwar/DHQ/16/52
cals Limited, Nasik.
Tablets IP
72
73
Betnesol
Betnesol

Assay
Betamethasone
NH 181, Jul08,
NZ/UP/Badalpur/
GSK Pharmaceuti-
Sodium Phosphate
May10 & NH182,
T/16/158
Tablets IP
Jul08, Jun10
Betamethasone
NH 153, Jun08,
SZ/Kerala/Thrissur/
GSK Pharmaceuti-
Sodium Phosphate
May10
BC/16/1929
Tablets IP
28

Assay
Assay
74
75
76
77
78
79
80
81
Betnesol
Betnesol
Betnelan
Betnelan
Betnelan
Betnelan
Betnelan
Betamethasone
NH 102, May08,
SZ/Kerala/Village/
GSK Pharmaceuti-
Sodium Phosphate
Apr10 & NG 974,
Vil/16/5920
Tablets IP
Dec07, Nov09
Assay
Betamethasone
NH007, Jan08,
EZ/WB/Kol/
GSK Pharmaceuti-
Sodium Phosphate
Dec09 & NH 213,
MC/16/1962
Tablets IP
Aug08, Jul10
Betamethasone tab-
NB 611, Jul08,
EZ/Assam/Lunding/
GlaxoSmithKline
lets IP
Jun11
Vil/17/381
Pharmaceuticals
Limited, Nasik.
Assay
Assay
Betamethasone tab-
NB 616, Jul08,
WZ/Maharashtra/
GlaxoSmithKline
lets IP
Jun11
Amrawati/DHQ/17/29
Pharmaceuticals
Limited, Nasik.
Assay
Betamethasone tab-
NB 520, Feb08,
NZ/Punjab/Ludhiana/
GlaxoSmithKline
lets IP
Jan11
BC/17/182
Pharmaceuticals
Limited, Nasik.
Assay
Betamethasone tab-
NB 590, Jun08,
SZ/Tamilnadu/
GlaxoSmithKline
lets IP
May11
Thiruthuraipoondi/
Pharmaceuticals
T/17/463
Limited, Nasik.
Assay
Betamethasone tab-
NB 527, Feb08,
SZ/Tamilnadu/
GlaxoSmithKline
lets IP
Jan11
Chennai(J)/
Pharmaceuticals
MC/17/1504
Limited, Nasik.
Assay
Neoloridin
Desloratadine Tab-
ZH 1382, 07/2008,
WZ/Madhya Pradesh/
Cadila Healthcare
Rapitab
lets
06/2010
Sagar/DHQ/18/41
Ltd, Solan, H.P.

Assay
82
Neoloridin
Desloratadine Tab-
ZH 1382, 07/2008,
Cadila Healthcare
Rapitab
lets
06/2010
Vil/18/5189
Ltd, Solan, H.P.

Assay
83
Neoloridin
Desloratadine Tab-
ZH1382 07/2008,
WZ/Chhattisgarh/
Cadila Healthcare
Rapitab
lets
06/2010
Bilaspur/BC/18/64
Ltd, Solan, H.P.

Assay
84
Neoloridin
Desloratadine Tab-
ZH 1382, 07/2008,
SZ/Tamilnadu/
Cadila Healthcare
Rapitab
lets
06/2010
Chennai-U/
Ltd, Solan, H.P.
MC/18/5518
85
Assay
Neoloridin
Desloratadine Tab-
ZH11052 01/2008,
EZ/Assam/Jorhat/
Cadila Healthcare
Rapitab
lets
12/2009
Town/18/628
Ltd, Solan, H.P.

Assay
86
Lorfast
Loratadine Tablets
JK8002 05/2008,
SZ/Tamilnadu/Salem/
Cadila Pharmaceuti-
USP
04/2010
BC/19/17
cals ltd, Jammu

Assay
29
87
Lorfast
Loratadine & Pseu-
JK 8004, Sep08,
WZ/Maharashtra/
Cadila Pharmaceuti-
doephedrine Hyder-
Aug10
Nandurabar/T/19/01
cals ltd, Jammu
ochloride Extended
Assay
Release Tablets
88
Lorfast
Loratadine Tablets
JK8002 05/2008,
Cadila Pharmaceuti-
USP
04/2010 JK7006
Vil/19/5017
cals ltd, Jammu
11/2007, 10/2009
89
Lorfast
Assay
Loratadine Ambrox-
JK8006 10/2008,
Nz/UP/Ghaziabad/
Cadila Pharmaceuti-
ol Tablets
09/2010
DHQ/19/1488
cals ltd, Jammu

Assay
90
Lorfast
Loratadine Tablets
JK8004 09/2008,
EZ/WB/Kolkata/
Cadila Pharmaceuti-
USP
08/2010
MC/19/3377
cals ltd, Jammu

Assay
91
CLARIDIN
Loratadine Tablets
P7337 08/2007,
SZ/Tamilnadu/
Morepen Laborato-
07/2010
Madurai/BC/20/111
ries Ltd, Solan, H.P.

Assay
92
CLARIDIN
Loratadine Tablets
P8267 05/2008,
NZ/Haryana/Hassi/
Morepen Laborato-
04/2011
T/20/48

Assay
93
CLARIDIN
Loratadine Tablets
P7337 08/2007,
WZ/Gujarat/Junagarh/
Morepen Laborato-
07/2010
DHQ/20/05

Assay
94
CLARIDIN
Loratadine Tablets
P7478 10/2007,
EZ/OR/Bedepur/
Morepen Laborato-
09/2010
Vil/20/495

Assay
95
CLARIDIN
Loratadine Tablets
P8027 01/2008,
NZ/UP/Lucknow/
Morepen Laborato-
12/2010
BC/20/472

Assay
96
Cetzine
Cetirizine
L 379, Nov07,
EZ/JH/Ranchi/
Emcure Pharmceuti-
Hydrochloride
Oct10
BC/21/104
cals Ltd., Pune.

Assay
Tablets
97
Cetzine
Cetirizine
L407, Feb08,
NZ/UP/Phulpur/
Emcure Pharmceuti-
Hydrochloride
Jan11
Village/21/311
cals Ltd., Pune.
Tablets
98
Cetzine
Assay
Cetirizine
L 417, Mar08,
WZ/Chhattisgarh/
Emcure Pharmceuti-
Hydrochloride
Feb11
Rajgad/DHQ/21/13
cals Ltd., Pune.
Tablets
99
Cetzine
Cetirizine
L 420, Mar08,
SZ/Andhra Pradesh/
Emcure Pharmceuti-
Hydrochloride
Feb11
Kavali/T/21/4491
cals Ltd., Pune.
Tablets
30
Assay
Assay
100
Cetzine
Cetirizine
L 413, Mar08,
SZ/Tamilnadu/
Emcure Pharmceuti-
Hydrochloride
Feb11
Chennai (B)/
cals Ltd., Pune.
Tablets
101
Cetrizet
MC/21/1081
Cetirizine
GK71145 08/2007,
SZ/Tamilnadu/
Sun Pharmaceuti-
Hydrochloride
07/2010
Chennai/
cals Ind., Jammu
Tablets
102
Cetrizet
Assay
MC/22/5141
Assay
Cetirizine Hydro-
GK61376 10/2006,
NZ/Haryana/Rohtak/
Sun Pharmaceuti-
chloride Tablets
09/2009
BC/22/332
cals Ind., Jammu

Assay
103
Cetrizet
Cetirizine Hydro-
GK70475 04/2007,
SZ/Tamilnadu/
Sun Pharmaceuti-
chloride Tablets
03/2010
Thanjavur/
cals Ind., Jammu
DHQ/22/308
104
Cetrizet
Cetirizine Hydro-
GK80588 05/2008,
chloride Tablets
04/2011
NZ/UP/Loni/T/22/893
Assay
Sun Pharmaceuti-
cals Ind., Jammu

Assay
105
Cetrizet
Cetirizine Hydro-
GK71145 08/2007,
Sun Pharmaceuti-
chloride Tablets
07/2010 &
Vil/22/849
cals Ind., Jammu
GK80588, 05/2008,
Assay
04/2011
106
Zyncet
Cetirizine Hydro-
BZN07004 11/2007,
EZ/OR/Balasore/
chloride Tablets
10/2010
DHQ/23/139
Unichem, Baddi

Assay
107
Zyncet
Cetirizine Hydro-
BZN08002 01/2008,
EZ/wb/Kolkata/
chloride Tablets
12/2010
MC/23/67
Unichem, Baddi

Assay
108
Zyncet
Cetirizine Hydro-
BZN07004 11/2007,
SZ/Kerala/Village/
chloride Tablets
10/2010
Vil/23/2430
Unichem, Baddi

Assay
109
110
111
Zyncet
Zyncet
Avil
Cetirizine Hydro-
BZN08002 01/2008,
SZ/Andhra Pradesh/
chloride Tablets
12/2010
Narsi Patanam/
T/23/2615
Assay
Unichem, Baddi
Cetirizine Hydro-
BZN08002 01/2008,
NZ/Chandigarh
chloride Tablets
12/2010
Admn./Chandigarh/
BC/23/26
Assay
Unichem, Baddi
Pheniramine
027088 12/2007,
EZ/WB/Kol/
Aventis Pharma
Maleate Tablets IP
11/2011
MC/24/1475
Ltd, Ankleshwar

Assay
112
Avil
Pheniramine
028039 07/2008,
WZ/Chhattisgarh/
Aventis Pharma
Maleate Tablets IP
02/2012
Bilaspur/BC/24/38
Ltd, Ankleshwar

Assay
31
113
Avil
Pheniramine
028020 03/2008,
EZ/BR/Danapur/
Aventis Pharma
Maleate Tablets IP
02/2012
DHQ/24/759
Ltd, Ankleshwar

Assay
114
Avil
Pheniramine
027012 01/2007,
NZ/UP/Phaphaman/
Aventis Pharma
Maleate Tablets IP
12/2010
Vil/24/110
Ltd, Ankleshwar

Assay
115
Avil
Pheniramine
027063 09/2007,
SZ/Tamilnadu
Aventis Pharma
Maleate Tablets IP
02/2011
Nagerwil/T/24/675
Ltd, Ankleshwar

Assay
116
Amlosafe
Amlodipine
11803D8M 04/2008,
WZ/Chhattisgarh/
Aristo Pharamceuti-
Besilate Tablets
03/2010
Ambikapur/
cals Pvt. Ltd, M.P.
DHQ/25/31
117
Amlosafe
Assay
Amlodipine
11701G8M 07/2008,
SZ/Tamilnadu/
Aristo Pharamceuti-
Besilate Tablets
06/2010
Chennai (S)/
cals Pvt. Ltd, M.P.
MC/25/5289
118
119
Amlosafe
Amlosafe
Assay
Amlodipine Besilate
11701B8 02/2008,
NZ/Uttaranchal/
Aristo Pharamceuti-
Does not conform with
Tablets
01/2010
Dehradun/BC/25/499
cals Pvt. Ltd, M.P.
respect to Assay (84.8%)
Amlodipine
11801G8M, Jul08,
WZ/Chhattisgarh/
Aristo Pharamceuti-
Besilate Tablets
Jun10
Jagadalpur/Vil/25/04
cals Pvt. Ltd, M.P.

Assay
120
Amlosafe
Amlodipine
11803F8M 06/2008,
EZ/WB/Budge Budge/
Aristo Pharamceuti-
Besilate Tablets
05/2010 11804D8M
T/25/3353
cals Pvt. Ltd, M.P.
04/2008, 03/2011
121
Amlopres
Assay
Amlodipine
D82678 05/2008,
WZ/Maharashtra/
Atenolol Tablets
04/2011 D82571
Nasik/T/26/28
Cipla Ltd, Solan
Assay
05/2008, 04/2011
122
Amlopres

Amlodipine
D82146, Mar08,
SZ/Andhra Pradesh/
Besilate Tablets
Feb11
Nellore/DHQ/26/2723
Cipla Ltd, Solan

Assay
123
Amlopres
Amlodipine
D71125 04/2007,
EZ/OR/Beshupur/
Besilate Tablets
03/2010
Vil/26/18
Cipla Ltd, Solan

Assay
124
Amlopres
Amlodipine
D83005 07/2008,
NZ/UP/Lucknow/
Besilate Tablets
06/2011
BC/26/340
Cipla Ltd, Solan

Assay
125
Amlopres
Amlodipine
D83371 08/2008,
EZ/WB/Kolkata/
Besilate Tablets
07/2011
MC/26/830
Cipla Ltd, Solan

Assay
32
126
Amdepin
Amlodepine
JK8004, May08,
WZ/Madhya Pradesh/
Cadila Pharmaceuti-
Besilate Tablets
Apr10
Sagar/DHQ/27/39
cals ltd, Jammu

Assay
127
Amdepin
Amlodepine
JK8003, Apr08,
SZ/Tamilnadu/
Cadila Pharmaceuti-
Besilate Tablets
Mar10
Chennai-U/
cals ltd, Jammu
MC/27/5525
128
Amdepin
Assay
Amlodepine
JK8003, Apr08,
Cadila Pharmaceuti-
Besilate Tablets
Mar10
Vil/27/797
cals ltd, Jammu

Assay
129
Amdepin
Amlodepine
JK8004, Jun08,
NZ/UP/Reti Street/
Cadila Pharmaceuti-
Besilate Tablets
May10
T/27/600
cals ltd, Jammu

Assay
130
Amdepin
Amlodepine
JK 8005, Jul08,
EZ/BR/Patna/
Cadila Pharmaceuti-
Besilate Tablets
Jun10
BC/27/440
cals ltd, Jammu

Assay
131
Tenolol-50
Atenolol Tablets IP
HO8002AK,
NZ/Uttarakhand/
Ipca Laboratories
Apr08, Mar12
Srinagar/T/28/82
Ltd., Dehradun.

Assay
132
Tenolol-50
Atenolol Tablets IP
HO8001AK,
WZ/Maharashtra/
Ipca Laboratories
Feb08, Jan12
Raigad/Vil/28/42
Ltd., Dehradun.

Assay
133
Tenolol-50
Atenolol Tablets IP
HO8003AK,
SZ/Andhra Pradesh/
Ipca Laboratories
Apr2008, Mar2012
Vijayawada/
Ltd., Dehradun.
BC/28/3563
134
Tenolol-50
Atenolol Tablets IP
Assay
HO8002AK,
EZ/BR/Muzaffarpur/
Ipca Laboratories
Apr08, Mar12
DHQ/28/376
Ltd., Dehradun.

Assay
135
Tenolol-50
Atenolol Tablets IP
HO8003AK,
EZ/WB/Kolkata/
Ipca Laboratories
Apr2008, Mar2012
MC/28/635
Ltd., Dehradun.

Assay
136
ATEN-50
Atenolol Tablets IP
ZH1558, 09/2008,
50 mg
08/2011
SZ/Village/Vil/29/5968
Cadila Healthcare
Ltd, Baddi, H.P.

Assay
137
ATEN-50
Atenolol Tablets IP
ZH1307, 05/2008,
SZ/Kerala/Aluva/
Cadila Healthcare
50 mg
04/2011
T/29/2227
Ltd, Baddi, H.P.

Assay
138
ATEN-50
Atenolol Tablets IP
ZH1558, 09/2008,
WZ/Maharashtra/
Cadila Healthcare
50 mg
08/2011
Chandrapur/
Ltd, Baddi, H.P.
DHQ/29/40
Assay
33
139
ATEN-50
Atenolol Tablets IP
ZH1178, 03/2008,
NZ/Punjab/Ludhiana/
Cadila Healthcare
50 mg
02/2011
BC/29/246
Ltd, Baddi, H.P.

Assay
140
ATEN-50
Atenolol Tablets IP
ZH1381, 08/2008,
EZ/WB/Kolkata/
Cadila Healthcare
50 mg
07/2011
MC/29/1215
Ltd, Baddi, H.P.

Assay
141
ZIBLOK 50
Atenolol Tablets IP
JDT8031, 03/2008,
NZ/Haryana/
50 mg
02/2010
Ballabgarh/T/30/163
FDC Ltd, Goa

Assay
142
ZIBLOK 50
Atenolol Tablets IP
JDT8051, 05/2008,
50 mg
04/2010
Vil/30/629
FDC Ltd, Goa

Assay
143
ZIBLOK 50
Atenolol Tablets IP
JDT8052, 05/2008,
WZ/Chhattisgarh/
50 mg
04/2010
Bilaspur/BC/30/25
FDC Ltd, Goa

Assay
144
145
ZIBLOK 50
ZIBLOK 50
Atenolol Tablets IP
JDT7111, 11/2007,
SZ/Tamilnadu/
50 mg
10/2009
Chennai/(H)/
MC/30/1364
Assay
Atenolol Tablets IP
JDT7121, 12/2007,
EZ/BR/Muzaffarpur/
50 mg
11/2009
DHQ/30/367
FDC Ltd, Goa
FDC Ltd, Goa

Assay
146
ZIVAST-10
Atorvastatin
AWT8071, 07/2008,
SZ/Tamilnadu/
Tablets IP 10 mg
06/2010
Villupuram/T/31/1652
FDC Ltd, Goa

Assay
147
ZIVAST-10
Atorvastatin
AWT8071, 07/2008,
NZ/Delhi/Delhi/
Tablets IP 10 mg
06/2010
MC/31/305
FDC Ltd, Goa

Assay
148
ZIVAST-10
Atorvastatin T
AWT8081, 08/2008,
WZ/Maharashtra/
ablets IP 10 mg
07/2010
Nagpur/BC/31/64
FDC Ltd, Goa

Assay
149
ZIVAST-10
Atorvastatin Tablets
AWT8041, 04/2008,
WZ/Maharashtra/
IP 10 mg
03/2010 AWT8031
Raigad/Vil/31/43
FDC Ltd, Goa
03/2008, 02/2010
150
ZIVAST-10
Assay
Atorvastatin
AWT8011, 01/2008,
WZ/Gujarat/Mehsana/
Tablets IP 10 mg
12/2009 AWT7111,
DHQ/31/9
FDC Ltd, Goa
Assay
Atherochek-
Atrovastatin
KB1E8V, May08,
NZ/Rajasthan/
Indoco Remedies
10
Methylcoblamin-Fo-
Oct09
Suratgarh/T/32/482
Ltd., Aurangabad.
lic Acid B6
34

11/2007, 10/2009
151
Assay
152
Atherochek-
Atrovastatin
KB1E8V, May08,
SZ/Karnataka/Kocari/
Indoco Remedies
10
Methylcoblamin-Fo-
Oct09
DHQ/32/4146
Ltd., Aurangabad.
lic Acid B6
153
Assay
Atherochek-
Atrovastatin Meth-
KB1E8V, May08,
EZ/OR/Nimapara/
Indoco Remedies
10
ylcoblamin-Folic
Oct09
Vil/32/537
Ltd., Aurangabad.
respect to Assay (86%)
Atrovastatin
KB1E8V, May08,
WZ/Marahastra/
Indoco Remedies
Methylcoblamin-Fo-
Oct09
Aurangabad/
Ltd., Aurangabad.
Acid B6
154
Atherochek-10
lic Acid B6
155
BC/32/31
Assay
Atherochek-
Atrovastatin
KB1E8V, May08,
EZ/WB/Kolkata/
Indoco Remedies
10
Methylcoblamin-Fo-
Oct09
MC/32/1704
Ltd., Aurangabad.
respect to Assay (89.3%)
Atorvastatin
T00208, 04/2008,
EZ/BR/Ara/
Solrex Pharmaceu-
Calcium Tablets
03/2010 & T00108,
DHQ/33/405
ticals Co. Baddi,
HP. For Ranbaxy
Assay
lic Acid B6
156
Storvas-10
04/2008, 03/2010
Laboratories Ltd.,
New Delhi.
157
Storvas-10
Atorvastatin
T00108, 04/2008,
WZ/Maharashtra/
Solrex Pharmaceu-
Calcium Tablets
03/2010 7 903559,
Pune/BC/33/33
ticals Co. Baddi,
HP. For Ranbaxy
Assay
11/2007, 10/2009
Laboratories Ltd.,
New Delhi.
158
Storvas-10
Atorvastatin
T00108, 04/2008,
NZ/Raj/Mohar/
Solrex Pharmaceu-
Calcium Tablets
03/2010
T/33/116
ticals Co. Baddi,
HP. For Ranbaxy
Assay
Laboratories Ltd.,
New Delhi.
159
Storvas-10
Atorvastatin
T01508, 06/2008,
WZ/Maharashtra/
Solrex Pharmaceu-
Calcium Tablets
05/2010
Amrwati/Vil/33/26
ticals Co. Baddi,
HP. For Ranbaxy
Assay
Laboratories Ltd.,
New Delhi.
160
Storvas-10
Atorvastatin
T00708, 05/2008,
SZ/Tamilnadu/
Solrex Pharmaceu-
Calcium Tablets
04/2010
Chennai-Q/
ticals Co. Baddi,
MC/33/5480
HP. For Ranbaxy
Assay
Laboratories Ltd.,
New Delhi.
161
162
Glyciphage
Glyciphage
Metformin
8114, 04/2008,
WZ/Maharashtra/
Frano-Indian Phar-
Tablets IP
03/2011
Mumbai/MC/34/443
maceuticals Pvt.
Ltd, Mumbai
Assay
Metformin
8027, 01/2008,
EZ/Jharkhand/
Frano-Indian Phar-
Tablets IP
12/2010
Lohardaga/
maceuticals Pvt.
DHQ/34/144
Ltd, Mumbai
Assay
35
163
164
165
166
Glyciphage
Glyciphage
Glyciphage
Glycomet
Metformin
R6055, 11/2006,
NZ/Punjab/Rajpura/
Frano-Indian Phar-
Tablets IP
10/2009
T/34/58
maceuticals Pvt.
Ltd, Mumbai
Assay
Metformin
PT8013, 07/2008,
NZ/Rajasthan/
Frano-Indian Phar-
Tablets IP
06/2011
Ratidpura/Vil/34/371
maceuticals Pvt.
Ltd, Mumbai
Assay
Metformin
M8099, 09/2008,
SZ/Karnataka/
Frano-Indian Phar-
Tablets IP
08/2011
Bangalore-South/
maceuticals Pvt.
BC/34/3939
Ltd, Mumbai
Assay
USV Ltd., Banglore.
Metformin
13001909, 10/2007,
EZ/WB/Kol/
Hydrochloride Tab-
09/2010
MC/35/1968
lets IP
167
Glycomet
Assay
Metformin
33000109, Jun08,
WZ/Goa/Panji/
Hydrochloride Tab-
May11
BC/35/37
USV Ltd., HP.
lets IP
168
Glycomet
Assay
Metformin
28000965, 01/2008,
EZ/Nagaland/Kohima/
Hydrochloride Tab-
12/2010
DHQ/35/204
USV Ltd., HP.
Glycomet
Assay
Metformin
33000125, Jul08,
NZ/Uttarakhand/
Hydrochloride Tab-
Jun11
Barinag/T/35/226
USV Ltd., HP.
Glycomet
Assay
Metformin
28001143, Apr08,
Hydrochloride Tab-
Mar11
Vil/35/4745
USV Ltd., HP.
Gluformin

lets IP
171

lets IP
170

lets IP
169
Assay
Metformin
GFA 7013, 03/2007,
WZ/Maharashtra/
Nicholas Piramal
Tablets IP
02/2010
Nandurbar/T/36/23
(India) Ltd., H.P.

Assay
172
Gluformin
Metformin
GFA 8020, 07/2008,
WZ/MP/Tikamgarh/
Nicholas Piramal
Tablets IP
06/2011
DHQ/36/08
(India) Ltd., H.P.

Assay
173
Gluformin
Metformin
GFA 8012, 04/2008,
EZ/WB/Barrackpore/
Nicholas Piramal
Tablets IP
03/2011
MC/36/3475
(India) Ltd., H.P.

Assay
174
Gluformin
Metformin
GFA 8013, 06/2008,
SZ/Kerala/Village/
Nicholas Piramal
Tablets IP
05/2011
Vil./36/5732
(India) Ltd., H.P.

Assay
175
Gluformin
Metformin
GFA8015 06/2008,
NZ/Uttarakhand/
Nicholas Piramal
Tablets IP
05/2011
Pithoragarh/
(India) Ltd., H.P.
BC/36/127
36
Assay
176
177
178
179
180
181
Glizide-80
Glizide-80
Glizide-80
Glizide-80
Glizide-80
Gliclazide
1048502, 05/2008,
Tablets BP
04/2011
NZ/UP/Town/T/37/899
Panacea Biotec Ltd.,
Dist. Solan, Nal-
agarh.
Assay
Gliclazide
1048505, 09/2008,
EZ/WB/Kolkata/
Tablets BP
04/2011
MC/37/2957
Dist. Solan, Nal-
agarh.
Assay
Gliclazide
1047504, 09/2007,
NZ/Punjab/Sherpur/
Tablets BP
08/2010
Vil/37/124
Dist. Solan, Nal-
agarh.
Assay
Gliclazide
1048502, 05/2008,
SZ/Tamilnadu/Saton/
Tablets BP
04/2011
BC/37/33
Dist. Solan, Nal-
agarh.
Assay
Gliclazide
1046510, 02/2007,
WZ/Madhya
Tablets BP
01/2010
Pradesh/Tikamgarh/
Dist. Solan, Nal-
DHQ/37/17
agarh.
Assay
Glycigon
Gliclazide
58L018, 05/2008,
WZ/Maharashtra/
Aristo Pharamaceu-
Tablets
Tablets BP 80 mg
10/2010
Mumbai/MC/38/702
ticals Pvt. Ltd, M.P.

Assay
182
183
Glycigon
Gliclazide
58D017, 04/2007,
NZ/Haryana/
Aristo Pharamaceu-
Tablets
Tablets BP 80 mg
09/2009, 58E028,
Faridabad/
05/2008, 10/2010
DHQ/38/143
Assay
Glycigon
Gliclazide
58G017, 07/2007,
SZ/Kerala/Village/
Aristo Pharamaceu-
Tablets
Tablets BP 80 mg
12/2009
Vil/38/5734

Assay
184
Glycigon
Gliclazide
58D027, 04/2007,
SZ/Tamilnadu/
Aristo Pharamaceu-
Tablets
Tablets BP 80 mg
09/2009
Virudhachalam/T/

Assay
38/3175
185
Glycigon
Gliclazide
58L017, 11/2007,
EZ/Jharkhand/
Aristo Pharamaceu-
Tablets
Tablets BP 80 mg
04/2010
Dhanbad/BC/38/235

Assay
186
187
188
Reclide
Reclide
Reclide
Gliclazide
V80282, Jul08,
EZ/WB/Siliguri/
Dr. Reddys Labo-
Tablets BP 80 mg
Jun10
DHQ/39/460
ratories Ltd., Baddi,
HP.
Assay
Gliclazide
V80282, Jul08,
NZ/Rajasthan/
Dr. Reddys Labo-
Tablets BP 80 mg
Jun10
Rawatsar/T/39/262
HP.
Assay
Gliclazide
V80309, Jul2008,
WZ/Maharashtra/
Dr. Reddys Labo-
Tablets BP 80 mg
Jun2010
Mumbai/MC/39/574
HP.
Assay
37
189
190
191
Reclide
Reclide
Glimiprex 2
Gliclazide
V80150, Apr08,
WZ/Gujrat/Jamnagar/
Dr. Reddys Labo-
Tablets BP 80 mg
Mar10
Vil/39/32
HP.
Assay
Gliclazide
V80263, Jun08,
SZ/Karnataka/
Dr. Reddys Labo-
Tablets BP 80 mg
May10
Dharwad/BC/39/4043
HP.
Assay
Glimepiride
21502F7, 06/2007,
WZ/Madhya
Aristo Pharamaceu-
Tablets 2mg
05/2010
Pradesh/Tikamgarh
/DHQ/40/56
192
Glimiprex 2
Assay
Glimepiride
21504F7, 06/2007,
SZ/Karnataka/Mysore/
Aristo Pharamaceu-
Tablets 2mg
05/2010
BC/40/4655

Assay
193
Glimiprex 2
Glimepiride
21502E8M, 05/2007,
NZ/Rajasthan/
Aristo Pharamaceu-
Tablets 2mg
04/2011
Suratgarh/T/40/632

Assay
194
Glimiprex 2
Glimepiride
21501F7, 06/2007,
NZ/Punjab/Sherpur/
Aristo Pharamaceu-
Tablets 2mg
05/2010
Vil/40/392

Assay
195
Glimiprex 2
Glimepiride
21501HM, 08/2007,
EZ/WB/Kolkata/
Aristo Pharamaceu-
Tablets 2mg
07/2010
MC/40/1219

Assay
196
Amaryl-2
Glimepiride
298023, 10/2008,
EZ/WB/Hasnabad/
Aventis Pharma
Tablets 2mg
09/2010
Vil/41/2239
Ltd, Goa

Assay
197
Amaryl-2
Glimepiride
298005, 03/2008,
WZ/Gujarat/Jamnagar/
Aventis Pharma
Tablets 2mg
02/2010
T/41/17
Ltd, Goa

Assay
198
Amaryl-2
Glimepiride
298003, 01/2008,
NZ/Uttarakhand/
Aventis Pharma
Tablets 2mg
12/2009
Rudrapur/
Ltd, Goa
DHQ/41/411
199
Amaryl-2
Assay
Glimepiride
297043, 11/2007,
NZ/Punjab/Ludhiana/
Aventis Pharma
Tablets 2mg
10/2009
BC/41/86
Ltd, Goa

Assay
200
Amaryl-2
Glimepiride
298011, 06/2008,
SZ/Tamilnadu/
Aventis Pharma
Tablets 2mg
05/2010,
Chennai-U/
Ltd, Goa
298016, 08/2008,
MC/41/5538
Assay
07/2010
201
Glyree-2
Glimepiride
Y78003 R, Apr08,
EZ/WB/Burdwar/
Ipca Laboratories
Tablets IP 2mg
Mar10
T/42/1018
Ltd., Mumbai.

Assay
38
202
Glyree-2
Glimepiride
Y78001 R, Jan08,
WZ/Madhya Pradesh/
Ipca Laboratories
Tablets IP 2mg
Dec09
Ujjain/Vil/42/35
Ltd., Mumbai.

Assay
203
Glyree-2
Glimepiride
Y78002 R, Mar08,
SZ/Kerala/Pacakad/
Ipca Laboratories
Tablets IP 2mg
Feb10
DHQ/42/2781
Ltd., Mumbai.

Assay
204
Glyree-2
Glimepiride
Y78003 R, Apr08,
NZ/Punjab/Patiala/
Ipca Laboratories
Tablets IP 2mg
Mar10
BC/42/434
Ltd., Mumbai.

Assay
205
Glyree-2
Glimepiride
Y78002 R, Mar08,
NZ/NCT Delhi/DL/
Ipca Laboratories
Tablets IP 2mg
Feb10
MC/42/534
Ltd., Mumbai.

Assay
206
Lariago
Chloroquine
C68021R, Apr-2008,
NZ/UP/
Ipca laboratories
Phosphate
Mar-2011
Mohammadpur/
Ltd., Ratlam
Tables IP
207
Lariago
Vil/43/731
Assay
Chloroquine
C68045R, 06/2008,
EZ/WB/Habra/
Ipca laboratories
Phosphate
05/2011
T/43/2333
Ltd., Ratlam
Tables IP
208
Lariago
Assay
Chloroquine
C67042 R,
WZ/Madhya
Ipca laboratories
Phosphate
Aug.2007, July 2010
Pradesh/Chhindwara/
Ltd., Ratlam
Tables IP
209
Lariago
DHQ/43/149
Chloroquine
C68012R, Mar
SZ/Tamilnadu/
Ipca laboratories
Phosphate
2008, Feb 2011
Chennai (F)/
Ltd., Ratlam
Tables IP
210
Lariago
Assay
MC/43/1288
Assay
Chloroquine
C68024 R, Apr-
WZ/Gujarat/Surat/
Ipca laboratories
Phosphate
2008, Mar-2011
BC/43/31
Ltd., Ratlam

Assay
Tables IP
211
212
213
214
Reziz
Reziz
Reziz
Reziz
Pyrimethamine and
R08415119,
NZ/NCT Delhi/Delhi/
Shreya Life Sciences
Sulphadoxine I.P.
Sep2008, Aug2010
MC/44/675
Pvt. Ltd., Uttara-
khand.
Assay
Pyrimethamine and
R08415112, Aug08,
NZ/Haryana,
Sulphadoxine I.P.
Jul10
Faridabad/
Pvt. Ltd., Uttara-
DHQ/44/542
khand.
Assay
Pyrimethamine and
R08415112, Aug08,
SZ/Andhra Pradesh/
Sulphadoxine I.P.
Jul10
LUDRA/T/44/3426
Pvt. Ltd., Uttara-
khand.
Assay
Pyrimethamine and
SE0847102,
WZ/Maharashtra/
Sulphadoxine I.P.
Feb2008, Jan2010
Solapur/Vil/44/08
Pvt. Ltd., Uttara-
khand.
Assay
39
215
216
217
218
219
220
221
Reziz
Nimulid
Nimulid
Nimulid
Nimulid
Nimulid
Nicip
Pyrimethamine and
R08415117, Aug08,
EZ/Jharkhand/
Sulphadoxine I.P.
Jul10
Jamshedpur/
Pvt. Ltd., Uttara-
BC/44/348
khand.
Assay
0388509, 05/2008,
SZ/Tamilnadu/
04/2013
Kanyakumari/
Dist. Solan, Nal-
DHQ/45/4948
agarh.
Assay
0388520, 07/2008,
EZ/WB/Kol/
05/2013
MC/45/1559
Dist. Solan, Nal-
agarh.
Assay
Nimesulide Tablets
Nimesulide Tablets
Nimesulide Tablets
Nimesulide Tablets
Nimesulide Tablets
0387537, 01/2008,
NZ/Rajasthan/
12/2011
Suratgar/T/45/505
Dist. Solan, Nal-
agarh.
Assay
0388510, 05/2008,
EZ/WB/Chatpura/
04/2013
Vil/45/2273
Dist. Solan, Nal-
agarh.
Assay
0388512, 06/2008,
SZ/Tamilnadu/
12/2012
Tirvnelveli/BC/45/232
Dist. Solan, Nal-
agarh.
Assay
Nimesulide Tablets
DD8220, 04/2008,
NZ/NCT Delhi/DL/
Cipla Ltd, Baddi,
100 mg
03/2011
MC/46/646
H.P.

Assay
222
Nicip
Nimesulide Tablets
DD8280, 05/2008,
Cipla Ltd, Baddi,
100 mg
04/2011
Vil/46/826
H.P.

Assay
223
Nicip
Nimesulide Tablets
DD8144, 01/2008,
EZ/AP/Itanagar/
Cipla Ltd, Baddi,
100 mg
12/2010
BC/46/108
H.P.

Assay
224
Nicip
Nimesulide Tablets
DD8358, 06/2008,
EZ/Nagaland/Kohima/
Cipla Ltd, Baddi,
100 mg
05/2011
DHQ/46/186
H.P.

Assay
225
Nicip
Nimesulide Tablets
DD7168, 05/2007,
WZ/Gujarat/
Cipla Ltd, Baddi,
100 mg
04/2010
Porbandar/T/46/34
H.P.

Assay
226
227
40
Nise
Nise
Nimusulide Tabelts
V80573, Sep08,
EZ/WB/Grarapota
Dr. Reddys Labo-
100mg.
Aug11
Bazar/Vil/47/2199
HP.
Assay
Nimusulide Tabelts
V80484, Sep08,
EZ/WB/Kolkatta/
Dr. Reddys Labo-
100mg.
Aug11
MC/47/832
HP.
Assay
228
229
230
231
Nise
Nise
Nise
Crocin
Nimusulide Tabelts
V80426, Aug08,
NZ/J&K/Sanjay Nagar/
Dr. Reddys Labo-
100mg.
Jul11
T/47/163
HP.
Assay
Nimusulide Tabelts
V80521, Sep08,
SZ/Andhra
Dr. Reddys Labo-
100mg.
Aug11
Pradesh/Srikakulam/
DHQ/47/3761
HP.
Assay
Nimusulide Tabelts
V80468, Aug08,
WZ/Maharashtra/
Dr. Reddys Labo-
100mg.
Jul11
Thane/BC/47/43
HP.
Assay
Paracetamol
R8133, May08,
SZ/Tamilnadu/
Remidex Pharma
Tables IP 500mg
Apr11
Thiruvarur/T/48/3245
Pvt. Ltd., Banglore.

Assay
232
Crocin
Paracetamol
R8284, Aug08,
EZ/WB/Nalikul/
Remidex Pharma
Tables IP 500mg
Jul11
Vil/48/2085

Assay
233
Crocin
Paracetamol
R8169 & R8109,
WZ/Madhya Pradesh/
Remidex Pharma
Tables IP 500mg
Jun08, May11 &
Bhopal/BC/48/06
Apr08, Mar11
234
Crocin
Assay
Paracetamol
R8206, Jul08,
EZ/WB/Kolkata/
Remidex Pharma
Tables IP 500mg
Jun11
MC/48/183

Assay
235
Crocin
Paracetamol
R8303, Aug08,
NZ/UP/Ghaziabad/
Remidex Pharma
Tables IP 500mg
Jul11
DHQ/48/1160

Assay
236
Pacimol
Paracetamol Tables
GR7078Q, Jul07,
SZ/Kerala/Attingal/
Ipca Laboratories
IP
Jun10
T/49/2280
Ltd., Gujarat.

Assay
237
Pacimol
Paracetamol Tables
GR8050Q, May08,
EZ/WB/Barrackpore/
Ipca Laboratories
IP
Apr11
MC/49/3486
Ltd., Gujarat.

Assay
238
Pacimol
Paracetamol Tables
GR8089Q, Jul08,
WZ/Gujarat/
Ipca Laboratories
IP
Jun11
Ahmedabad/
Ltd., Gujarat.
BC/49/132
239
Pacimol
Assay
Paracetamol Tables
GR8067Q, Jun08,
NZ/Haryana/Narnu/
Ipca Laboratories
IP
May11
DHQ/49/72
Ltd., Gujarat.

Assay
240
Pacimol
Paracetamol Tables
GR8018Q, Apr08,
Ipca Laboratories
IP
mar11
Vil/49/4556
Ltd., Gujarat.

Assay
41
241
Paracip
Paracetamol
DD7510, 09/2007,
EZ/Meghalaya/
Tablets IP 500mg
08/2010
Shillong/BC/50/244
Cipla Ltd, Baddi

Assay
242
Paracip
Paracetamol
DF8369, 08/2008,
WZ/Maharashtra/
Tablets IP 500mg
07/2011
Mumbai/MC/50/845
Cipla Ltd, Baddi

Assay
243
Paracip
Paracetamol
DF 8020, Jan08,
WZ/Gujarat/Mehsana/
Tablets IP 500mg
Dec10
Vil/50/14
Cipla Ltd, Baddi

Assay
244
Paracip
Paracetamol
DD7524, 09/2007,
SZ/Tamilnadu/
Tablets IP 500mg
08/2010
Ulundurpet/T/50/3038
Cipla Ltd, Baddi

Assay
245
Paracip
Paracetamol
DF8109, 04/2008,
NZ/Uttarakhand/
Tablets IP 500mg
03/2011
Haridwar/DHQ/50/67
Cipla Ltd, Baddi

Assay
246
247
248
249
250
251
Calpol Tab-
Paracetamol
EN444, Jan08,
NZ/Punjab/Patiala/
GlaxoSmithKline
lets
Tablets IP 500mg
Dec10
BC/51/217
Pharmaceuticals
Limited, Mumbai.
Assay
Calpol Tab-
Paracetamol
EN572, Jun08,
WZ/Maharashtra/
GlaxoSmithKline
lets
Tablets IP 500mg
May11
Mumbai/MC/51/9541
Pharmaceuticals
Limited, Mumbai.
Assay
Calpol Tab-
Paracetamol
EN575, Jun08,
SZ/Andhra Pradesh/
GlaxoSmithKline
lets
Tablets IP 500mg
May11
NPCCORT/
Pharmaceuticals
DHQ/51/4477
Limited, Mumbai.
Assay
Calpol Tab-
Paracetamol
EN543, May08,
WZ/Maharashtra/
GlaxoSmithKline
lets
Tablets IP 500mg
Arp11
Raigad/Vill/51/16
Pharmaceuticals
Limited, Mumbai.
Assay
Calpol Tab-
Paracetamol
EN651, Aug08,
EZ/Assam/Tinsukia/
GlaxoSmithKline
lets
Tablets IP 500mg
Jul11
T/51/575
Pharmaceuticals
Limited, Mumbai.
Assay
Brufen
Ibuprofen Tablets
67808D7, 07/2008,
WZ/Gujarat/
Abbott India Ltd.,
IP
06/2011
Mahasana/Vill/52/09
Goa.

Assay
252
Brufen
Ibuprofen Tablets
67802DT, 07/2008,
NZ/J&K/Jammu/
Abbott India Ltd.,
IP
06/2011
BC/52/220
Goa.

Assay
253
Brufen
Ibuprofen Tablets
67808D7, 07/2008,
SZ/Tamil Nadu/
Abbott India Ltd.,
IP
06/2011
Poonambulure/
Goa.
T/52/3014
42
Assay
254
Brufen
Ibuprofen Tablets
SC 178, Oct07,
SZ/Tamilnadu/
Briocia Pharma In-
IP
Sep10 & TCC 052,
Chennai (B)/
dia Pvt. Ltd., Jejuri.
Mar08, Feb11
MC/52/1107
& Briocia Pharma
Assay
India Pvt. Ltd., Rajpipla, Gujarat.

255
Brufen
Ibuprofen Tablets
67803D7, 07/2008,
EZ/WB/Bankura/
Abbott India Ltd.,
IP
06/2011
DHQ/52/2813
Goa.

Assay
256
Ibugesic
Ibuprofen Tablets
DA 7671, Sep07,
WZ/Maharashtra/
IP 400 mg
Aug10 & DA
Mumbai/MC/53/156
Cipla Ltd, Daman.
7576, Aug07, Jul10

257
Ibugesic

Assay
Ibuprofen Tablets
DA7674, 09/2007,
SZ/Kerala/Village/
IP 400 mg
08/2010
Vil/53/5714
Cipla Ltd, Daman.

Assay
258
Ibugesic
Ibuprofen Tablets
DA7670, 09/2007
EZ/Assam/Sonitpur/
IP 400 mg
08/2010,
T/53/233
Cipla Ltd, Daman.

Assay
259
260
Ibugesic
Ibugesic
Ibuprofen Tablets
DJ 8477, May08,
SZ/Tamil Nadu/
IP 200 mg
Apr11
Cuddalore/
DHQ/53/372
Assay
Ibuprofen Tablets
DJ 8349, Apr08,
NZ/UP/Varanasi/
IP 400 mg
Mar11
BC/53/873
Cipla Ltd, Daman.
Cipla Ltd, Daman.

Assay
261
R-Cinex
Rifampin & Isoni-
J080889, 07/2008,
NZ/Punjab/Jalandhar/
Lupin Ltd., Jammu,
zide Capsules USP
06/2010 & J080893,
BC/54/395
J & K.
07/2008, 06/2010
262
R-Cinex
Assay
Rifampin &
J080889, 07/2008,
EZ/WB/Kolkata/
Lupin Ltd., Jammu,
Isonizide
06/2010
MC/54/475
J & K.
Capsules USP
263
R-Cinex
Assay
Rifampin &
EF80026, 09/2008,
Lupin Ltd., Aurang-
Isonizide
08/2010
Vil/54/5052
abad.

Assay
Capsules USP
264
R-Cinex
Rifampin &
EF80020, 08/2008,
WZ/Gujarat/Mehsana/
Lupin Ltd., Aurang-
Isonizide
07/2010
T/54/28
abad.
Capsules USP
265
R-Cinex
Assay
Rifampin &
J080892, 07/2008,
NZ/Haryana/Panipat/
Lupin Ltd., Jammu,
Isonizide
06/2010
DHQ/54/146
J & K.
Capsules USP
Assay
43
266
Rimactazid
Rifampicin &
RZ8A07L, 01/2008,
EZ/WB/Siliguri/
Novartis India Lim-
Isonizide Tablets
09/2010
DHQ/55/462
ited, Sandoz Busi-
ness Unit, Maval,
Assay
Pune.
267
Rimactazid
Rifampicin &
RZ7F32L, 06/2007,
NZ/Rajasthan/Bhooha/
Novartis India Lim-
Isonizide Tablets
04/2010
T/55/391
ited, Sandoz Busi-
ness Unit, Maval,
Assay
Pune.
268
Rimactazid
Rifampicin &
RZ8A07L, 01/2008,
EZ/WB/Kolkata/
Novartis India Lim-
Isonizide Tablets
09/2010
MC/55/2940
ited, Sandoz Busi-
ness Unit, Maval,
Assay
Pune.
269
Rimactazid
Rifampicin &
RD8A02L,
WZ/Chhattisgarh/
Novartis India Lim-
Isonizide Tablets
Jan2008, Sep2010
Raipur/BC/55/87
ited, Sandoz Busi-
ness Unit, Maval,
Assay
Pune.
270
Rimactazid
Rifampicin &
RD7G13L, Jul2007,
Novartis India Lim-
Isonizide Tablets
Apr2010
Vil/55/5222
ited, Sandoz Busi-
ness Unit, Maval,
Assay
Pune.
271
AKT-4
(a)Ethambutol
J080139, 01/2008,
EZ/JH/Raturoad/
Lupin Ltd., Jammu,
Hydrochloride and
12/2009
T/56/20
J & K.
Isonizid Tablets
Assay
(b) Pyraziname Tablets IP

272
AKT-4
(a) Ethambutol
J080277, 02/2008,
NZ/UP/Allahabad/
Lupin Ltd.,
Hydrochloride and
01/2010
BC/56/293
Jammu,
J & K.
Assay
Isonizid Tablets
273
AKT-4
(a)Ethambutol
J080697, 05/2008,
SZ/Tamilnadu/
Lupin Ltd., Jammu,
Hydrochloride and
04/2010
Chennai(M)/
J & K.
Isonizid Tablets
MC/56/1486
Assay

274
AKT-4
(a)Ethambutol
J080045, 12/2007,
WZ/Maharashtra/
Lupin Ltd., Jammu,
Hydrochloride and
11/2009
Amrawati/DHQ/56/10
J & K.
Isonizid Tablets
44
Assay
275
AKT-4
(a)Ethambutol
J080568, 03/2008,
WZ/Gujrat/Mahsana/
Lupin Ltd., Jammu,
Hydrochloride and
02/2010
Vil/56/34
J & K.
Isonizid Tablets
Assay

276
PZA-CIBA
Pyrazimamide Tab-
PC7B01L, 02/2007,
SZ/Tamilnadu/
Novartis India Lim-
lets IP
01/2011
Thiruvannamalai/
ited, Sandoz Busi-
T/57/2601
ness Unit, Maval,
Assay
Pune.
277
PZA-CIBA
Pyrazimamide Tab-
PB7E10L, 05/2007,
WZ/Maharashtra/
Novartis India Lim-
lets IP
04/2011
Amravati/Vil/57/14
ited, Sandoz Busi-
ness Unit, Maval,
Assay
Pune.
278
PZA-CIBA
Pyrazimamide Tab-
PB7K23L, 11/2007,
NZ/Haryana/Gurgaon/
Novartis India Lim-
lets IP
10/2011
DHQ/57/253
ited, Sandoz Busi-
ness Unit, Maval,
Assay
Pune.
279
280
PZA-CIBA
PZA-CIBA
Pyrazimamide Tab-
PB7L24L, 12/2007,
WZ/Maharashtra/
Novartis India Lim-
lets IP
11/2011 &
Mumbai/MC/57/407
ited, Sandoz Busi-
PB8A07L, 01/2008,
ness Unit, Maval,
Assay
12/2011
Pune.
Pyrazimamide Tab-
PC7F04L, 06/07,
EZ/Jharkhand/
Novartis India Lim-
lets IP
05/11 & PC6L07L,
Jamshedpur/
ited, Sandoz Busi-
12/06, 11/10
BC/57/340
ness Unit, Maval,
Assay
Pune.
281
282
283
284
P-Zide 500
P-Zide 750
P-Zide 750
P-Zide 750
Pyrazinamide Tab-
7003, Mar07,
NZ/NCT Delhi/Delhi/
Cadila Pharmaceu-
lets IP
Feb11
MC/58/35
ticals Ltd., Ahmed-
abad.
Assay
Pyrazinamide Tab-
6015, Nov06,
Cadila Pharmaceu-
lets IP
Oct10
Vil/58/809
ticals Ltd., Ahmed-
abad.
Assay
Pyrazinamide
6013, Oct06,
EZ/Jharkhand/
Cadila Pharmaceu-
Tablets IP
Sep10
Lohardaga/
ticals Ltd., Ahmed-
DHQ/58/138
abad.
Assay
Pyrazinamide
7007 & JK8006,
WZ/Madhya Pradesh/
Cadila Pharmaceu-
Tablets IP
Oct07, Sep11 &
Ujjain/T/58/53
ticals Ltd., Ahmed-
abad. & Cadila
Assay
May08, Apr12
Pharmaceuticals
Ltd.,Jammu, J&K.
285
P-Zide 750
Pyrazinamide
8001, Jan08,
WZ/Gujarat/Rajkot/
Cadila Pharmaceu-
Tablets IP
Dec11
BC/58/14
ticals Ltd., Ahmed-
abad.
Assay
45
286
287
288
289
290
291
Revital
Revital
Revital
Revital
Revital
Vitamins &
1884144, 04/2008,
NZ/NCT Delhi/Delhi/
Ranbaxy Labora-
Minerals
03/2010
MC/59/464
mour, HP.
Assay
Vitamins &
1904026, 05/2008,
SZ/Andra Pradesh/
Ranbaxy Labora-
Minerals
05/2010
Srikakulam/
DHQ/59/3766
mour, HP.
Assay
Vitamins &
1914018, 06/08,
WZ/Gujrat/Rajkot/
Ranbaxy Labora-
Minerals
06/10
BC/59/43
mour, HP.
Assay
Vitamins &
1865533, 02/1008,
EZ/Assam/Golghat/
Ranbaxy Labora-
Minerals
01/2010
Vil/59/353
mour, HP.
Assay
Vitamins &
1900920, 05/08,
NZ/Himachal
Ranbaxy Labora-
Minerals
05/10
Pradesh/Sundernagar/
T/59/276
mour, HP.
Assay
Becadexa-
Multivitamin
BD 339, Apr08,
EZ/OR/Bhadrak/
GlaxoSmithKline
min
Multimineral
Sep09
DHQ/60/396
Pharmaceuticals
Ltd., Bangalore.
Assay
Capsules
292
Becadexa-
Multivitamin
BD 410, Aug08,
WZ/Maharashtra/
GlaxoSmithKline
min
Multimineral
Jan10
Mumbai/MC/601060
Pharmaceuticals
Ltd., Bangalore.
Assay
Capsules
293
Becadexa-
Multivitamin
BD 402, Aug08,
SZ/ Andhra Pradesh/
GlaxoSmithKline
min
Multimineral
Jan10
Gudur/T/60/2316
Pharmaceuticals
Ltd., Bangalore.
Assay
Capsules
294
Becadexa-
Multivitamin
BD 356, May08,
NZ/UP/Lucknow/
GlaxoSmithKline
min
Multimineral
Oct09
BC/60/451
Pharmaceuticals
Ltd., Bangalore.
Assay
Capsules
295
Becadexa-
Multivitamin
BD 381, Jun08,
NZ/Rajasthan/Panchu/
GlaxoSmithKline
min
Multimineral
Nov09
Vil/60/214
Pharmaceuticals
Ltd., Bangalore.
Assay
Capsules
296
DSN Cap-
sules
0814108, Mar2008,
WZ/Gujrat/Rajkot/
Feb2010
BC/61/24
Pvt. Ltd., Mumbai.

Assay
297
DSN Cap-
sules
0814125, Jun08,
SZ/Andhra
May10
Pradesh/Srikakulam/
Pvt. Ltd., Mumbai.
DHQ/61/3767
298
DSN Capsules
Assay
0714161, Nov07,
NZ/Rajasthan/Joikyar/
Oct09
Vil/61/381
Pvt. Ltd., Mumbai.

Assay
46
299
DSN Cap-
sules
0801101, Apr08,
EZ/WB/Kolkata/
Mar10
MC/61/517
Pvt. Ltd., Mumbai.

Assay
300
DSN Cap-
sules
0814118, May08,
EZ/OR/Bhemnagar/
Apr10
T/61/457
Pvt. Ltd., Mumbai.

Assay
301
302
303
Zeva Tab-
Nutritional Suppli-
P80501, May08,
EZ/WB/Nabghara/
Pamax Lab.Pvt. Ltd,
lets
ment with vitamins,
Best Before 18
Vil/62/1375
D&NH
minerals and anti-
months of mfd.
oxidants
Date.
Zeva Tab-
Nutritional Suppli-
P80501 05/2008,
NZ/Haryana/Panipat/
Pamax Lab.Pvt. Ltd,
lets
ment with vitamins,
Best Before
DHQ/62/34
D&NH
minerals and anti-
18 Months of
oxidants
Manufacture
Zeva Tab-
Nutritional Suppli-
P80703, Jul08, Best
SZ/Karnataka/Hubli/
Pamax Lab.Pvt. Ltd,
lets
ment with vitamins,
Before 18 months of
BC/62/4375
D&NH
minerals and anti-
Mfd. Date.
Assay
Assay
Assay
oxidants
304
Zeva Tab-
Nutritional Suppli-
P80703, Jul08, Best
EZ/WB/Kharagpur/
Pamax Lab.Pvt. Ltd,
lets
ment with vitamins,
Before 18 months of
T/62/929
D&NH
minerals and anti-
Mfd. Date.
Assay
oxidants
305
Zeva Tab-
Nutritional Suppli-
P80804, Aug08,
WZ/Maharashtra/
Pamax Lab.Pvt. Ltd,
lets
ment with vitamins,
Best Before 18
Mumbai/MC/62/348
D&NH
minerals and anti-
months of Mfd.
oxidants
Date.
Assay
47
8.0
Further sampling from the Residual stock:
On the basis of directive received from the Ministry of Health & FW, further 2,671 Samples from the residual stock of drugs
were collected at random and sent for chemical analysis to different Central Govt. Testing Laboratories shown in Table 7.
All the samples were declared as standard quality with respect to identification and assay details of which has been shown
in table no. 8 as Annexure VI.
Table 7
Therapeutic Category
Generic
Name
Ciprofloxacin
Tablets
Anti- infective
Amoxycillin
Capsules
Sulphamethoxazole &
Trimethoprim
Tablets
Dexamethasone Tablets
No. of
samples
collected
under
survey
No. of samples
further drawn
for laboratory
analysis
Brand
Name
Manufactured By
Name of the
Laboratory
Cifran
Ranbaxy Laboratories Ltd
513
50
CDTL, Chennai
Ciplox
Cipla Ltd
551
50
CDTL, Chennai
Ciprobid
Cadila Health Care Ltd
436
50
CDTL, Chennai
Mox
511
50
CDTL, Chennai
Novamox
Cipla Ltd
533
50
CDTL, Chennai
Septran
Glaxo Smith Kline Pharm

Ltd. (GSK)
565
50
CDTL, Chennai
Ciplin
Cipla Ltd
113
10
CDTL, Chennai
Bactrim
Nicholas Piramal (I) Ltd
505
50
CDTL, Chennai
Dexona
Cadila Health Care Ltd.
522
50
CDL, Kolkata
Decdan
Wockhardt Ltd
474
50
CDL, Kolkata
Decdac ST
Nax Par Lab (p) Ltd.
73
CDL, Kolkata
Wysolone
Wyeth Ltd
583
50
RDTL, Guwhati
Omnacortil
Macleods Pharmaceuticals
Ltd
506
50
RDTL, Guwhati
Medrol
Pharmacia Italia/Pfizer Products India
394
50
RDTL, Guwhati
Betnisol
GSK Ltd
537
50
RDTL, Guwhati
Betnilan
GSK Ltd
443
50
RDTL, Guwhati
Steroids
Prednisolone
Tablets
Betamethasone
Tablets
48
Neoloridin
176
20
RDTL, Guwhati
Lorfast
Cadila Pharmaceuticals
340
50
RDTL, Guwhati
Claridine
Morepen Laboratories Ltd
93
10
RDTL, Guwhati
Cetzine
Emcure Pharmaceuticals
407
50
CDTL, Mumbai
Cetrizet
Sun Pharma Ltd
30
10
CDTL, Mumbai
Zyncet
Unichem Laboratories Ltd
303
50
CDTL, Mumbai
Pheniramine
Maleate
Tablets
Avil
Aventis Pharma Ltd.
550
50
CDTL, Mumbai
Amlodipin
Tablets
Amlosafe
Tablet
Aristo pharmaceuticals
396
50
CDTL, Mumbai
Amlopress
tablet
Cipla Ltd.
497
50
CDTL, Mumbai
Amdepine
Tablet
Cadila Pharmaceuticals
190
20
CDTL, Mumbai
Tenolol Tablet
IPCA Lab. Ltd
501
50
IPC, Ghaziabad
Aten-50 Tablet
Ziblok-50
Tablet
FDC Ltd.
Zivast-10
Tablet
FDC Ltd
291
Atherochek-10
Tablet
Indoco Remidies Ltd
149
Storvas-10
Tablet
435
Glyciphage
Tablet
Franco Indian Pharma (P)

Ltd
481
Glycomet
Tablet
USV Ltd
490
Gluformin
Tablet
Nicholas Piramal (India) Ltd
366
Antihistaminic
Loratidine
Tablets
Cetirizine Tablets
Cardiovascular
Atenolol
Tablets
Atorvastatin
Tablets
Anti-diabetic
Metformin
Tablets
547
254
50
50
IPC, Ghaziabad
IPC, Ghaziabad
50
CDL, Kolkata
20
CDL, Kolkata
50
CDL, Kolkata
50
RDTL, Chandigarh
50
RDTL, Chandigarh
50
RDTL, Chandigarh
49
Gliclazide
Tablets
Glizid-80
Tablet
Panacea Biotech Ltd
414
Glycigon-80
Tablet
Aristo Pharmaceuticals Ltd
329
Reclide-80
Tablet
Dr. Reddys Lab. Ltd.
355
Glimiprex
Tablet
Aristo Pharmaceuticals Ltd
293
Amaryl Tablet
Aventis Pharma Ltd
Glyree Tablet
Chloroquine
Tablets
50
RDTL, Chandigarh
50
RDTL, Chandigarh
50
RDTL, Chandigarh
30
CDL, Kolkata
435
50
CDL, Kolkata
IPCA Lab. Ltd.
279
30
CDL, Kolkata
Lariago
IPCA Lab Ltd
499
50
CDTL, Mumbai
Pyramithamine
+ Sulphodoxin
Tablets
Reziz
Medibios Labs (P) Ltd
290
50
CDTL, Mumbai
Nimesulide
Tablet
Nimulid
Panacea Biotech Ltd
459
50
CDL, Kolkata
Nicip
Cipla Ltd
507
50
CDL, Kolkata
Nise
Dr. Reddys Labs Ltd
580
50
CDL, Kolkata
Crocin
GSK Ltd.
664
50
CDTL, Mumbai
Pacimol
IPCA Lab. Ltd.
335
50
CDTL, Mumbai
Paracip
Cipla Ltd.
257
30
CDTL, Mumbai
Calpol
Remidex Pharma
662
50
CDTL, Mumbai
Brufen
Briocia Pharma (I) Pvt Ltd
585
50
CDTL, Mumbai
Ibugesic
Cipla Ltd
292
50
CDTL, Mumbai
R-Cinex
Lupin Limited
445
50
CDTL, Mumbai
Rimactazid
Novartis India Ltd
285
50
CDTL, Mumbai
Ethambutol
+ INH + PYZ
+Rifampicin
AKT-4
Lupin Ltd
547
50
CDTL, Mumbai
Pyrazinamide
Tablets
PZA-CIBA
Novertis India Ltd.
333
50
RDTL, Guwhati
Pzide-750
Cadila Pharmaceuticals Ltd
155
20
RDTL, Guwhati
Glimepride
Tablets
Anti-malarial
NSAIDS
Paracetamol
Tablets
Ibuprofen
Tablets
Anti-TB
50
Rifampicin +
Isoniazide
Multivitamins &
Minerals
9.0
Vitamins &
Minerals
Revital Capusules
Ranbaxy Laboratories Ltd.
546
Becadexamine
Capsules
GSK Pharma Ltd.
387
DSN Capsules
Marketed by Sherya Life

Sciences Pvt. Ltd
290
Zeva Tablets
Pamax Labs (P) Ltd
Recent Study on Spurious Drugs
9.1
SEARPharm Forum in Association with WHO
(SEARO) carried out a survey on the extent of spurious
(counterfeit) medicines in India in 2007 and collected 10,743
drug samples containing 56 popular brands belonging to 12
therapeutic categories. According to their report, extents of
counterfeit suspects were to the tune of 3.1 %. However from
the laboratory analysis 0.3 % did not meet the Pharmacopoeia
Standards in terms of label claim.
9.2
Operation Jupiter co-ordinated by the WHOs
Western Pacific Regional Office, the International Criminal
Police Organisation (INTERPOL) and the Welcome TrustUniversity of Oxford South-east Asian Tropical Medicine
Research Programme, in close cooperation with the Chinese
authorities, set out to investigate where counterfeit Artesunate
(anti malarial drug) was being manufactured and to develop
an intelligence document that could be presented to the
affected governments. Laboratory analysis focused on 391
samples of genuine and counterfeit Artesunate, collected
in Vietnam, Cambodia, Laos and Myanmar, as well as
on the Thai/Myanmar border, between 1999 and 2006 by
the Welcome Trust-Oxford SE Asian Tropical Medicine
Research Programme. Samples were subjected to high
performance liquid chromatography (HPLC), organic mass
spectrometry, gas-chromatographic head space analysis of
the gases surrounding tablets in blister packs, palynology
followed by detailed inspection of packaging. What these
analyses highlighted in particular was the considerable
diversity in counterfeit artesunate emanating from and
distributed in SE Asia. For example, a total of 16 different
types of fake hologram were identified on packaging, ranging
from crude stickers to highly sophisticated copies. In terms
of the samples chemical composition, all of the specimens
,thought to be counterfeit (195 out of 391, or 49.9 per cent)
50
CDTL, Mumbai
50
CDTL, Mumbai
50
CDTL, Mumbai
158
20
CDTL, Mumbai
24136
2671
on the basis of their packaging turned out to contain either

no or small quantities (up to 12mg per tablet, as opposed to
50mg per genuine tablet) of artesunate. Of the 321 samples,
labelled as manufactured by one major and heavily targeted
Asian producer, Guilin Pharmaceutical from Chinas
Guangxi autonomous region, 195 or 61% were found to be
counterfeit. The researchers also detected a wide variety of
substitute active ingredients in the counterfeit artesunate,
including paracetamol, several different erythromycin
antibiotics, banned compounds such as metamizole, the
carcinogen safrole, and raw material for the production of
methylene dioxymethamphetamine (ecstasy).
51
10.0 Comparison of present study with the study conducted by SEARPharm

Parameter
Study Conducted by
SEARPharm
Present Study
No. of samples collected
10,743
24,136
No. of Therapeutic category
12
Name of the stratum from

where the samples were
collected
Number of brands
56
No. of samples checked

Physically
100 % by the study team
100 % through respective manufacturer

(matching of following Parameters)
Foil matching
Text matter matching
Font size of brand
Brand Symbol
Dimensions of the strip
Description of the product from
the transparent side of the strip)
Extent of counterfeit suspects

on the basis of physical
examination.
In the tune of 3.1%
0.046 % (11 samples were not accepted

by the manufacturers as their
products)
No. of samples tested

chemically
2,455 (suspect and genuine

samples are mixed) through PVT.
Laboratories, which is around 25%
of the total sample collected.
2976 samples (from 24,125 unsuspected

samples) through Govt. Testing
Laboratories which is around 12.336 %
of the total samples collected.
Parameter tested for chemical

analysis
Identification and Assay
Identification and Assay
Failing in Pharmacopoeia
standards in terms of label
claim on laboratory analysis
(Not of Standard Quality)
0.3 %
{Out of 2,455, 08 samples do not
conform to claim}.
0.101 %
{Out of 2976 unsuspected samples, 03
samples do not conform to claim with
respect to Assay (84.8 to 89.3% of the
claim)}.
52
Metro Cities (MC)

Big Cities (BC)
District Head Quarters (DHQ)
Metro Cities (MC)

Big Cities (BC)
District Head Quarters (DHQ)
Towns (T)
Village (Vill)
61
11.0
Observations:
i)
Most of the pharmacy retail outlets in Metro Cities
refused to sale the schedule drug without prescription
ii)
Most of the drugs were not available in the retail
outlet situated in the village
iii)
Availability of all the selected brands throughout the
country are uniform
iv)
To collect Twenty-four Thousand One Hundred
thirty-six (24,136) drug samples, much more number of retail
outlets were visited due to non availability or refusal to sale
the product without prescription (approximately 40,000 retail
outlets were visited).
v)
In most of the retail outlets situated in Towns and
District HQ, there was a tendency to replace the asked
product with the local brands.
vi)
Most of the retail shops did not provide cash memo
without demand and in few cases refused to give cash memo
even on demand.
vii)
From laboratory reports of all the eleven (11) drug
samples which were not accepted as genuine by the respective
S.No. Name of the Drug

1.
2.
3.
Atherochek-10
(Atorvastatin Tablet 10 mg)
Atherochek-10
(Atorvastatin Tablet 10 mg)
Amlosafe 2.5
(Amlodipine Basilate Tablet BP
2.5 mg)
manufacturer, it was observed that none of the sample failed

in identification tests. However, Eight samples were found
substandard with respect to the content of active ingredient
as claimed on the label (Assay) and three samples were found
conforming to claim with respect to Assay (it is pertinent to
mention here that, in case these three samples would have
been drawn on a routine basis by the Drugs Inspectors under
the Act, these samples might not be declared as spurious by
the Government Analyst, since the said samples conforms to
the label claim with respect to Identification and Assay).
viii)
Out of eleven (11) drug samples which were not
accepted as genuine by the respective manufacturer it was
observed that five samples collected from Bihar, three from
West Bengal, two from UP and one from Gujarat State.
ix)
From laboratory test reports of three hundred five
(305) samples which were drawn at random (five sample
from each brand) from the stocks which were accepted by the
respective manufacturer as genuine, it was observed that all
the samples conforms to claim with respect to Identification
& Assay except the following drugs:
Sample No.
EZ/OR/Nomapara /
Vil/32/537
EZ/WB/Kolkata /
MC/32/1704
NZ/Uttaranchal/
Dehradun/BC/25/499
x)
Further sampling from the residual stocks
(2671 samples) of the collected samples showed 100 %
conformity with respect to Identification & Assay by the
Government analyst at various Central Government Testing
Laboratories.
12.0 Conclusions:In view of above observations and data obtained from
the manufacturers, after physical verification of all the
drug samples and subsequent chemical analysis report on
the representative of samples taken at random, it may be
concluded that:
Identification
Failed in Assay
Positive
86 %
Positive
89.3%
Positive
84.8%
(i)
The extent of spurious drug in retail pharmacy
is much below the projections made by various
media, WHO, SEARO, and other studies i.e. only 0.046 %
(11 samples out of 24,136 samples).
(ii)
Extents of substandard drugs among the branded
items are only 0.1 % {Out of two thousand nine hundred
seventy six (2976) unsuspected samples, 03 samples do
not conform to claim with respect to Assay on chemical
analysis}.
53
13.0 Future Study Design: Future study may

be designed covering following aspects:
13.1
Extent of spurious / substandard drugs involved in
import & export
Extent of spurious / substandard drugs in channels other
than Retails
Extent of spurious / substandard drugs among the brands
of relatively smaller manufacturers.
Extent of spurious / substandard drugs among the Generic
products.
Extent of spurious / substandard drugs in relatively low sales
turnover products.
Other dosage formulations i.e. Injectables, Oral Liquids,
Ointments etc. should also be considered in future studies.
13.2
Sampling Plan
Samples should be collected in the pattern of NSQED.
13.3
Selection of Drugs to be collected
Category of drugs for survey shall be fixed by DCGI from
time to time.
13.4
No. of Samples to be collected
All the State Drugs Controllers and the Zonal Officers
of CDSCO may be directed to initiate necessary steps to
collect at least 200 survey samples every month from various
stratum.
13.5
Testing of drug samples
Few Approved Drug Testing Laboratories as decided by
Drugs Controller General (India) may be designated for the
purpose of testing of survey samples.
Samples should be collected at regular intervals though
various consumer association/NGOs/ Drugs Samplers as
surrogate patient.
14.0
Future Administrative Control
14.1
Necessary funds towards the cost, collection and
testing charges of these drug samples should be made
available to the Central and States Govt.
14.2
A rapid alert system should be in place so that detection of
any spurious drugs in any corner of the country can be informed to
all concerned for taking immediate action.
****************
54
ANNEXURE-I
57
58
59
60
61
62
63
64
65
ANNEXURE-II
Determination of Sample Size and Samples

for
Estimation of Counterfeit Drugs
ISI, Hyderabad
Introduction
This report is prepared by Indian Statistical Institute, Hyderabad, in response to a request from Drug Controller General
(I) Ic seeking advice on determination of sample size and the samples for estimating the percentage of counterfeit drugs in
India (see below for details). It should be mentioned here that the scope of this assignment is confined to only to the extent
of determining the sample size and the sampling is subject to the limitations of the available data.
Background
Drug Control Authority of India (DCA) has faced with the problem of estimating the percentage of counterfeit drugs. The
definition of counterfeit drug is as per the specifications of DCA and it is assumed that given a sample of a drug (tablet,
syrup, or other forms), it is possible to identify unambiguously whether the sample is from the original manufacturer or a
counterfeit. The problem posed by DCA may be described as follows. Consider a drug such as Crocin. A Crocin tablet
(purchased from some place) is either a counterfeit or it is manufactured by the original manufacturer of Crocin. The problem that DCA is faced with is to estimate the extent of counterfeit, either in terms of number or as a percentage expressed
against the extent of true Crocin. To fix ideas, let us say during January 07 the number of original Crocin tablets prevailing
in the market is N, the number of counterfeit Crocin prevailing in the market is K, then the DCA wants to estimate 100K/N
or 100K/(K+N). The statistical problem posed to ISI (by DCA) is: what is the sample size required to estimate the extent of
counterfeit? Furthermore, according to the objectives of DCA, the counterfeit estimates are required separately for each of
the following strata: Counterfeit in (i) the Metros, (ii) in the big cities, (iii) district headquarters, (iv) taluk headquarters, and
(v) villages.
One more task of the assignment is as follows. DCA proposes to estimate the extent of counterfeit, through a
survey, as follows:
(i) Select n retail outlets at random (n is the sample size),
(ii) each sampled retail outlet is visited (only once) by a surveyor posing like a patient and ask for the drug,
(iii) buy the drug if it is available,
(iv) analyze the drug and decide whether it is a counterfeit or not,
(v) compile the data and estimate the extent of counterfeit.
The task is to prepare a list of the sample outlets to be approached for collecting the samples.
69
Analysis
Before taking up the assignment, the problem has been analyzed and the following points were observed and brought
to the notice of DCA.
1
If the survey is conducted as described above, then it

may be difficult to obtain meaningful estimates of the
parameter of interest (100K/N or 100K/(K+N)). The reason is that in the survey, the quantity of drug available in
the sampled retail outlet is not being obtained (it is only
observed whether the purchased drug is counterfeit or
not).
From practical view point, the parameter (100K/N or
100K/(K+N)) is not the one that the DCA should be interested in. What is important is the answer to the following question: What is the chance that when a patient asks
for a drug, he or she will get a counterfeit (paraphrasing
the question, what proportion of the drugs sold are counterfeit drugs?).
From the type of survey described above it is possible to
estimate the proportion of counterfeit among the drugs
sold. For this estimation, the sample size can be determined. However, the sample size will turn out to be a
function of the proportion of the counterfeit drugs sold
and also the proportion of retail outlets that possess the
drug. When a patient approaches a retail outlet and asks
for a drug there are three possible outcomes: (i) the drug
is not available in the retail outlet, (ii) the patient gets a
counterfeit, and (iii) the patient gets the original drug
(we are assuming that the outcome of a patient getting a
combination of counterfeit and the original is ruled out).
What has been said just above is that the sample size will
depend on the extent of counterfeit and on the extent of
outcome (i). Extent of outcome (i) will in turn depend on
the quantity of drug available (both counterfeit and the
original).
The probability model for the problem involves cumbersome expressions. A simulation module is built to arrive
at the sample size required. As mentioned above, the
sample size will be determined using the following three
parameters: (i) total number of outlets in the population
(N), (ii) number of outlets which sell counterfeit (F), and
(iii) number of outlets which do not have the drug (M).
Here our interest is to estimate F/(N-M), the counterfeit
proportion of drugs sold. While the complaints are that
70
the counterfeit is about 30%, DCAs experts are of the

opinion that it is as low as 0.3%. Therefore, we propose
to study the effect of sample size by computing the errors
for various sample sizes and various possible values of
the counterfeit in the range of 0.3% to 30%, and look for
a suitable samples size.
After reviewing and understanding the above analysis, DCA
has requested ISI to go ahead with determination of the
sample size and list of outlets to be surveyed. The proposed
survey is to be conducted, according to DCA, for about 10
popular branded medicines and it has been agreed upon
that ISI would determine the sample size and the samples
keeping only one brand in mind. In view of the cost involved
in sampling, DCA may consider some compromise on determining the samples separately for each brand independently.
Therefore, the scope of this assignment, that is determining
the sample size and the samples, is restricted to one brand.
Some suggestions are hinted for conducting the survey for all
the brands that DCA is contemplating. In the next section,
the method of determining the sample size and the samples
is discussed.
Method of Estimation and Sample Size Determination
Consider any branded medicine. It is of interest to estimate
the chance that a person purchasing a medicine at a retail
outlet will get a counterfeit of the branded medicine. Let N
be the number of total outlets in the population; let p be the
proportion of outlets that will respond by selling the drug
when asked for; let f be the conditional probability that a
purchase at a randomly picked outlet will result in a counterfeit given that the retail outlet will respond positively (positively means that the store will sell the drug, either original
or counterfeit). We shall treat N, p and f as the parameters
of the model and study the effect of sample size for some
selected possible values of (N, p, f).
Let n be the proposed sample size, that is, the number of
outlets to be approached in the survey. When an outlet is
approached for the branded medicine in question, there are
three possible outcomes: (i) the outlet says that the medicine is not available, (ii) the outlet sells a counterfeit medicine, and (iii) the outlet sells original medicine. Let C be the
number of outlets, out of the n outlets approached, selling
counterfeit drug; and let D be the number of outlets, out of

the n outlets approached, selling original drug. The estimate
for the chance of a person getting counterfeit drug is taken
as C/(C+D) (=T, say). Let f be the counterfeit proportion.
That is, f is the chance that a purchased medicine is a counterfeit. Note that T is an estimate of f and as the sample size
n increases, T becomes more and more reliable. Since the
statistical behaviour of T is nontrivial, the simulation tool is
used to determine the sample size. The details of the statistical framework and simulation procedure are presented in
Annexure-I.
The effect of sample size and its implications can be understood from the following. Suppose there are 400000 outlets
(that is N=400000) in the population and suppose that 80%
of these outlets sell the medicine when approached (that is,
p=0.80). Further, suppose the counterfeit proportion is 10%
(that is, f=0.1). Suppose we take a sample of size 1500 (that is,
n = 1500). Using the simulation model, it is possible to simulate outcomes of this exercise. One such outcome, from the
simulation model, has resulted in the following outcome: 293
outlets said the medicine was not available, 122 outlets sold
counterfeit drug and 1085 outlets sold original drug. This
results in an estimate of 0.101 (note that C=122, D=1085 and
T = 0.101). It must be noted that the estimate depends on
which 1500 outlets are covered under the sample. Another
outcome of the simulation resulted in the following: C=106,
D=1103 and T=0.088. A repetition of this simulation exercise
100 times results in 100 estimates. For comprehension, a set
of 100 such estimates generated through simulation exercise
are presented in Table-1 below. These data are also summarized in the form of a histogram (see Figure-1). It may
be noted that, in this case, the estimates range from 0.080
to 0.120 with an average of 0.099. The range [0.080, 0.120]
is called a confidence interval for the estimate of the counterfeit chance, and the average behaviour of the estimator is
satisfactory (because the average value, 0.099, is close to the
true value f = 0.100. In this case, it may be noted that the error in estimating f is about 0.02. By increasing the sample
size it is possible to reduce this error.
Table-1: Simulated Estimates

0.106
0.099
0.093
0.110
0.111
0.107
0.084
0.101
0.101
0.104
0.109
0.088
0.100
0.103
0.106
0.100
0.090
0.093
0.106
0.098
0.094
0.101
0.089
0.102
0.108
0.096
0.101
0.100
0.097
0.102
0.094
0.111
0.099
0.083
0.095
0.095
0.092
0.114
0.089
0.097
0.099
0.082
0.109
0.100
0.120
0.084
0.113
0.104
0.094
0.081
0.118
0.109
0.093
0.091
0.101
0.116
0.111
0.093
0.091
0.092
0.092
0.105
0.108
0.101
0.110
0.104
0.103
0.116
0.089
0.107
0.091
0.110
0.098
0.117
0.103
0.109
0.093
0.107
0.087
0.100
0.091
0.111
0.102
0.093
0.093
0.091
0.090
0.100
0.111
0.103
0.098
0.111
0.084
0.100
0.096
0.097
0.094
0.109
0.091
0.100
71
To understand the behaviour of the estimator T, under a

different scenario, let us examine the simulation results for
N=300000, p = 0.70 and f = 0.003. The simulation for this
situation with n = 1500 has resulted in a range (confidence
interval) of [0.000, 0.007] for f and with an average of 0.003.
Another simulation exercise with n = 2000 for the same situation resulted in a range of [0.001, 0.006] with an average
of 0.003. Simulation results for some selected values of the

parameters (N, p and f) with different sample sizes are presented in Table-2. DCA authorities felt that the medicines for
which the survey will be conducted are so popular that the
chance of non-availability of the medicine will be less than
0.2. In view of this, we have taken N=400000 and p=0.8.
Table-2: Effect of Sample Size on Estimation
F
0.001
0.001
0.001
0.001
0.001
Size
500
1000
1500
2000
2500
Min
0.0000
0.0000
0.0000
0.0000
0.0000
Average
0.0008
0.0012
0.0009
0.0010
0.0010
StdDev
0.0014
0.0013
0.0009
0.0008
0.0007
Max
0.0051
0.0062
0.0034
0.0039
0.0035
Std. Error
0.0027
0.0027
0.0018
0.0017
0.0015
Cv
168
111
97
83
74
0.003
500
0.0000
0.0035
0.0028
0.0105
0.0056
168
0.003
1000
0.0000
0.0031
0.0024
0.0117
0.0049
111
0.003
1500
0.0000
0.0031
0.0015
0.0074
0.0031
97
0.003
2000
0.0000
0.0029
0.0013
0.0065
0.0026
83
0.003
2500
0.0010
0.0030
0.0012
0.0059
0.0024
74
72
0.01
500
0.0000
0.0097
0.0049
0.0221
0.0099
51
0.01
1000
0.0037
0.0100
0.0036
0.0208
0.0072
36
0.01
1500
0.0041
0.0100
0.0030
0.0177
0.0059
30
0.01
2000
0.0056
0.0103
0.0026
0.0158
0.0052
25
0.01
2500
0.0050
0.0098
0.0022
0.0154
0.0044
22
0.1
500
0.0672
0.0988
0.0136
0.1376
0.0272
14
0.1
1000
0.0736
0.0992
0.0110
0.1364
0.0219
11
0.1
1500
0.0725
0.0985
0.0082
0.1226
0.0164
0.1
2000
0.0825
0.1013
0.0074
0.1187
0.0149
0.1
2500
0.0833
0.0995
0.0067
0.1188
0.0135
0.2
500
0.1550
0.2012
0.0175
0.2394
0.0349
0.2
1000
0.1709
0.2016
0.0123
0.2322
0.0245
0.2
1500
0.1794
0.2002
0.0105
0.2274
0.0210
0.2
2000
0.1731
0.2006
0.0098
0.2270
0.0196
0.2
2500
0.1784
0.1987
0.0089
0.2218
0.0179
0.3
500
0.2353
0.2990
0.0229
0.3573
0.0458
0.3
1000
0.2568
0.3002
0.0163
0.3527
0.0327
0.3
1500
0.2666
0.2982
0.0140
0.3314
0.0279
0.3
2000
0.2777
0.2999
0.0102
0.3268
0.0204
0.3
2500
0.2729
0.2984
0.0103
0.3234
0.0207
An extract of Table-2 is presented in Table-3. Table-2 and Table-3 can be used as a guide in determining the sample size.
Table-3: Coefficients of variation (Cv) of the Estimates
0.001
0.003
0.01
0.1
0.2
0.3
500
168
168
51
14
1000
111
111
36
11
1500
97
97
30
2000
83
83
25
2500
74
74
22
Note: The coefficient of variation is computed as fol-
m and s are the mean and standard deviation of the 100
lows. Consider the figure 14 in the body of the table
estimates simulated with parameters N=400000, p=0.8, f=0.1
against 500 and 0.1. The Cv =14 is equal to 100s/m where
and sample size equal to 500.
73
Sampling of Outlets
data, we had to adapt census data. For this purpose, we

procured the India Census 2001 data [1]. These data were
While determining the sample size, it was implicitly assumed
available in 12 CDs with different states data in different
that the sampling will be done using simple random sam-
CDs. One of the strata under our consideration is big cities.
pling of outlets without replacement. The basic reason for
However, the definition of big city is not explicitly defined
this is that no auxiliary information (such as areas known for
(either by DCA or in the census). In the census, there is a
counterfeit drugs or areas where living conditions are poor
category called one million plus city, which meant a city
or good, etc) was available to work on reduction of sample
with a population of above one million. Therefore, we have
size. Even drawing simple random sampling was not a feasi-
taken the big cities as one million plus cities. Next, consider
ble proposition as the only information available was on the
the stratum of villages. The DCA had in mind only those vil-
number of outlets and not the list of outlets with addresses
lages which have medical retail outlets. But such a list of vil-
(see Annexure-II for the data made available on the retail
lages is not available. One of the conditions for entitlement
outlets). Furthermore, the numbers were only approximate
of village, according to the census, is that the population
estimates.
size should be less than 5000. But villages with populations

are unlikely to have outlets. For this purpose we decided to
In view of the difficulties with respect to sampling using out-
consider only those villages with population between 2000
let identities it was decided to adopt the Indian census for
and 5000. Even then our problem was not resolved because
the purpose sampling. Consider the case of estimating the
there were more than 6,00,000 villages and the list of these
counterfeit in the Metros. There are eight metros and about
villages along with population was not available. Therefore,
40000 retail outlets in these metros. Since there was no list
we have drawn and listed a sample of 50000 villages so that
of outlets, the wards in the metros were taken as the primary
if the required sample size is 1500, then investigate the first
sampling units. From the census (India Census 2001), the list
1500 feasible units in the listing.
of wards of the metros was available. If the required sample

size is 1600 (that is the number of outlets to be approached),
The case of selecting samples from taluk headquarters was
then a sample of wards of size 1600 from the list of wards of
another issue. There was no uniformity in the concept of ta-
the metros is drawn (with replacement) and then an outlet in
luk headquarters among all states. Taluk headquarters exist
that ward is picked (at random by the surveyor at the time
in some states but not in all the states. Only thing that was
of actual survey). Suppose in this sample a ward is selected
useful in this case was the concept of subdistrict (a sub-dis-
5 times, then collect five samples from that ward (preferably
trict is somewhat equivalent to a taluk headquarters). A list
from five different outlets of that ward if possible). Attempts
of all available sub-districts (in the census) was prepared and
were made to adopt similar strategy for other strata, that is,
a sample was drawn from that list. Preparing the list of sub-
for big cities, district headquarters, taluk headquarters and
districts was a very laborious task as this has to be extracted
villages. But due to non-availability of proper information
from each of the 600 and odd districts almost manually.
from the census, some compromises were inevitable. Some

of the difficulties encountered in dealing with the census data
Plan of Sampling
for this purpose are briefly outlined in the next paragraph

below.
With all difficulties explained above, the lists of places to be

surveyed are prepared. These lists are provided in Annex-
Given the time constraints and non-availability of required
74
ure-III (as the lists are too large in size, these are given in the
soft form on a CD) for each of the five strata, namely, met-
pertinent data, a number of compromises had to be made
ros, big cities, district headquarters, taluk headquarters and
in selection procedure of the samples. Nevertheless, due to
villages. Tables 2 and 3 can be used for choosing the sample
adequately large sample sizes, the estimates are expected to
size. Looking at Table-3, a sample of size 1500 per stratum
be fairly good.
should be adequate. The standard error in this case does

not exceed 0.03 (see the Std. Error of rows with sample size
The selection of locations for drawing samples has been
1500 in of Table-2). As per DCA, a standard error of 1 is ac-
worked out for a single drug. Ideally, the selection (random
ceptable. Therefore, a sample of size 1500 may be adequate
selection of samples) should be done independently for each
for the purpose. It must be noted that the sample size speci-
drug separately. However, this might escalate the cost and
fied here is for a particular brand and particular stratum.
effort phenomenally. Therefore, it may be imperative to re-
Hence, if there are 10 brands, then the total sample size for
strict the freedom of selecting independent samples. Under
all brands and all strata will be about 75000. The actual plan
these circumstances, efforts should be made to select the out-
for execution is outlined in the next paragraph.
lets randomly from a given location for different drugs.
Annexure-III presents list of all units for each stratum from
Finally, it is extremely important to plan the activities of the
samples are drawn. The term unit here refers to ward/district
actual field survey. This involves decision on various aspects
headquarters/taluk headquarters/villages.
such as qualification of surveyors who will collect the field

data, the procedure of collecting samples, the data collection
The actual units (retail outlets) must be picked up from the
formats, planning of sequence of visits to the selected loca-
sampled units at the time of survey. The list of sampled units
tions, etc. These activities are outside the scope of this as-
will include more than the required size (1500). There are
signment. Taking help from sampling experts and previous
two reasons for this: (i) If for some reasons it is decided to
surveys [2] for similar objectives will be useful in planning
go for a different sample size, say 1600, then the same list
these activities.
can be used for the survey, and (ii) if for some reasons It is
not possible to survey a unit in the list of sampled units, then
Last but not the least, it is utmost important to keep a good
one can choose the next in the list. Therefore, the sampling
control on the non-sampling errors as the sample size is very
should be executed as follows. First decide on the sample
large (about 75000). Some of the non-sampling errors in-
size, say for the argument sake 1500 (the recommended
clude picking up samples from convenient places, loosing
sample size). Take sample as the first 1500 feasible units. It
traceability of the samples, measurement errors, wrong clas-
must be remembered that if an outlet results in saying the
sifications (a counterfeit as original or vice versa), etc.
medicine not available as a part of the sample.

Concluding Remarks and Recommendations
In this report we have tried to address only the effect of sample size in estimating the chance of a person getting counterfeit drug purchased from a retail outlet. The study is useful in
estimating the approximate sample size for a given requirement of precision of the estimate. Due to non-availability of
75
ANNEXURE-III
LIST OF CONSUMER ASSOCIATIONS / N.G.Os ZONE WISE THROUGH WHICH

ALL THE DRUGS SAMPLES HAVE BEEN COLLECTED.
SOUTH ZONE
S.No. Name of the Organization

1.
Federation of Consumer Organisation of Tamil Nadu
(FEDCOT)
2.
Vishaka Consumer Council (VCC) Andhra Pradesh.
3.
Grahashakthi Voluntary Consumer Organiation,
Bangalore.
4.
THANAL, Kerla
Contact Person
Prof. P. Durasisingam
Chairman
Dr. Rama Rao
Mr. Somasekar
Performance
Excellent
Not so satisfactory
Most unsatisfactory
Mr. C. Jayakumar
Excellent
Contact Person
Mrs. Vibha, Founder
& CEO
Dr. Rohit Nair
Mr. Mukhram Sharan
Mr. Harish Khulbe
Mr. Subhash
Mendhapurkar
Mr. Nigam Gupta
Mr. Anurag Gupta
Performance
Satisfactory
NORTH ZONE

1.
MUSKAAN, Lucknow 226021
2.
3.
4.
5.
AAROHI, Uttarakhand 263 138

Urmul Setu Sansthan, Rajasthan.
INHERE, Distt. Almora, Uttarakhand
SUTRA, Himachal Pradesh
6.
7.
Swasthya Sansar NGO, Jammu

GRAVIS, Jodhpur, Rajasthan
8.
Community Radio Henvalvani/Asstha, Tehri

Garhwal, Uttrakhand.
Mr. Darmyan Rana
Satisfactory
Excellent
Satisfactory
Satisfactory
Satisfactory
Most unsatisfactory.
They have withdrawn
their responsibility at
the last moment.
-Do-
WEST ZONE

1.
Consumer Education and Research Centre,
Ahmedabad.
Contact Person
Dr. P. K. Ghosh,
Managing Trustee
Performance
Satisfactory
Contact Person
Performance
Denied to collect samples.
Satisfactory
EAST ZONE

1.
Child in Need Institute, West Bengal
2.
Community Development Medicinal Unit,
West Bengal.
3.
Community Development Medical Unit, Orissa.
4.
Community Health Medicinal Unit, Bihar
5.
VHA, Jharkhand
6.
CHETANA centre for Womens studies, Tripura
7.
VHAAP, Arunachal Pradesh
Satisfactory
Denied to collect samples.
Satisfactory
Satisfactory
Satisfactory
79
ANNEXURE-IV
Sample No.
(To be filled by Zonal
Office)
FORMAT FOR RECORDING THE DETAILS OF SAMPLES DRAWN

(To be filled by the person who is collecting the sample)
S.No.
Heading
1.
Brand Name of the Drug
2.
Generic Name of the Drug
3.
Name of Manufacturer
4.
Batch No.
5.
Date of Manufacture
6.
Date of Expiry
7.
Price Paid
8.
Address of Pharmacy
Information
Name of Shop
Shop No.
Lane No.
Town/Village
State
Pin
9.
Cash Memo Details
Cash Memo no:

Cash memo given spontaneously
Y/N
Cash memo given on Demand
Y/N
Cash memo given on Denied
Y/N
83
Sample No.
(To be filled by Zonal
Office)
S.No.
Heading
10.
Date of Collection
11.
Prescription Details
Information
Whether sample was supplied/denied without prescription

Y/N
12.
Comment (if any)
Signature of sample Collector :
...................................................
Name of sample Collector
..........................................................................
Name of Organization
..........................................................................
Address
..........................................................................
..........................................................................
..........................................................................
Date :........................................
84
ANNEXURE-V
Sample No.
(To be filled by Zonal Office)
FORMAT FOR RECORDING THE DETAILS OF SAMPLES DRAWN
(To be filled by the CDSCO Zonal Office)
S.No.
Heading
1.
Brand Name of the Drug
2.
Generic Name of the Drug
3.
Name of Manufacturer
4.
Batch No.
5.
Date of manufacture
6.
Date of Expiry
7.
Nature of Stratum
8.
Name of the Retail Shop
Information
Signature of Office: ..................................
Designation: ..............................................
87
ANNEXURE-VI
DETAILS OF THE SAMPLES DRAWN FROM THE RESIDUAL STOCK WHICH HAS
BEEN ACCEPTED AS THEIR PRODUCT BY THE RESPECTIVE MANUFACTURING
FIRMS FOR FURTHER LABORATORY ANALYSIS,
TABLE 8
S.No.
1.
Name of
the Brand
Generic
Name
Sample No.
Name of the
Laboratory
Test report No.
Remarks
IdentifiAssay
cation
CIFRAN
Ciprofloxacin
Hydrochloride
Tablets
SZ/TAMILNADU/NAMAKKAL/T/01/573
CDTL,
Chennai
CS/006/09-10
(+) VE
96.54%
2.
WZ/GOA/PANAJI/BC/01/06
CS/033/09-10
(+) VE
100.82%
3.
WZ/GUJARAT/JAMNAGAR/VIL/01/26
CS/034/09-10
(+) VE
98.63%
4.
WZ/MP/INDORE/BC/01/111
CS/047/09-10
(+) VE
101.31%
5.
EZ/ORISSA/PARADIP/VIL/01/99
CS/025/09-10
(+) VE
93.42%
6.
WZ/MAHARASHTRA/MUMBAI/MC/01/412
CS/039/09-10
(+) VE
96.74%
7.
WZ/MAHARASHTRA/CHANDRAPUR/
DHQ/01/2
CS/038/09-10
(+) VE
104.33%
8.
SZ/TN/PANRUTI/T/01/1872
CS/007/09-10
(+) VE
97.85%
9.
EZ/ASSAM/TINSUKIA/T/01/568
CS/017/09-10
(+) VE
103.13%
10.
SZ/AP/NAYUDUPET/T/01/2029
CS/009/09-10
(+) VE
97.68%
11.
WZ/CHHATTISGARH/JAGDALPUR/
VIL/01/05
CS/029/09-10
(+) VE
99.79%
12.
NZ/UP/GHAZIABAD/DHQ/01/1009
CS/014/09-10
(+) VE
96.82%
13.
NZ/J&K/SAMBA/DHQ/01/84
CS/016/09-10
(+) VE
101.10%
14.
CS/040/09-10
(+) VE
100.46%
15.
WZ/MAHARASHTRA/SOLAPUR/T/01/31
CS/043/09-10
(+) VE
100.37%
16.
WZ/GUJARAT/RAJKOT/BC/01/11
CS/037/09-10
(+) VE
94.52%
17.
WZ/GUJARAT/PORBANDAR/DHQ/01/01
CS/036/09-10
(+) VE
95.34%
18.
EZ/AP/SEPPA/VIL/01/412
CS/019/09-10
(+) VE
94.64%
19.
WZ/GUJARAT/JUNAGARH/DHQ/ 01/74
CS/035/09-10
(+) VE
98.79%
20.
WZ/MAHARASHTRA/THANE/BC/01/80
CS/045/09-10
(+) VE
101.92%
21.
EZ/WB/KOLKATA/MC/01/82
CS/028/09-10
(+) VE
92.73%
22.
SZ/KERALA/ALUVA/T/01/2207
CS/011/09-10
(+) VE
92.57%
23.
EZ/NE/UDAIPUR/DHQ/01/90
CS/024/09-10
(+) VE
91.92%
24.
WZ/GOA/MARGO/DHQ/01/23
CS/032/09-10
(+) VE
101.43%
25.
NZ/J&K/KATRA/T/01/51
CS/015/09-10
(+) VE
91.90%
26.
WZ/MP/JABALPUR/BC/01/24
CS/048/09-10
(+) VE
100.22%
27.
WZ/CHHATTISGARH/BC/01/03
CS/030/09-10
(+) VE
97.99%
28.
SZ/TN/CHENGALPATTU/T/01/3710
CS/004/09-10
(+) VE
90.24%
29.
SZ/KERALA/CALICUT/T/01/5554
CS/012/09-10
(+) VE
95.07%
30.
WZ/MAHARASHTRA/NASHIK/DHQ/01/28
CS/041/09-10
(+) VE
99.37%
31.
WZ/MAHARASHTRA/PUNE/BC/01/74
CS/042/09-10
(+) VE
99.84%
32.
EZ/ASSAM/GUWAHATI/MC/01/503
CS/018/09-10
(+) VE
97.14%
33.
SZ/TN/CHENNAI/MC/01/1260
CS/001/09-10
(+) VE
100.27%
34.
EZ/WB/NILGANJ/MC/01/3667
CS/027/09-10
(+) VE
90.21%
35.
EZ/MEGHALAYA/SHILLONG/BC/01/271
CS/022/09-10
(+) VE
93.60%
36.
CS/003/09-10
(+) VE
91.40%
37.
SZ/PONDICHERRY/T/01/4414
CS/008/09-10
(+) VE
96.36%
38.
EZ/BR/MUZAFFARPUR/DHQ/01/2
CS/021/09-10
(+) VE
91.32%
39.
EZ/WB/BERHAMPUR/BC/01/1136
CS/026/09-10
(+) VE
94.78%
40.
WZ/MP/TIKAMGARH/DHQ/01/32
CS/050/09-10
(+) VE
101.35%
41.
WZ/MP/BHOPAL/BC/01/23
CS/046/09-10
(+) VE
101.33%
42.
WZ/GOA/MARGAO/T/01/4
CS/031/09-10
(+) VE
100.24%
43.
EZ/BR/CALGANGE/VIL/ 01/857
CS/020/09-10
(+) VE
93.27%
44.
CS/044/09-10
(+) VE
99.36%
45.
WZ/MP/SATNA/DHQ/01/141
CS/049/09-10
(+) VE
101.81%
91
46.
SZ/TN/PONNERI/T/01/2123
CS/013/09-10
(+) VE
99.82%
47.
SZ/TN/MADURAI/BC/01/100
CS/005/09-10
(+) VE
97.43%
48.
SZ/KARNATAKA/KARWAR/T/01/3966
CS/010/09-10
(+) VE
97.93%
49.
EZ/JH/RANCHI/BC/01/81
CS/023/09-10
(+) VE
95.16%
SZ/TN/CHENNAI/T/01/3473
CS/002/09-10
(+) VE
98.56%
CS/097/09-10
(+) VE
99.66%
CS/057/09-10
(+) VE
103.96%
50.
51.
52.
CIPLOX
Ciprofloxacin
Hydrochloride
Tablets
SZ/KARNATAKA/BANGALORE/
BC/02/4376
CDTL,
Chennai
53.
NZ/UP/MUZAFFARNAGAR/DHQ/02/1505
CS/070/09-10
(+) VE
95.78%
54.
EZ/WB/KOL/MC/02/1568
CS/081/09-10
(+) VE
93.17%
55.
SZ/ANDHRAPRADESH/NELLORE/
DHQ/02/4460
CS/055/09-10
(+) VE
104.35%
56.
CS/072/09-10
(+) VE
93.96%
57.
NZ/NCTDELHI/DELHI/MC/02/253
CS/065/09-10
(+) VE
94.88%
58.
CS/099/09-10
(+) VE
100.90%
59.
EZ/WB/BARRACKPORE/MC/02/3498
CS/080/09-10
(+) VE
99.05%
60.
WZ/GUJARAT/GODHRA/T/02/01
CS/092/09-10
(+) VE
97.42%
61.
WZ/GUJARAT/JAMJSA/T/02/05
CS/094/09-10
(+) VE
102.21%
62.
EZ/JHARKHAND/HAZARIBAGH/
BC/02/472
CS/077/09-10
(+) VE
92.42%
63.
CS/084/09-10
(+) VE
90.61%
64.
CS/086/09-10
(+) VE
98.76%
65.
EZ/WB/RANAGHAT/T/02/2534
CS/088/09-10
(+) VE
100.07%
66.
CS/083/09-10
(+) VE
91.02%
67.
SZ/KERALA/KASARGEN/DHQ/02/2050
CS/062/09-10
(+) VE
94.39%
68.
SZ/KERALA/VILLAGE/VIL/02/5796
CS/063/09-10
(+) VE
98.24%
69.
SZ/KARNATAKA/KARWARI/T/02/3967
CS/060/09-10
(+) VE
95.52%
70.
SZ/KARNATAKA/DHARWAD/BC/02/4010
CS/059/09-10
(+) VE
96.60%
71.
WZ/MADHYA PRADESH/UJJAIN/T/02/23
CS/100/09-10
(+) VE
99.76%
72.
EZ/NAGALAND/KOHIMA/DHQ/02/189
CS/078/09-10
(+) VE
98.74%
73.
SZ/TAMILNADU/TRICHY/BC/02/59
CS/052/09-10
(+) VE
103.64%
74.
EZ/ASSAM/JORHAT/TOWN/02/608
CS/073/09-10
(+) VE
96.22%
75.
WZ/GUJARAT/PHVNAGN/T/02/02
CS/091/09-10
(+) VE
97.00%
76.
SZ/KARNATAKA/BANGALORE-N/
BC/02/4067
CS/058/09-10
(+) VE
95.65%
77.
CS/087/09-10
(+) VE
97.28%
78.
NZ/NCT DELHI/DELHI/MC/02/237
CS/064/09-10
(+) VE
94.94%
79.
NZ/ASSAM/BANDERDWEWAN/VIL/02/340
CS/075/09-10
(+) VE
91.20%
80.
WZ/GUJARAT/HIMMATNAGAR/
DHQ/02/31
CS/093/09-10
(+) VE
97.21%
81.
SZ/KERALA/KANNUR/DHQ/02/2075
CS/061/09-10
(+) VE
96.47%
82.
EZ/BR/DARBHANGA/DHQ/02/764
CS/076/09-10
(+) VE
92.23%
83.
SZ/ANDHRAPRADESH/VIZIANAGARAM/
T/02/4505
CS/056/09-10
(+) VE
102.67%
84.
SZ/TAMILNADU/MADURAI-II/BC/02/4781
CS/051/09-10
(+) VE
101.30%
85.
CS/074/09-10
(+) VE
96.51%
86.
EZ/TAMILNADU/VILLAGE/VIL/02/4527
CS/054/09-10
(+) VE
99.89%
87.
CS/066/09-10
(+) VE
93.39%
88.
CS/069/09-10
(+) VE
92.55%
89.
WZ/CHHATTISGARH/AMBIKAPUR/T/02/12
CS/090/09-10
(+) VE
98.36%
90.
WZ/GUJARAT/MEHSANA/T/02/58
CS/095/09-10
(+) VE
100.62%
91.
CS/085/09-10
(+) VE
90.85%
92.
WZ/MAHARASHTRA/NASHIK/T/02/04
CS/098/09-10
(+) VE
98.27%
93.
EZ/OR/JHASUGUD/VIL/02/752
CS/079/09-10
(+) VE
92.64%
94.
WZ/CHHATTISGARH/AMBIKAPUR/
DHQ/02/02
CS/089/09-10
(+) VE
99.39%
92
95.
NZ/HARYANA/SONEPAT/DHQ/02/421
CS/067/09-10
(+) VE
94.64%
96.
WZ/GUJARAT/PALANPUR/DHQ/02/33
CS/096/09-10
(+) VE
96.03%
97.
NZ/UP/MEERUT/BC/02/969
CS/068/09-10
(+) VE
91.09%
98.
NZ/UP/BILGRAM/T/02/604
CS/071/09-10
(+) VE
91.08%
99.
SZ/TAMILNADU/VILLAGE/VIL/02/813
CS/053/09-10
(+) VE
100.87%
100.
CS/082/09-10
(+) VE
93.65%
CS/137/09-10
(+) VE
100.73%
101.
CIPROBID
Ciprofloxacin
Tablets
CDTL,
Chennai
102.
NZ/RAJASTHAN/DESHNOKE/T/03/03
CS/127/09-10
(+) VE
96.93%
103.
CS/141/09-10
(+) VE
103.80%
104.
CS/117/09-10
(+) VE
97.13%
105.
NZ/UP/RAIBARELI/DHQ/03/814
CS/125/09-10
(+) VE
93.70%
106.
WZ/GUJARAT/GANDHIDHAM/T/03/03
CS/136/09-10
(+) VE
105.03%
107.
WZ/MAHARASHTRA/NAGPUR/BC/3/26
CS/143/09-10
(+) VE
100.90%
108.
CS/123/09-10
(+) VE
97.51%
109.
NZ/HR/FARIDABAD/DHQ/03/577
CS/122/09-10
(+) VE
94.95%
110.
CS/140/09-10
(+) VE
98.86%
111.
SZ/TAMILNADU/THIRUVARUR/T/03/3226
CS/107/09-10
(+) VE
94.86%
112.
SZ/TAMILNADU/VILLUPURAM/T/03/1628
CS/109/09-10
(+) VE
91.42%
113.
WZ/MAHARASHTRA/RAIGAD/DHQ/3/24
CS/144/09-10
(+) VE
102.00%
114.
SZ/TAMILNADU/NEYVELI/T/03/4565
CS/110/09-10
(+) VE
96.32%
115.
CS/134/09-10
(+) VE
101.28%
116.
NZ/RAJASTHAN/SIKAR/03/08
CS/129/09-10
(+) VE
97.28%
117.
SZ/ANDHRA PRADESH/KAKINADA/
T/03/3263
CS/112/09-10
(+) VE
95.89%
118.
WZ/MADHYAPRADESH/UJJAIN/VIL/3/10
CS/149/09-10
(+) VE
102.27%
119.
SZ/PONDICHERRY-3/T/03/4416
CS/111/09-10
(+) VE
97.16%
120.
EZ/BR/MAIRWA/T/03/817
CS/130/09-10
(+) VE
97.04%
121.
CS/142/09-10
(+) VE
102.18%
122.
WZ/CHHATTISGARH/BILASPUR/BC/3/80
CS/138/09-10
(+) VE
103.11%
123.
CS/103/09-10
(+) VE
99.85%
124.
SZ/TAMIL NADU/CHENNAI (V)/

MC/03/5410
CS/105/09-10
(+) VE
95.09%
125.
CS/121/09-10
(+) VE
95.68%
126.
CS/120/09-10
(+) VE
97.65%
127.
CS/106/09-10
(+) VE
100.68%
128.
EZ/BR/SIWAN/DHQ/03/744
CS/131/09-10
(+) VE
103.31%
129.
SZ/ANDHRAPRADESH/VILLAGE/VIL/
O3/3878
CS/113/09-10
(+) VE
91.72%
130.
NZ/UP/LUCKNOW/BC/03/799
CS/124/09-10
(+) VE
96.99%
131.
SZ/KERALA/KOCHI /BC/03/3067
CS/115/09-10
(+) VE
92.17%
132.
WZ/MAHARASHTRA/AMRAVATI/03/40
CS/139/09-10
(+) VE
91.24%
133.
SZ/TAMILNADU/CHENNAI (E)/
MC/03/1215
CS/101/09-10
(+) VE
99.55%
134.
CS/114/09-10
(+) VE
96.20%
135.
WZ/MADHYAPRADESH/CHHINDWARA/
DHQ/03/45
CS/145/09-10
(+) VE
101.65%
136.
WZ/MADHYA PRADESH/SATNA/
DHQ/03/50
CS/148/09-10
(+) VE
100.09%
137.
CS/119/09-10
(+) VE
94.73%
138.
NZ/RAJASTHAN/HANUMANGARH/
DHQ/03/09
CS/128/09-10
(+) VE
92.34%
139.
SZ/TAMIL NADU/CHENNAI/MC/03/5074
CS/102/09-10
(+) VE
95.97%
140.
WZ/MADHYA PRADESH/DUGER /
DHQ/03/103
CS/147/09-10
(+) VE
103.03%
141.
WZ/GUJARAT/BHAVNAGAR/ DHQ/03/03
CS/135/09-10
(+) VE
99.68%
142.
SZ/TAMILNADU/TIRUNELVELI/BC/3/198
CS/108/09-10
(+) VE
102.91%
93
143.
SZ/TAMIL NADU/CHENNAI (M)/

MC/03/1442
CS/104/09-10
(+) VE
96.55%
144.
NZ/HIMACHAL PRADESH/NAHAN/
DHQ/03/75
CS/126/09-10
(+) VE
91.33%
145.
WZ/MADHYA PRADESH/SAGAR/
DHQ/03/29
CS/146/09-10
(+) VE
101.52%
146.
CS/116/09-10
(+) VE
96.82%
147.
CS/118/09-10
(+) VE
93.71%
148.
EZ/NAGALAND /KOHIMA/DHQ/03/185
CS/132/09-10
(+) VE
97.29%
149.
CS/133/09-10
(+) VE
98.27%
150.
WZ/MADHYA PRADESH/TIKAMGARH/
DHQ/03/81
CS/150/09-10
(+) VE
101.07%
Amoxycillin
Capsules
CDTL,
Chennai
CS/179/09-10
(+) VE
93.83%
152.
CS/180/09-10
(+) VE
95.34%
153.
EZ/BR/ARA/DHQ/04/436
CS/183/09-10
(+) VE
97.76%
154.
EZ/WB/CHATPARA/VIL/04/2268
CS/178/09-10
(+) VE
91.39%
155.
CS/169/09-10
(+) VE
103.36%
156.
NZ/UP/GZB/DHQ/04/1483
CS/172/09-10
(+) VE
99.59%
157.
CS/170/09-10
(+) VE
100.25%
158.
CS/171/09-10
(+) VE
102.15%
159.
EZ/WB/CHAKDH/T/04/2458
CS/177/09-10
(+) VE
90.90%
160.
WZ/MADHYA PRADESH/CHHINDWARA
/DHQ/04/58
CS/197/09-10
(+) VE
93.22%
161.
CS/196/09-10
(+) VE
91.88%
162.
NZ/RAJASTHAN/JANRANAR/VIL/04/497
CS/174/09-10
(+) VE
97.70%
163.
NZ/GUJARAT/SURAT/BC/4/23
CS/192/09-10
(+) VE
93.93%
164.
CS/182/09-10
(+) VE
93.19%
165.
CS/173/09-10
(+) VE
101.51%
166.
EZ/WB/BURDWAN/T/04/1025
CS/176/09-10
(+) VE
91.04%
167.
EZ/OR/CUTTACK/BC/04/287
CS/184/09-10
(+) VE
101.55%
168.
SZ/ANDHRA PRADESH/ANAKAPALLE/
VIL/04/2543
CS/160/09-10
(+) VE
101.51%
169.
WZ/MADHYA RADESH/TIKAMGARH/
DHQ/04/143
CS/200/09-10
(+) VE
92.03%
170.
SZ/KARNATAKA/VILLAGE/VIL/04/4667
CS/162/09-10
(+) VE
97.06%
171.
CS/195/09-10
(+) VE
92.29%
172.
SZ/TAMILNADU/PARAMAKUDI/T/04/4967
CS/156/09-10
(+) VE
100.24%
173.
CS/168/09-10
(+) VE
101.90%
174.
CS/158/09-10
(+) VE
102.78%
175.
SZ/TAMILNADU/CHENNAI-U/MC/4/5508
CS/155/09-10
(+) VE
102.13%
176.
CS/181/09-10
(+) VE
98.63%
177.
CS/164/09-10
(+) VE
99.37%
178.
SZ/TAMILNADU/CHENNAI(N) /
MC/04/1683
CS/151/09-10
(+) VE
99.45%
179.
SZ/TN/PONNELI/T/04/2124
CS/157/09-10
(+) VE
104.00%
180.
CS/167/09-10
(+) VE
96.38%
181.
SZ/ANDHRA PRADESH/CHITTOOR/
T/04/3363
CS/161/09-10
(+) VE
104.31%
182.
CS/166/09-10
(+) VE
102.80%
183.
CS/165/09-10
(+) VE
99.04%
184.
SZ/TAMILNADU/CHENNAI/MC/04/5126
CS/152/09-10
(+) VE
98.60%
185.
CS/163/09-10
(+) VE
103.12%
186.
CS/159/09-10
(+) VE
103.62%
187.
SZ/TAMILNADU/CHENNAI-S/MC/04/5275
CS/154/09-10
(+) VE
97.69%
188.
CS/153/09-10
(+) VE
97.50%
189.
WZ/MADHYAPRADESH/TIKAMGARH/
DHQ/04/06
CS/199/09-10
(+) VE
94.01%
151.
94
MOX
190.
WZ/MAHARASHTRA/AMRAVATI/T/04/04
CS/193/09-10
(+) VE
92.39%
191.
CS/194/09-10
(+) VE
96.14%
192.
WZ/GUJARAT/GUNAGADH/T/04/34
CS/190/09-10
(+) VE
101.13%
193.
WZ/GUJARAT/BHAVNAGAR/DHQ/04/04
CS/189/09-10
(+) VE
95.18%
194.
WZ/GUJARAT/AHMEDABAD/BC/04/41
CS/187/09-10
(+) VE
98.75%
195.
EZ/WB/BAJEMALIA/VIL/04/2081
CS/175/09-10
(+) VE
99.32%
196.
WZ/GUJARAT/PORBANDAR/VIL/04/17
CS/191/09-10
(+) VE
98.57%
197.
WZ/MADHYA PRADESH/CHHINDWARA
/DHQ/04/104
CS/198/09-10
(+) VE
91.04%
198.
CS/188/09-10
(+) VE
98.39%
199.
DHQ/04/19
CS/185/09-10
(+) VE
99.39%
200.
WZ/CHHATTISGARH/RAIGARH/
DHQ/04/33
CS/186/09-10
(+) VE
98.20%
CS/221/09-10
(+) VE
97.03%
201.
NOVAMOX
Amoxycillin
Capsules
SZ/KERALA/THIRUVANANTHAPURAM/
BC/05/1816
CDTL,
Chennai
202.
WZ/CHHATTISGARH/ JAGDALPUR/
DHQ/05/15
CS/245/09-10
(+) VE
92.46%
203.
SZ/ANDHRAPRADESH /HYDERABAD/
BC/05/2642
CS/213/09-10
(+) VE
102.35%
204.
EZ/WB/SODEPUR/ MC/5/3753
CS/242/09-10
(+) VE
93.97%
205.
SZ/ANDHRAPRADESH/VISHAKHAPATNAM/BC/05/3315
CS/215/09-10
(+) VE
93.28%
206.
CS/237/09-10
(+) VE
92.42%
207.
WZ/MAHARASHTRA/ NANDURBAR/
DHQ/05/08
CS/249/09-10
(+) VE
99.59%
208.
SZ/KARNATKA/TUMKUR/DHQ/05/4261
CS/216/09-10
(+) VE
96.49%
209.
EZ/WB/PATNA/BC/05/775
CS/241/09-10
(+) VE
95.28%
210.
SZ/TAMIL NADU/CHENNAI-Q/MC/05/5459
CS/204/09-10
(+) VE
100.63%
211.
EZ/WB/KOL/MC/5/1666
CS/238/09-10
(+) VE
96.15%
212.
CS/235/09-10
(+) VE
96.17%
213.
CS/226/09-10
(+) VE
94.43%
214.
SZ/ANDHRA PRADESH/ SULURPET/

T/05/2010
CS/214/09-10
(+) VE
99.66%
215.
CS/236/09-10
(+) VE
97.58%
216.
CS/230/09-10
(+) VE
92.74%
217.
SZ/KARNATAKA/ VILLAGE/VIL/05/4668
CS/218/09-10
(+) VE
95.76%
218.
SZ/TAMILNADU/CUDDALORE/
DHQ/05/979
CS/206/09-10
(+) VE
96.21%
219.
SZ/KARNATAKA/ KOLAR/DHQ/05/4126
CS/217/09-10
(+) VE
92.68%
220.
EZ/WB/KOL/MC/5/1454
CS/232/09-10
(+) VE
92.75%
221.
EZ/WB/ KOL/MC/5/1464
CS/233/09-10
(+) VE
93.76%
222.
EZ/WB/KOL/MC/5/1747
CS/234/09-10
(+) VE
94.60%
223.
SZ/KERALA/ VILLAGE/VIL/05/5724
CS/223/09-10
(+) VE
102.28%
224.
WZ/GUJARAT/SURAT/BC/5/74
CS/246/09-10
(+) VE
100.66%
225.
EZ/WB/BANKURA/DHQ/5/2839
CS/240/09-10
(+) VE
92.55%
226.
SZ/TAMIL NADU/CHENNAI(F)/MC/05/1262
CS/201/09-10
(+) VE
97.25%
227.
NZ/NCT DELHI/DELHI/MC/O5/402
CS/227/09-10
(+) VE
93.32%
228.
SZ/TAMILNADU/THIRUVANNAMALAI
/T/05/2580
CS/209/09-10
(+) VE
102.13%
229.
NZ/HP/BADDI/T/05/286
CS/228/09-10
(+) VE
97.49%
230.
CS/231/09-10
(+) VE
94.71%
231.
SZ/TAMILNADU/PANRUTI/T/05/1875
CS/208/09-10
(+) VE
94.03%
232.
SZ/TAMILNADU/CHENNAI (W)/
MC/05/4592
CS/203/09-10
(+) VE
101.25%
233.
EZ/JHK/RANCHI/BC/05/113
CS/244/09-10
(+) VE
99.01%
95
234.
CS/205/09-10
(+) VE
95.92%
235.
NZ/HARYANA/PANIPAT/DHQ/05/601
CS/229/09-10
(+) VE
95.38%
236.
CS/248/09-10
(+) VE
96.85%
237.
WZ/MADHYA PRADESH/ INDORE/

BC/05/26
CS/247/09-10
(+) VE
99.63%
238.
WZ/MADHYA PRADESH/ TIKAMGARH/

DHQ/05/138
CS/250/09-10
(+) VE
99.28%
239.
SZ/TAMILNADU/KUMBAKONAM/T/
O5/934
CS/207/09-10
(+) VE
97.88%
240.
CS/220/09-10
(+) VE
91.87%
241.
T/05/3364
CS/211/09-10
(+) VE
102.71%
242.
SZ/ANDHRA PRADESH/NELLORE/
DHQ/05/2710
CS/212/09-10
(+) VE
101.99%
243.
CS/224/09-10
(+) VE
93.30%
244.
EZ/WB/KOL/MC/5/1508
CS/243/09-10
(+) VE
99.51%
245.
EZ/WB/KOL/MC/5/1747
CS/239/09-10
(+) VE
99.89%
246.
CS/219/09-10
(+) VE
98.40%
247.
CS/225/09-10
(+) VE
93.98%
248.
CS/222/09-10
(+) VE
95.53%
249.
SZ/TAMIL NADU/CHENNAI (M)/

MC/05/1444
CS/202/09-10
(+) VE
96.04%
250.
CS/210/09-10
(+) VE
102.80%
CS/297/09-10
(+) VE
102.60%
104.55%
251.
SEPTRAN
Co-trimoxazole
Tablets
EZ/WB/NALIKUL/VIL/07/2095
CDTL,
Chennai
252.
CS/288/09-10
(+) VE
98.46%
96.02%
253.
SZ/TAMILNADU/MANNURGUDI/T/07/2857
CS/255/09-10
(+) VE
105.80%
99.37%
254.
EZ/WB/ICHAPUR/TOWN/07/3568
CS/300/09-10
(+) VE
99.43%
102.68%
255.
CS/267/09-10
(+) VE
98.93%
97.90%
256.
SZ/TAMILNADU/CHENNAI/T/MC/7/4827
CS/264/09-10
(+) VE
257.
SZ/TN/SRIPERUMDUDUN/T/07/1736
CS/259/09-10
(+) VE
98.61%
101.32%
258.
SZ/TAMILNADU/VILLAGE/07/4729
CS/269/09-10
(+) VE
100.21%
97.91%
259.
SZ/TAMILNADU/VADALUR/T/07/2348
CS/266/09-10
(+) VE
98.21%
105.42%
260.
CS/286/09-10
(+) VE
102.92%
97.23%
SZ/TN/PONNEGI/T/07/2127
CS/258/09-10
(+) VE
99.19%
101.26%
262.
CS/260/09-10
(+) VE
101.49%
102.94%
263.
NZ/UP/SAHARANPUR/DHQ/07/896
CS/281/09-10
(+) VE
102.58%
97.50%
264.
SZ/TAMILNADU/COIMBATORE/BC/07/146
CS/253/09-10
(+) VE
97.50%
105.50%
265.
CS/261/09-10
(+) VE
94.62%
98.43%
266.
SZ/TAMILNADU/KANYAKUMARI/
DHQ/07/4912
CS/254/09-10
(+) VE
95.96%
99.42%
261.
96
98.61%
101.32%
267.
SZ/WB/NAIHATI/T/07/2647
CS/296/09-10
(+) VE
99.05%
101.60%
268.
EZ/WB/CHANDONNAGAR/T/07/2981
CS/291/09-10
(+) VE
99.28%
98.72%
269.
CS/290/09-10
(+) VE
97.88%
100.39%
270.
CS/287/09-10
(+) VE
98.15%
101.26%
271.
EZ/WB/TITAGAR/MC/07/3644
CS/299/09-10
(+) VE
100.12%
98.28%
272.
CS/277/09-10
(+) VE
102.64%
97.62%
273.
NZ/UTTARPRADESH/DADRI/T/07/1085
CS/275/09-10
(+) VE
102.01%
93.69%
274.
NZ/UTTAR PRADESH/BULANDSHAHAR/
DHQ/07/1286
CS/273/09-10
(+) VE
100.92%
99.39%
275.
CS/278/09-10
(+) VE
100.27%
104.53%
276.
NZ/UP/AGRA/BC/07/1344
CS/272/09-10
(+) VE
100.01%
103.39%
277.
NZ/UP/ROHTA/T/07/628
CS/280/09-10
(+) VE
98.66%
101.39%
278.
NZ/UP/GHAZIABAD/DHQ./07/1017
CS/276/09-10
(+) VE
106.10%
100.55%
279.
SZ/TAMIL NADU/CHENNAI-Q/MC/07/5466
CS/251/09-10
(+) VE
105.21%
100.17%
280.
SZ/KARNATAKA/MANGALORE/
BC/07/4179
CS/271/09-10
(+) VE
105.28%
101.58%
281.
CS/262/09-10
(+) VE
104.15%
100.36%
282.
CS/268/09-10
(+) VE
98.56%
96.34%
283.
SZ/TAMILNADU/CHIDAMBARAM/
T/07/2503
CS/252/09-10
(+) VE
102.99%
99.71%
284.
SZ/TAMILNADU/MAYILKADUTURAI/
T/07/3047
CS/256/09-10
(+) VE
104.64%
97.56%
285.
CS/257/09-10
(+) VE
97.70%
98.07%
286.
EZ/WB/HOW/DHQ/07/3058
CS/294/09-10
(+) VE
96.52%
104.38%
287.
CS/285/09-10
(+) VE
99.94%
96.38%
288.
NZ/UTTAR PRADESH/BULANDSHAHAR/
DHQ/07/1308
CS/274/09-10
(+) VE
101.43%
98.51%
289.
EZ/WB/SURJYAPUR/VIL/07/3031
CS/298/09-10
(+) VE
101.25%
104.53%
290.
SZ/TAMILNADU/CHENNAI(W)
MC/07/1495
CS/263/09-10
(+) VE
100.61%
101.76%
291.
CS/279/09-10
(+) VE
104.45%
95.02%
292.
CS/295/09-10
(+) VE
103.18%
105.75%
293.
CS/282/09-10
(+) VE
99.78%
103.96%
294.
EZ/WB/ HINDMOTOR/T/07/2098
CS/293/09-10
(+) VE
99.41%
96.01%
97
295.
CS/284/09-10
(+) VE
96.04%
100.04%
296.
CS/283/09-10
(+) VE
92.68%
97.46%
297.
CS/289/09-10
(+) VE
100.72%
99.49%
298.
CS/265/09-10
(+) VE
95.47%
101.10%
299.
EZ/WB/DEULA/VIL/07/2770
CS/292/09-10
(+) VE
100.83%
97.10%
300.
CS/270/09-10
(+) VE
101.13%
96.16%
CS/302/09-10
(+) VE
105.59%
102.52%
301.
CIPLIN
Co-trimoxazole
Tablets
NZ/UTTARANCHAL/DEHRADUN/
BC/08/494
CDTL,
Chennai
302.
NZ/UP/RAIBARELI/DHQ/08/666
CS/304/09-10
(+) VE
103.43%
98.56%
303.
BC/08/4072
CS/301/09-10
(+) VE
102.39%
103.09%
304.
CS/308/09-10
(+) VE
99.18%
105.43%
305.
WZ/MADHYA PRADESH/BHOPAL/
BC/08/10
CS/310/09-10
(+) VE
98.16%
104.40%
306.
WZ/MAHARASTRA/MUMBAI/MC/08/385
CS/309/09-10
(+) VE
99.85%
102.66%
307.
WZ/MAHARSHTRA/AURANGABAD/
BC/08/13
CS/307/09-10
(+) VE
94.61%
98.41%
308.
NZ/UP/KITHOR/T/08/30/995
CS/303/09-10
(+) VE
95.72%
99.99%
309.
WZ/GUJARAT/DAWAN/DHQ/08/09
CS/305/09-10
(+) VE
96.07%
98.34%
310.
CS/306/09-10
(+) VE
94.69%
99.29%
CS/318/09-10
(+) VE
93.40%
99.93%
311.
BACTRIM
Trimethoprim &
Sulphamethoxazole
Tablets
CDTL,
Chennai
312.
CS/331/09-10
(+) VE
102.79%
101.49%
313.
CS/314/09-10
(+) VE
102.44%
103.58%
314.
CS/335/09-10
(+) VE
98.68%
98.82%
315.
SZ/ANDHRAPRADESH/VIJAYWARA/
BC/09/3549
CS/322/09-10
(+) VE
98.24%
103.53%
316.
SZ/ANDHRAPRADESH/NELLORE/
DHQ/09/2713
CS/324/09-10
(+) VE
102.00%
102.03%
317.
SZ/KERALA/THRISSUR/BC/09/1917
CS/327/09-10
(+) VE
97.79%
96.50%
318.
SZ/TAMILNADU/KANCHIPURAM/
DHQ/09/253
CS/315/09-10
(+) VE
104.76%
102.20%
319.
CS/337/09-10
(+) VE
100.20%
101.21%
320.
EZ/BR/CHHAPRA/DHQ/09/498
CS/344/09-10
(+) VE
99.71%
97.60%
321.
WZ/MAHARASHTRA/SOLAPUR/DHQ/
T/29
CS/358/09-10
(+) VE
97.31%
98.84%
98
322.
CS/317/09-10
(+) VE
99.93%
105.83%
323.
NZ/PUNJAB/VILLAGE/VIL/09/504
CS/333/09-10
(+) VE
100.74%
98.99%
324.
CS/330/09-10
(+) VE
96.99%
99.60%
325.
CS/355/09-10
(+) VE
104.29%
106.03%
326.
SZ/TAMILNADU/ULUNDURPET/T/09/3024
CS/316/09-10
(+) VE
95.55%
103.64%
327.
SZ/TAMILNADU/CHENNAI(E)/MC/09/1218
CS/313/09-10
(+) VE
96.59%
99.98%
328.
SZ/ANDHRA PRADESH/GUNTUR/
T/09/2947
CS/323/09-10
(+) VE
97.18%
102.59%
329.
SZ/ANDHRA PRADESH/GUDUR/T/09/2292
CS/320/09-10
(+) VE
100.86%
99.19%
330.
WZ/MAHARASHTRA/RAIGAD/VIL/09/24
CS/357/09-10
(+) VE
100.56%
102.14%
331.
CS/353/09-10
(+) VE
96.93%
98.45%
332.
CS/338/09-10
(+) VE
100.67%
99.70%
333.
EZ/WB/KALYANI/T/09/2745
CS/341/09-10
(+) VE
100.36%
101.87%
334.
WZ/MAHARASHTRA/AURANGABAD/
BC/09/14
CS/354/09-10
(+) VE
100.66%
102.26%
335.
NZ/UTTARAKHAND/PITHORAGARH/
BC/09/415
CS/334/09-10
(+) VE
98.87%
99.34%
336.
CS/356/09-10
(+) VE
97.12%
96.21%
337.
EZ/ASSAM/TINSUKIA/TOWN/09/566
CS/343/09-10
(+) VE
96.18%
97.99%
338.
SZ/KERALA/THIRUVANAN THAPURAM/
BC/09/1819
CS/326/09-10
(+) VE
102.51%
97.35%
339.
CS/336/09-10
(+) VE
96.58%
102.05%
340
SZ/KARNATAKA/UDUPI/DHQ/09/4220
CS/325/09-10
(+) VE
99.32%
100.88%
341.
EZ/JHARKHAND/JAMSHEDPUR/BC/09/329
CS/348/09-10
(+) VE
96.40%
97.92%
342.
DHQ/09/90
CS/360/09-10
(+) VE
100.17%
101.69%
343.
EZ/OR/DHENKANAL/T/09/719
CS/346/09-10
(+) VE
99.14%
100.67%
344.
EZ/WB/JAYNGOR/T/09/3402
CS/340/09-10
(+) VE
103.19%
103.85%
345.
CS/339/09-10
(+) VE
102.33%
100.63%
346.
CS/342/09-10
(+) VE
98.94%
101.35%
347.
WZ/MADHYA PRADESH/TIKAMGARH
/DHQ/09/34
CS/359/09-10
(+) VE
101.73%
103.36%
348.
EZ/NE/AGARTALA/BC/09/178
CS/345/09-10
(+) VE
100.99%
102.63%
349.
WZ/GUJARAT/AHMEDABAD/BC/47
CS/350/09-10
(+) VE
97.68%
99.18%
99
350.
SZ/TAMILNADU/CHENNAI(M)/MC/09/1446
CS/311/09-10
(+) VE
95.16%
99.00%
351.
SZ/TAMILNADU/DHARAMPUR/T/09/5664
CS/312/09-10
(+) VE
99.39%
98.67%
352.
WZ/GUJARAT/BHAVNAGAR/VIL/09/93
CS/352/09-10
(+) VE
98.08%
99.63%
353.
WZ/CHHATTISGARH/DURG/DHQ/09/09
CS/349/09-10
(+) VE
100.97%
102.50%
354.
CS/328/09-10
(+) VE
102.29%
94.99%
355.
CS/329/09-10
(+) VE
98.09%
100.02%
356.
CS/319/09-10
(+) VE
99.45%
103.93%
357.
SZ/ANDHRAPRADESH/NAGUDUPPET/
T/09/2031
CS/321/09-10
(+) VE
100.89%
101.58%
358.
WZ/GUJARAT/GANDHINAGAR/
DHQ/09/10
CS/351/09-10
(+) VE
101.95%
103.55%
359.
EZ/OR/JAGATSINGHPUR/T/09/110
CS/347/09-10
(+) VE
95.74%
97.22%
360.
NZ/PUNJAB/BASTI/VIL/09/498
CS/332/09-10
(+) VE
100.37%
98.47%
32-4/2009-SS/SZN-76
(+) VE
107.9%
361.
DEXONA
Dexamethasone
Tablets
NZ/J&K/UDHAMPUR/DHQ/10/283
CDL,
Kolkata
362.
WZ/MADHYAPRADESH/UJJAIN/
DHQ/10/43
32-4/2009-SS/SZN-84
(+) VE
110.0%
363.
EZ/BR/SIWAN/T/10/755
32-4/2009-SS/SZN-57
(+) VE
104.8%
364.
32-4/2009-SS/SZN-97
(+) VE
98.8%
365.
32-4/2009-SS/SZN-102
(+) VE
109.4%
366.
EZ/OR/BERHAMPUR/VIL/10/07
32-4/2009-SS/SZN-69
(+) VE
100.5%
367.
SZ/TAMILNADU/KALLUKURUCHI/
T/10/3297
32-4/2009-SS/SZN-99
(+) VE
99.3%
368.
DHQ/10/129
32-4/2009-SS/SZN-89
(+) VE
91.4%
369.
NZ/UTTARAKHAND/DUNAGREE
CHURHU/VIL/10/333
32-4/2009-SS/SZN-71
(+) VE
103.0%
370.
32-4/2009-SS/SZN-86
(+) VE
94.7%
371.
EZ/BR/POTHO/VIL/10/88
32-4/2009-SS/SZN-61
(+) VE
101.8%
372.
WZ/MAHARASTHRA/SOLAPUR/T/10/47
32-4/2009-SS/SZN-88
(+) VE
93.6%
373.
NZ/HIMACHAL PRADESH/BAIJNATH/
T/10/37
32-4/2009-SS/SZN-77
(+) VE
110.0%
374.
32-4/2009-SS/SZN-93
(+) VE
96.9%
375.
NZ/RAJ/SITAPURA/T/10/105
32-4/2009-SS/SZN-72
(+) VE
94.2%
376.
EZ/OR/CUTTACK/DHQ/10/311
32-4/2009-SS/SZN-65
(+) VE
92.2%
377.
WZ/CHHATTISGARH/RAIGAD/
DHQ/10/03
32-4/2009-SS/SZN-90
(+) VE
92.2%
378.
EZ/WB/SILIGURI/T/10/437
32-4/2009-SS/SZN-58
(+) VE
107.2%
379.
SZ/KARNATAKA/KOCARS/DHQ/10/4130
32-4/2009-SS/SZN-98
(+) VE
107.7%
380.
EZ/JHARKHAND/DEOGHAR/T/10/559
32-4/2009-SS/SZN-64
(+) VE
96.7%
381.
32-4/2009-SS/SZN-95
(+) VE
95.9V
382.
EZ/WB/KOLKATA/MC/10/3097/55
32-4/2009-SS/SZN-66
(+) VE
106.0%
383.
32-4/2009-SS/SZN-87
(+) VE
95.0%
384.
NZ/PUNJAB/ZIRAKAPUR/T/10/553
32-4/2009-SS/SZN-73
(+) VE
96.9%
385.
NZ/UTTARPRADESH/GHAZIABAD/
DHQ/10/1325
32-4/2009-SS/SZN-78
(+) VE
105.2%
386.
32-4/2009-SS/SZN-63
(+) VE
107.0%
387.
32-4/2009-SS/SZN-67
(+) VE
106.5%
100
388.
EZ/TAMILNADU/CUDDALORE/
DHQ/10/983
32-4/2009-SS/SZN-103
(+) VE
110.0%
389.
EZ/WB/KHARAGPUR/T/10/898
32-4/2009-SS/SZN-62
(+) VE
102.8%
390.
32-4/2009-SS/SZN-85
(+) VE
90.8%
391.
32-4/2009-SS/SZN-104
(+) VE
110.0%
392.
32-4/2009-SS/SZN-68
(+) VE
97.5%
393.
EZ/ASSAM/TEZPUR/TOWN/10/512
32-4/2009-SS/SZN-56
(+) VE
92.0%
394.
EZ/ASSAM/GOLAGHAT/VIL/10/359
32-4/2009-SS/SZN-70
(+) VE
97.4%
395.
SZ/ANDHRA PRADESH/SULURPUR/
T/10/2012
32-4/2009-SS/SZN-91
(+) VE
102.2%
396.
EZ/WB/SHEAKHALA/VIL/10/3228
32-4/2009-SS/SZN-59
(+) VE
110.0%
397.
SZ/TAMILNADU/CHENNAI(H)/MC/10/1347
32-4/2009-SS/SZN-105
(+) VE
97.7%
398.
32-4/2009-SS/SZN-83
(+) VE
110.0%
399.
32-4/2009-SS/SZN-96
(+) VE
97.6%
400.
SZ/KERALA/ALLEPEY/DHQ/10/3599/
32-4/2009-SS/SZN-94
(+) VE
95.7%
401.
EZ/WB/RAJPUR/MC/10/2348
32-4/2009-SS/SZN-60
(+) VE
105.0%
402.
32-4/2009-SS/SZN-82
(+) VE
95.7%
403.
NZ/UTTARPRADESH/DADRI/T/10/1071
32-4/2009-SS/SZN-80
(+) VE
102.9%
404.
32-4/2009-SS/SZN-81
(+) VE
98.7%
405.
SZ/TAMILNADU/KURNDAKONAM/
T/10/2880
32-4/2009-SS/SZN-101
(+) VE
108.4%
406.
SZ/KERALA/CHALAKUDY/T/10/2916
32-4/2009-SS/SZN-92
(+) VE
97.7%
407.
NZ/UP/MUZAFFARNAGAR/DHQ/1672
32-4/2009-SS/SZN-74
(+) VE
90.0%
408.
SZ/TAMILNADU/CHENNAI (M)/
MC/10/1447
32-4/2009-SS/SZN-100
(+) VE
98.2%
409.
NZ/UP/MASOURI/VIL/10/1422
32-4/2009-SS/SZN-75
(+) VE
100.4%
32-4/2009-SS/SZN-79
(+) VE
110.0%
32-4/2009-SS/SZN-107
(+) VE
90.0%
410.
411.
NZ/RAJ/JUKARNAGAR/T/10/97
DECDAN
Dexamethasone
Tablets
EZ/WB/JULIA/VIL/11/3461
CDL,
Kolkata
412.
EZ/WB/SUBHASGRAM/MC/11/2409
32-4/2009-SS/SZN-112
(+) VE
106.0%
413.
EZ/JH/RATUROAD/T/11/58
32-4/2009-SS/SZN-116
(+) VE
90.0%
414.
EZ/BR/GAYA/DHQ/11/603
32-4/2009-SS/SZN-117
(+) VE
90.0%
415.
32-4/2009-SS/SZN-154
(+) VE
98.5%
416.
32-4/2009-SS/SZN-147
(+) VE
96.0%
417.
32-4/2009-SS/SZN-146
(+) VE
102.0%
418.
EZ/WB/NAIHATI/T/11/2731
32-4/2009-SS/SZN-106
(+) VE
105.2%
419.
SZ/KERALA/ATTINBAL/T/11/2260
32-4/2009-SS/SZN-141
(+) VE
92.4%
420.
NZ/J&K/MIRANSAHIB/T/11/295
32-4/2009-SS/SZN-126
(+) VE
108.0%
421.
EZ/OR/PURI/DHQ/11/527
32-4/2009-SS/SZN-120
(+) VE
101.2%
422.
NZ/UP/ZAIDPUR/TOWN/11/384
32-4/2009-SS/SZN-130
(+) VE
98.2%
423.
NZ/J&K/JAMMU/BC/11/335
32-4/2009-SS/SZN-137
(+) VE
98.2%
424.
BC/11/500
32-4/2009-SS/SZN-123
(+) VE
97.6%
425.
EZ/JHARKHAND/BOKARO//BC/11/190
32-4/2009-SS/SZN-118
(+) VE
96.7%
426.
SZ/TAMILNADU/THIRUTAVRAIPOONZI/
T/11/458
32-4/2009-SS/SZN-149
(+) VE
96.0%
427.
32-4/2009-SS/SZN-153
(+) VE
98.7%
428.
32-4/2009-SS/SZN-139
(+) VE
104.0%
429.
SZ/TAMILNADU/KUMBOKONAM/T/11/2881
32-4/2009-SS/SZN-151
(+) VE
99.5%
430.
SZ/ANDHRAPRADESH/SULURPET/T/11/2013
32-4/2009-SS/SZN-136
(+) VE
98.8%
431.
32-4/2009-SS/SZN-111
(+) VE
98.0%
432.
32-4/2009-SS/SZN-113
(+) VE
99.0%
433.
EZWB/ULVBERIA/VIL/11/1376
32-4/2009-SS/SZN-109
(+) VE
94.7%
434.
EZ/WB/KUMBHAT/VIL/11/2396
32-4/2009-SS/SZN-121
(+) VE
102.0%
435.
SZ/KERALA/PALAKAD/DHQ/11/2759
32-4/2009-SS/SZN-140
(+) VE
99.5%
436.
NZ/J&K/BAKSHINAGER/T/11/1881
32-4/2009-SS/SZN-125
(+) VE
102.0%
437.
NZ/PUNJAB/JALANDHAR/BC/11/343
32-4/2009-SS/SZN-122
(+) VE
98.6%
101
438.
NZ/HIMACHALPRADESH//KANGRA/
T/11/20
32-4/2009-SS/SZN-127
(+) VE
91.0%
439.
NZ/UP/BHADOHI/DHQ/11/392
32-4/2009-SS/SZN-131
(+) VE
100.2%
440.
NZ/UP/ZAIDPUR/TOWN/11/383
32-4/2009-SS/SZN-135
(+) VE
91.8%
441.
EZ/WB/SONARPUR/MC/11/2361
32-4/2009-SS/SZN-115
(+) VE
102.6%
442.
NZ/UP/MOHAMADPUR/VILLAGE/11/393
32-4/2009-SS/SZN-133
(+) VE
90.0%
443.
EZ/NE/IRINAI/VIL/11/183
32-4/2009-SS/SZN-114
(+) VE
97.0%
444.
32-4/2009-SS/SZN-155
(+) VE
92.3%
445.
EZ/OR/BALASORE/T/11/174
32-4/2009-SS/SZN-119
(+) VE
99.5%
446.
NZ/HIMACHAL PRADESH/HAROLI/
VIL/11/21
32-4/2009-SS/SZN-129
(+) VE
92.5%
447.
NZ/RAJASTHAN/BIKANER/DHQ/11/585
32-4/2009-SS/SZN-124
(+) VE
100.0%
448.
NZ/HIMACHAL PRADESH/SUNDER NAGAR/T/11/22
32-4/2009-SS/SZN-128
(+) VE
92.0%
449.
NZ/UTTAR PRADESH/MODINAGAR/
T/11/1238
32-4/2009-SS/SZN-132
(+) VE
94.0%
450.
NZ/TAMILNADU/NAGERCOIL/T/11/667
32-4/2009-SS/SZN-148
(+) VE
99.2%
451.
32-4/2009-SS/SZN-142
(+) VE
95.0%
452.
NZ/UP/ROHTA/VILLAGE/11/386
32-4/2009-SS/SZN-134
(+) VE
110.0%
453.
32-4/2009-SS/SZN-152
(+) VE
98.0%
454.
SZ/TN/JHIRAVALLU/T/11/1804
32-4/2009-SS/SZN-145
(+) VE
98.0%
455.
32-4/2009-SS/SZN-138
(+) VE
105.5%
456.
SZ/TAMILNADU/TANJORE/DHQ/11/891
32-4/2009-SS/SZN-143
(+) VE
96.0%
457.
SZ/TAMIL NADU/VIRUDHACHALAM/
T/11/3146
32-4/2009-SS/SZN-150
(+) VE
90.2%
458.
32-4/2009-SS/SZN-144
(+) VE
96.0%
459.
32-4/2009-SS/SZN-108
(+) VE
96.0%
460.
32-4/2009-SS/SZN-110
(+) VE
105.3%
461.
Decdak ST
Dexamethasone
Sodium
Phosphate
Tablets
CDL,
Kolkata
32-4/2009-SS/SZN-156
(+) VE
95.28%
462.
Wysolone
Prednisolone
Tablets
RDTL,
Guwahati
RDTL/DCGI/Survey/09-10/72
(+) VE
99.7%%
463.
EZ/WB/BANGAON/T/13/2144
(+) VE
100.8%
464.
EZ/WB/CHANDANAGAR/T/13/2963
(+) VE
102.0%
465.
EZ/WB/ASANSOL/T/13/1063
(+) VE
96.8%
466.
(+) VE
101.7%
467.
(+) VE
100.0%
468.
EZ/WB/ROHORA/TOWN/13/3626
(+) VE
98.1%
469.
(+) VE
96.5%
470.
(+) VE
98.8%
471.
EZ/WB/MAYAPUR/TOWN/13/3707
(+) VE
97.7%
472.
EZ/WB/KANCHRAPARA/T/13/2501
(+) VE
99.8%
473.
WZ/GUJARAT/GANDHINAGAR/T/13/20
(+) VE
99.1%
474.
EZ/WB/CHAKDAH/T/13/2461
(+) VE
97.6%
475.
(+) VE
99.5%
476.
(+) VE
98.2%
477.
(+) VE
100.8%
478.
EZ/WB/NABADWIP/TOWN/13/3680
(+) VE
98.7%
479.
(+) VE
100.4%
480.
(+) VE
98.7%
481.
(+) VE
101.6%
482.
(+) VE
100.5%
483.
(+) VE
99.8%
484.
(+) VE
100.5%
485.
WZ/MAHARASHTRA/MUMBAI/
MC/13/1281
(+) VE
99.1%
102
486.
(+) VE
97.3%
487.
(+) VE
99.3%
488.
NZ/UTTAR PRADESH/RAZAPUR/
VIL/13/1303
(+) VE
100.8%
489.
(+) VE
102.0%
490.
(+) VE
101.6%
491.
WZ/MAHARASHTRA/NANDURBAR/
DHQ/13/05
(+) VE
97.3%
492.
(+) VE
100.5%
493.
WZ/MAHARASHTRA/ THANE/BC/13/25
(+) VE
100.6%
494.
WZ/MAHARASHTRA/NANDED/T/13/15
(+) VE
98.3%
495.
(+) VE
98.8%
496.
(+) VE
98.7%
497.
(+) VE
101.4%
92.6%
498.
(+) VE
499.
WZ/MADHYAPRADESH/UJJAIN/T/13/33
(+) VE
99.9%
500.
(+) VE
98.0%
501.
(+) VE
99.8%
502.
EZ/WB/PALTA/TOWN/13/3542
(+) VE
94.9%
503.
(+) VE
96.3%
504.
WZ/GUJARAT/JUNAGARH/T/13/30
(+) VE
98.9%
505.
SZ/TN/CHENALPATTU/T/13/3719
(+) VE
100.2%
506.
DHQ/13/2716
(+) VE
96.1%
507.
(+) VE
102.0%
508.
(+) VE
98.4%
509.
(+) VE
102.0%
510.
SZ/PONDICHERRY-3/13/4424
(+) VE
105.8%
511.
SZ/TN/TAMBALAM/T/13/2327
(+) VE
95.2%
(+) VE
93.6%
512.
Omnacortil-5
Prednisolone
Dispersible Tablets
EZ/WB/SILIGURI/DHQ/14/455
RDTL,
Guwahati
513.
(+) VE
95.4%
514.
SZ/TAMILNADU/DHARMURI/T/14/549
(+) VE
95.8%
515.
SZ/TAMILNADU/CHENNAI (V)/
MC/14/5416
(+) VE
98.0%
516.
SZ/TN/JHIRUVALUR/T/14/3721
(+) VE
91.0%
517.
SZ/TAMIL NADU/SALEM/BC/14/12
(+) VE
90.2%
518.
SZ/TAMILNADU/CHENNAI/ (J)/ MC
14/1501
(+) VE
95.4%
519.
(+) VE
91.2%
520.
(+) VE
95.8%
521.
EZ/WB/KATWA/T/14/3247
(+) VE
93.5%
522.
SZ/TAMIL NADU/CHENNAI/MC/14/5368
(+) VE
92.6%
523.
(+) VE
93.8%
524.
NZ/UP/ALLAHABAD/BC/14/701
(+) VE
90.6%
525.
EZ/WB/CHANDARNAGAR/T/14/2971
(+) VE
92.2%
526.
EZ/WB/NADADUIP/TOWN/14/3693
(+) VE
90.4%
527.
(+) VE
93.0%
528.
EZ/WB/NANAYANTOLA/VIL/14/3032
(+) VE
90.2%
529.
(+) VE
94.6%
530.
SZ/TAMILNADU/CHENNAI (H)/MC/1351
(+) VE
90.0%
531.
SZ/TN/THIRUVANNAMALAI/T/14//2583
(+) VE
90.2%
532.
(+) VE
92.0%
533.
EZ/WB/JARAI/VIL/14/3156
(+) VE
90.4%
534.
(+) VE
90.8%
535.
NZ/UP/KHATTALI/TOWN/14/714
(+) VE
90.4%
103
536.
(+) VE
92.2%
537.
(+) VE
98.0%
538.
EZ/WB/ASHOKNAGAR/T/14/2114
(+) VE
94.4%
539.
(+) VE
90.6%
540.
(+) VE
90.2%
541.
EZ/WB/BARNIRHAT/T/14/3060/18
(+) VE
93.8%
542.
EZ/WB/SHANTIPUR/T/14/2800
(+) VE
93.4%
543.
(+) VE
90.4%
544.
SZ/TAMILNADU/THANJAVURE/
DHQ/14/340
(+) VE
98.8%
545.
(+) VE
93.6%
546.
(+) VE
95.2%
547.
EZ/WB/HIND MOTOR/14/3150
(+) VE
91.4%
548.
(+) VE
90.6%
549.
(+) VE
96.6%
550.
SZ/TAMILNADU/CHENNAI (B)/MC/1076
(+) VE
92.6%
551.
SZ/TN/PONNERI/T/14/2133
(+) VE
92.0%
552.
SZ/TAMILNADU/VILLAPURAM/T/14/1638
(+) VE
93.2%
553.
SZ/TAMILNADU/CHENNAI/(T)/MC/14/4832
(+) VE
93.0%
554.
SZ/TAMILNADU/PUDUKOTTAI/T/14/504
(+) VE
91.2%
555.
EZ/WB/MALANDAPUR/VIL/14/2283
(+) VE
90.4%
556.
(+) VE
94.4%
557.
(+) VE
93.8%
558.
EZ/WB/DURGAPUR/T/14/1292
(+) VE
96.4%
559.
(+) VE
94.6%
560.
(+) VE
90.4%
561.
(+) VE
92.6%
(+) VE
95.5%
562.
MEDROL
Methylprednisolone
Tablets
RDTL,
Guwahati
563.
SZ/TAMILNADU/CHENNAI (V)/
MC/15/5417
(+) VE
97.5%
564.
SZ/TAMILNADU/CHENNAI (F)/
MC/15/1270
(+) VE
96.6%
565.
SZ/TAMILNADU/CHENNAI(C)/MC/15/1124
(+) VE
94.2%
566.
NZ/UTTARAKHAND/RANIKHET/
DHQ/15/292
(+) VE
98.9%
567.
(+) VE
100.8%
568.
(+) VE
99.7%
569.
(+) VE
92.3%
570.
(+) VE
99.9%
571.
SZ/TAMILNADU/THENI/DHQ/15/431
(+) VE
97.4%
572.
(+) VE
95.4%
573.
(+) VE
96.5%
574.
(+) VE
96.0%
575.
WZ/MAHARASHTRA/NASHIK/VIL/15/04
(+) VE
94.6%
576.
WZ/MAHARASHTRA/RAIGAD/T/15/20
(+) VE
99.2%
577.
(+) VE
97.9%
578.
SZ/ANDHRAPRADESH/VIJAYAWADA/
BC/15 /3553
(+) VE
95.8%
579.
SZ/TAMILNADU/CHENNAI(T)/ MC/15/4833
(+) VE
96.8%
580.
NZ/UTTARAKHAND/PURUMDARA/
VIL/15/289
(+) VE
92.5%
581.
(+) VE
96.7%
582.
NZ/UTTARAKHAND/HALDWANI/
DHQ/15/286
(+) VE
100.2%
583.
SZ/TAMILNADU/CHENNAI(D)/MC/15/1175
(+) VE
99.9%
104
584.
(+) VE
96.2%
585.
(+) VE
96.8%
586.
SZ/TAMILNADU/CHENNAI (M)/
MC/15/1451
(+) VE
101.2%
587.
(+) VE
98.5%
588.
SZ/TAMILNDU/VILLAGE/VIL/15/5032
(+) VE
97.5%
589.
SZ/TAMILNADU/CHENNAI (G)/MC/1309
(+) VE
103.1%
590.
SZ/KERALA/VILLAGE//VIL/15/5703
(+) VE
98.5%
591.
(+) VE
92.3%
592.
SZ/TAMILNADU/NAGAPATTINAM/
DHQ/15/388
(+) VE
94.0%
593.
NZ/UTTARAKHAND/GARAMPANI/
VIL/15/288
(+) VE
99.0%
594.
DHQ/15 /4919
(+) VE
98.0%
595.
WZ/GUJARAT/HIMMATNAGAR/T/15/20
(+) VE
103.7%
596.
NZ/UTTARAKHAND/NAINITAL/
DHQ/15/487
(+) VE
97.8%
597.
NZ/UTTARAKHAND/ALMORA/BC/15/488
(+) VE
100.0%
598.
SZ/ANDHRA PRADESH/HYDERABAD/
BC/15/2647
(+) VE
99.2%
599.
(+) VE
97.4%
600.
NZ/UTTARAKHAND/HARIDWAR/
DHQ/15/290
(+) VE
98.8%
601.
NZ/UTTARAKHAND/GOHAUR/T/15/291
(+) VE
100.3%
602.
(+) VE
97.9%
603.
(+) VE
94.0%
604.
(+) VE
99.5%
605.
WZ/GUJARAT/DAMAN/T/15/02
(+) VE
100.4%
606.
DHQ/15/258
(+) VE
99.1%
607.
(+) VE
99.9%
608.
(+) VE
99.4%
609.
(+) VE
93.0%
610.
(+) VE
94.0%
611.
SZ/KERALA/VILLLAGE/VIL/15/5757
(+) VE
98.7%
(+) VE
104.8%
612.
Betnesol
Betamethasone
Sodium
Phosphate
Tablets
RDTL,
Guwahati
613.
(+) VE
102.8%
614.
EZ/OR/JATNI/VIL/16/561
(+) VE
99.0%
615.
EZ/WB/JAGADDAL/T/2693
(+) VE
101.4%
616.
EZ/WB/NARENDRAPUR/MC//16/2370
(+) VE
102.0%
617.
NZ/UP/CHAKROTA/T/16/163
(+) VE
104.0%
618.
(+) VE
102.4%
619.
SZ/TN/JHIRUVALLUR/T/16/1806
(+) VE
101.6%
620.
NZ/UP/CHAKRATA/T/16/164
(+) VE
104.0%
621.
SZ/KERALA/KOCHI/BC/16/3083
(+) VE
105.2%
622.
NZ/UP/BAMNT/T/16/1363
(+) VE
98.8%
623.
EZ/WB/DUTTAPUKUR/VIL/16/2240
(+) VE
100.6%
624.
WZ/MADHYAPRDESH/INDORE/BC/16/03
(+) VE
103.8%
625.
(+) VE
100.8%
626.
NZ/UP/BHOPURA/VIL/16/934
(+) VE
104.0%
627.
(+) VE
97.2%
628.
(+) VE
92.6%
629.
(+) VE
99.6%
105
630.
EZ/AP/ITANAGAR/BC/16/122
(+) VE
101.6%
631.
SZ/ANDHRAPRADESH/SECUNDRABAD/
BC /3664
(+) VE
104.0%
632.
EZ/WB/KOL/MC/1570
(+) VE
100.2%
633.
(+) VE
103.2%
634.
(+) VE
98.2%
635.
NZ/HARYANA/FARIDABAD/DHQ/16/587
(+) VE
104.0%
636.
NZ/UP/SAINI/VIL/16/149
(+) VE
100.6%
637.
EZ/WB/BELPUR/VIL/16/387
(+) VE
102.2%
638.
SZ/KARNATAKA/KOCAAS/DHQ/16/4134
(+) VE
100.4%
639.
(+) VE
101.2%
640.
(+) VE
101.0%
641.
BC/16/3925
(+) VE
101.4%
642.
(+) VE
104.0%
643.
(+) VE
104.0%
644.
NZ/MAHARASHTRA/NAGPUR/BC/16/03
(+) VE
97.6%
645.
(+) VE
100.8%
646.
(+) VE
98.6%
647.
NZ/UTTARAKHAND/JUALIKHOT/
VIL/16/49
(+) VE
102.2%
648.
SZ/KERALA/KOLLAM/BC/16/2813
(+) VE
100.8%
649.
(+) VE
101.8%
650.
(+) VE
103.8%
651.
SZ/ANDHRAPRADESH/RAJAHMUNDRY
/BC/16/3807
(+) VE
104.6%
652.
BC/16/5833
(+) VE
99.6%
653.
(+) VE
104.0%
654.
(+) VE
103.4%
655.
(+) VE
97.8%
656.
(+) VE
104.0%
657.
EZ/WB/MIDNAPUR/T/16/966
(+) VE
104.0%
658.
EZ/WB/USTI/VIL/16/3467
(+) VE
98.6%
659.
(+) VE
102.8%
660.
WZ/CHHATTISGARH/RAIPUR/BC/16/98
(+) VE
97.85
661.
(+) VE
103.2%
(+) VE
91.2%
662.
Betnelan
Betamethasone
Tablets
RDTL,
Guwahati
663.
(+) VE
96.0%
664.
NZ/RAJASTHAN/RAJIASAR/T/17/602
(+) VE
94.4%
665.
NZ/RAJASTHAN/HANUMANGARH/
DHQ/17 /606
(+) VE
107.9%
666.
NZ/PUNJAB/LUDHIANA/BC/17/184
(+) VE
96.0%
667.
EZ/WB/BARUIPUR/DHQ/17/1327
(+) VE
98.0%
668.
(+) VE
101.2%
669.
(+) VE
96.4%
670.
WZ/MADHYA PRADESH/GWALIOR/
BC/17/49
(+) VE
98.0%
671.
(+) VE
98.0%
672.
WZ/MAHARASHTRA/SOLAPUR/VIL/17/40
(+) VE
100.7%
673.
NZ/RAJASTHAN/BHADRA/T/17/600
(+) VE
91.2%
674.
(+) VE
98.8%
675.
SZ/TAMILNADU/THANJAUUCE/
DHQ/17/305
(+) VE
94.0%
676.
(+) VE
94.0%
677.
(+) VE
92.5%
106
678.
SZ/TAMILNADU/DHARMAPURI/T/17/551
(+) VE
98.0%
679.
SZ/KERALA/ATTINGAL/T/17/2269
(+) VE
94.0%
680.
DHQ/17 /4921
(+) VE
92.0%
681.
SZ/KERALA/ALLEPEY/DHQ/17/3610
(+) VE
98.4%
682.
SZ/KERALA/WAYANAD/DHQ/17/2170
(+) VE
98.4%
683.
EZ/WB/MOHANPUR/VIL/17/2775
(+) VE
102.0%
684.
(+) VE
90.0%
685.
NZ/RAJASTHAN/SURATGARH/T/17/599
(+) VE
106.5%
686.
NZ/HARYANA/BALLABGARH/T/17/278
(+) VE
96.0%
687.
(+) VE
100.1%
688.
NZ/HARYANA/GURGAON/DHQ/17/272
(+) VE
96.6%
689.
NZ/RAJASTHAN/PALLU/T/17/603
(+) VE
97.9%
690.
NZ/RAJASTHAN/RAMPURA/VIL/17/609
(+) VE
97.8%
691.
NZ/PUNJAB/KURKULANI/VIL/17/185
(+) VE
96.0%
692.
NZ/HARYANA/ROHTAK/BC/17/275
(+) VE
98.0%
693.
NZ/HARYANA/JIND/DHQ/17/273
(+) VE
96.3%
694.
NZ/PUNJAB/RAJPURA/T/17/187
(+) VE
100.1%
695.
EZ/JHARKHAND/CHAIBRSA/DHQ/17/453
(+) VE
95.6%
696.
NZ/HARYANA/PALWAL/DHQ/17/270
(+) VE
95.9%
697.
NZ/HARYANA/FARUKHNAGAR/
VIL/17/277
(+) VE
98.8%
698.
(+) VE
103.2%
699.
VIL/17/36
(+) VE
98.0%
700.
WZ/MADHYA PRADESH/UJJAIN/
DHQ/17/24
(+) VE
94.0%
701.
(+) VE
96.0%
702.
(+) VE
104.5%
703.
(+) VE
92.0%
704.
(+) VE
94.0%
705.
SZ/KERALA/PALAKAD/DHQ/17/2765
(+) VE
96.0%
706.
(+) VE
92.0%
707.
(+) VE
91.7%
708.
SZ/TAMILNADU/PATTUKOTTAI & MANNAKGODI/T/17/ 5240
(+) VE
98.0%
709.
EZ/MANIPUR/IMPHAL/BC/17/31
(+) VE
95.1%
710.
(+) VE
96.0%
711.
SZ/ANDHRA PRADESH/ELURU/
DHQ/17/3776
(+) VE
98.0%
(+) VE
98.0%
712.
Neoloridin
Rapitab
Desloratadine
Tablets
SZ/TAMILNADU/CHENNAI(V)/MC/18/5420
RDTL,
Guwahati
713.
SZ/TAMILNADU/CHENNAI(R)/MC/18/5138
(+) VE
95.0%
714.
SZ/TAMILNADU/CHENNAI(B)/MC/18/5859
(+) VE
95.2%
715.
(+) VE
95.4%
716.
SZ/TAMILNADU/COIMBATORE/
BC/18/5857
(+) VE
95.4%
717.
(+) VE
96.4%
718.
(+) VE
99.6%
719.
(+) VE
95.2%
720.
SZ/TAMILNADU/MAYILADUTURAIS/T/18
/3055
(+) VE
99.2%
721.
NZ/J&K/BAKSHI NAGAR/T/18/119
(+) VE
95.2%
722.
EZ/WB/JAGADDAL/T/18/2687
(+) VE
99.0%
723.
(+) VE
95.2%
724.
(+) VE
95.2%
725.
SZ/TAMILNADU/THIRUVANNAMALAI/
T/18 /2585
(+) VE
99.6%
107
726.
(+) VE
97.6%
727.
(+) VE
Passes
728.
(+) VE
Passes
729.
(+) VE
Passes
730.
SZ/ANDHRA PRADESH/RAJAMUNDRY/
T/18/6079
(+) VE
Passes
731.
NZ/PUNJAB/TOWER MARKET/T/18/197
(+) VE
Passes
(+) VE
96.4%
732.
Lorfast
Loratadine
Tablets
NZ/J&K/TRIKUTA NAGAR/T/19/315
RDTL,
Guwahati
733.
(+) VE
101.1%
734.
(+) VE
93.8%
735.
EZ/TRIPURA/DHARNAGAR/T/19/232
(+) VE
101.4%
736.
EZ/ASSAM/DHEMAJI/T/19/279
(+) VE
101.4%
737.
(+) VE
96.7%
738.
(+) VE
102.1%
739.
SZ/ANDHRA PRADESH/TIRUPATI/
T/19/3845
(+) VE
93.8%
740.
(+) VE
93.8%
741.
(+) VE
97.0%
742.
VIL/19/02
(+) VE
101.4%
743.
SZ/ANDHRA PRADESH/VIJAYAWADA/
BC/19/3557
(+) VE
103.1%
744.
(+) VE
97.0%
745
(+) VE
96.9%
746.
T/19/02
(+) VE
91.5%
747.
BC/19/32
(+) VE
101.1%
748.
SZ/TAMILNADU/MARILADUTHURAI/
T/19 /3056
(+) VE
95.6%
749.
SZ/ANDHRA PRADESH/VILLAGE/
VIL/19/3518
(+) VE
90.9%
750.
SZ/ANDHRA PRADESH/KAVALI/T/19/4490
(+) VE
97.1%
751.
(+) VE
98.0%
752.
T/19/2510
(+) VE
98.4%
753.
DHQ/19/355
(+) VE
102.1%
754.
(+) VE
101.4%
755.
(+) VE
100.5%
756.
SZ/TAMILNADU/KANYA KUMARI/
DHQ/19/4923
(+) VE
93.5%
757.
(+) VE
103.1%
758.
T/19/3274
(+) VE
94.0%
759.
(+) VE
101.1%
760.
(+) VE
92.5%
761.
(+) VE
90.9%
762.
(+) VE
98.4%
763.
SZ/ANDHRA PRADESH/ANAKAPALLE
/VIL/19/ 2554
(+) VE
105.0%
764.
(+) VE
92.5%
765.
NZ/PUNJAB/MOHALI/T/19/570
(+) VE
96.4%
766.
(+) VE
96.5%
767.
(+) VE
98.4%
108
768.
BC/19/3928
(+) VE
95.6%
769.
(+) VE
96.9%
770.
WZ/GUJARAT/MEHSANA/VIL/19/31
(+) VE
93.9%
771.
DHQ/19/261
(+) VE
98.4%
772.
WZ/GUJARAT/PALANPUR/T/19/24
(+) VE
101.1%
773.
BC/19/4383
(+) VE
102.1%
774.
WZ/MADHYA PRADESH/UJJAIN/VIL/19/13
(+) VE
90.7%
775.
SZ/TAMILNADU/CHENNAI-Q/MC/19/5471
(+) VE
97.9%
776.
SZ/KERALA/ALLUA/T/19/2219
(+) VE
90.6%
777.
WZ/MADHYA PRADESH/JABALPUR/
BC/19/46
(+) VE
96.7%
778.
SZ/TAMILNADU/CHENNAI-A/MC/19/1030
(+) VE
94.3%
779.
(+) VE
93.8%
780.
(+) VE
96.9%
781.
(+) VE
101.4%
(+) VE
94.0%
782.
Claridin
Loratadine
Tablets
NZ/RAJASTHAN/JODHPUR/BC/20/82
RDTL,
Guwahati
783.
NZ/UP/JAUNPUR/DHQ/20/475
(+) VE
99.4%
784.
BC/20/01
(+) VE
98.2%
785.
NZ/HARYANA/RAJIVNAGAR/T/20/51
(+) VE
98.2%
786.
(+) VE
98.2%
787.
NZ/RAJASTHAN/PALLU/VIL/20/78
(+) VE
102.2%
788.
NZ/MADHYA PRADEHS/SATNA/
DHQ/20/01
(+) VE
102.2%
789.
(+) VE
97.8%
790.
(+) VE
98.6%
791.
WZ/MADHYA PRADESH/GWALIOR/
BC/20/43
(+) VE
102.2%
001149D/09-10
(+) VE
100.3%
792.
Cetzine
Cetirizine
Hydrochloride
Tablets
CDTL,
Mumbai
793.
SZ/TAMILNADU/CHENNAI(L)/MC/21/1600
001149D/09-10
(+) VE
97.8%
794.
SZ/TAMILNADU/CHENNAI(F)/MC/21/1274
001149D/09-10
(+) VE
94.5%
795.
SZ/TAMILNADU/CHENNAI( C)/
MC/21/1129
001149D/09-10
(+) VE
95.8%
796.
001149D/09-10
(+) VE
97.3%
797.
001149D/09-10
(+) VE
98.6%
798.
SZ/TAMILNADU/DHARAMPURI/T/21/552
001149D/09-10
(+) VE
92.3%
799.
DHQ/21/34
001149D/09-10
(+) VE
98.0%
800.
001149D/09-10
(+) VE
95.6%
801.
SZ/TAMILNADU/CHENNAI/(K)/
MC/21/1552
001149D/09-10
(+) VE
95.2%
802.
001149D/09-10
(+) VE
93.5%
803.
001149D/09-10
(+) VE
92.6%
804.
001149D/09-10
(+) VE
98.9%
805.
SZ/TAMILNADU/THIRUTHURAIPOONDI/T/21/464
001149D/09-10
(+) VE
96.3%
806.
SZ/TAMILNADU/CUDDALURE/
DHQ/21/991
001149D/09-10
(+) VE
93.7%
109
807.
SZ/TAMINADU/KANYAKUMARI/
DHQ/21/4925
001149D/09-10
(+) VE
91.8%
808.
SZ/KARNATAKA/HUBLI./BC/21/4343
001149D/09-10
(+) VE
97.9%
809.
001149D/09-10
(+) VE
98.9%
810.
001149D/09-10
(+) VE
98.9%
811.
EZ/BR/SAMASTIPUR/DHQ/21/215
001149D/09-10
(+) VE
97.4%
812.
SZ/TAMILNADU/VIRUDHACHALAM/
T/21/3161
001149D/09-10
(+) VE
813.
SZ/TAMILNADU/CHENNAI(T)/MC/21/4837
001149D/09-10
(+) VE
95.7%
814.
SZ/TAMILNADU/KUMBAKONAM/
T/21/946
001149D/09-10
(+) VE
97.2%
815.
SZ/TAMILNADU/CHENNAI(G)/MC/21/1408
001149D/09-10
(+) VE
92.3%
816.
SZ/TAMILNADU/TIRUNELVELI./BC/21/211
001149D/09-10
(+) VE
99.2%
98.8%
817.
SZ/TAMILNADU/CHENNAI(W)/MC/21/4603
001149D/09-10
(+) VE
95.4%
818.
001149D/09-10
(+) VE
95.6%
819.
EZ/BR/PATNA/BC/21/766
001149D/09-10
(+) VE
98.0%
820.
001149D/09-10
(+) VE
103.2%
821.
001149D/09-10
(+) VE
91.8%
822.
001149D/09-10
(+) VE
95.2%
823.
NZ/HARYANA/HASSI/T/21/316
001149D/09-10
(+) VE
95.5%
824.
NZ/HARYANA/FARUKHNAGAR/
VIL/21/321
001149D/09-10
(+) VE
96.9%
825.
EZ/BR/CHAPRA/DHQ/21/504
001149D/09-10
(+) VE
92.9%
826.
EZ/BR/BAISHALI/DHQ/21/876
001149D/09-10
(+) VE
95.7%
827.
EZ/BR/PURVA/VIL/21/21
001149D/09-10
(+) VE
98.8%
828.
EZ/BR/JEHANABAD/DHQ/21/562
001149D/09-10
(+) VE
93.5%
829.
001149D/09-10
(+) VE
96.2%
830.
EZ/BR/KATINAR/DHQ/21/76
001149D/09-10
(+) VE
98.5%
831.
EZ/BR/CALTEXCHOWK/T/21/122
001149D/09-10
(+) VE
97.0%
832.
EZ/BR/PURNEA/T/21/141
001149D/09-10
(+) VE
95.2%
833.
DHQ/21/100
001149D/09-10
(+) VE
93.2%
834.
WZ/MADHYAPRADESH/UJJAIN/T/21/10
001149D/09-10
(+) VE
95.8%
835.
WZ/MADHYAPRADESH/INDORE/
BC/21/83
001149D/09-10
(+) VE
91.6%
836.
WZ/MADHYAPRADESH/BHOPAL/
BC/21/49
001149D/09-10
(+) VE
103.7%
837.
WZ/MADHYAPRADESH/JABALPUR/
BC/21/16
001149D/09-10
(+) VE
95.5%
838.
WZ/MADHYAPRADESH/UJJAIN/VIL/21/37
001149D/09-10
(+) VE
97.4%
839.
DHQ/21/17
001149D/09-10
(+) VE
97.0%
840.
WZ/MADHYAPRADESH/UJJAIN/
DHQ/21/28
001149D/09-10
(+) VE
98.8%
841.
WZ/MADHYAPRADESH/SAGAR/
DHQ/21/61
001149D/09-10
(+) VE
95.5%
001399-D/09-10
(+) VE
102.0%
842.
Cetrizet
Cetirizine
Hydrochloride
Tablets
SZ/TAMILNADU/CHENNAI(N)/MC/22/1697
CDTL,
Mumbai
843.
001399-D/09-10
(+) VE
96.8%
844.
T/22/947
001399-D/09-10
(+) VE
102.1%
845.
001399-D/09-10
(+) VE
97.7%
846.
SZ/ANDHRA PRADESH/.RAJAMUNDRY/
BC/22/3811
001399-D/09-10
(+) VE
98.8%
847.
SZ/TAMILNADU/CHENNAI-P/MC/22/5375
001399-D/09-10
(+) VE
98.8%
110
848.
SZ/TAMILNADU/CHENNAI(W)/
MC/22/4604
001399-D/09-10
(+) VE
99.8%
849.
001399-D/09-10
(+) VE
100.1%
850.
001399-D/09-10
(+) VE
101.3%
851.
SZ/TAMILNADU/ULUNDUREPET/
T/22/3029
001399-D/09-10
(+) VE
101.0%
001409-D/09-10
(+) VE
96.8%
852.
Zyncet
Cetirizine
Hydrochloride
Tablets
CDTL,
Mumbai
853.
001409-D/09-10
(+) VE
95.8%
854.
001409-D/09-10
(+) VE
94.4%
855.
SZ/ANDHRAPRADESH/SECUNDERABAD/
BC/23/3670
001409-D/09-10
(+) VE
97.8%
856.
001409-D/09-10
(+) VE
99.2%
857.
001409-D/09-10
(+) VE
91.4%
858.
001409-D/09-10
(+) VE
95.9%
859.
SZ/KERALA/KAANUUR/DHQ/23/2092
001409-D/09-10
(+) VE
91.3%
860.
BC/23/1833
001409-D/09-10
(+) VE
91.3%
861.
001409-D/09-10
(+) VE
97..3%
862.
001409-D/09-10
(+) VE
92.1%
863.
001409-D/09-10
(+) VE
93.9%
864.
001409-D/09-10
(+) VE
93.5%
865.
001409-D/09-10
(+) VE
92.8%
866.
EZ/WB/SONARPUR/MC/23/2372
001409-D/09-10
(+) VE
99.0%
867.
001409-D/09-10
(+) VE
93.8%
868.
EZ/OR/SAMBALPUR/VIL/23/250
001409-D/09-10
(+) VE
93.3%
869.
EZ/WB/BATLALA/T/23/3135
001409-D/09-10
(+) VE
93.0%
870.
EZ/OR/BURLA/T/23/756
001409-D/09-10
(+) VE
92.9%
871.
EZ/OR/KHURDA/VIL/23/567
001409-D/09-10
(+) VE
93.5%
872.
NZ/RAJASTHAN/CHURU/DHQ/23/21
001409-D/09-10
(+) VE
97.1%
873.
001409-D/09-10
(+) VE
97.1%
874.
DHQ/23/31
001409-D/09-10
(+) VE
97.2%
875.
001409-D/09-10
(+) VE
91.6%
876.
001409-D/09-10
(+) VE
94.1%
877.
001409-D/09-10
(+) VE
94.6%
878.
BC/23/1834
001409-D/09-10
(+) VE
93.2%
879.
WZ/CHHATTISGARH/AMBIKAPUR/
DHQ/23/13
001409-D/09-10
(+) VE
99.4%
880.
SZ/TAMILNADU/NAGARCOIL/T/23/674
001409-D/09-10
(+) VE
96.9%
881.
001409-D/09-10
(+) VE
96.1%
882.
DHQ/23/3878
001409-D/09-10
(+) VE
97.7%
883.
WZ/GUJARAT/JAMNAGAR/DHQ/23/16
001409-D/09-10
(+) VE
92.6%
884.
001409-D/09-10
(+) VE
93.0%
885.
001409-D/09-10
(+) VE
96.1%
886.
EZ/OR/BERHAMPUR/VIL/23/15
001409-D/09-10
(+) VE
93.6%
887.
001409-D/09-10
(+) VE
92.5%
888.
EZ/OR/BARIPADA/VIL/23/317
001409-D/09-10
(+) VE
95.3%
889.
001409-D/09-10
(+) VE
95.8%
890.
001409-D/09-10
(+) VE
98.5%
891.
001409-D/09-10
(+) VE
91.2%
892.
001409-D/09-10
(+) VE
91.2%
893.
SZ/TAMILNADU/SALEM/BC/23/19
001409-D/09-10
(+) VE
98.3%
894.
SZ/TAMILNADU/CHENNAI(J)/MC/23/1508
001409-D/09-10
(+) VE
99.8%
895.
001409-D/09-10
(+) VE
98.1%
111
896.
BC/23/4083
001409-D/09-10
(+) VE
94.2%
897.
001409-D/09-10
(+) VE
91.3%
898.
WZ/GUJARAT/BHAVNAGAR/T/23/15
001409-D/09-10
(+) VE
96.9%
899.
001409-D/09-10
(+) VE
96.9%
900.
001409-D/09-10
(+) VE
99.8%
901.
001409-D/09-10
(+) VE
92.5%
001349-D/09-10
(+) VE
93.3%
902.
Avil-25
Pheniramine
Maleate
Tablets
CDTL,
Mumbai
903.
NZ/UP/MATHURA/DHQ/24/1333
001349-D/09-10
(+) VE
96.5%
904.
NZ/UP/SHAHPUR/T/24/127
001349-D/09-10
(+) VE
93.6%
905.
001349-D/09-10
(+) VE
92.0%
906.
NZ/UP/MEERAPUR/T/24/128
001349-D/09-10
(+) VE
93.9%
907.
EZ/OR/BURLA/VIL/24/768
001349-D/09-10
(+) VE
94.5%
908.
001349-D/09-10
(+) VE
94.5%
909.
EZ/BR/BHAGALPUR/DHQ/24/194
001349-D/09-10
(+) VE
94.2%
910.
EZ/ASSAM/SILCHEM/DHQ/24/18
001349-D/09-10
(+) VE
94.5%
911.
NZ/UP/BAHADROLI/VIL/24/1341
001349-D/09-10
(+) VE
95.0%
912.
001349-D/09-10
(+) VE
95.1%
913.
EZ/WB/HOWRAH/BC/24/1237
001349-D/09-10
(+) VE
96.2%
914.
001349-D/09-10
(+) VE
94.1%
915.
NZ/UP/LONI/T/24/938
001349-D/09-10
(+) VE
93.2%
916.
001349-D/09-10
(+) VE
93.2%
917.
EZ/AP/SEPPA/VIL/24/422
001349-D/09-10
(+) VE
93.2%
918.
EZ/OR/KULANAGA/VIL/24/125
001349-D/09-10
(+) VE
95.9%
919.
EZ/OR/DHENKANAL/VIL/24/699
001349-D/09-10
(+) VE
93.8%
920.
EZ/KERALA/KOCHI(BC)/24/3090
001349-D/09-10
(+) VE
93.3%
921.
EZ/WB/KHAGRA/BC/24/1162
001349-D/09-10
(+) VE
93.4%
922.
001349-D/09-10
(+) VE
93.0%
923.
EZ/JHARKHAND/HAZARIBAGH/
BC/24/473
001349-D/09-10
(+) VE
93.0%
924.
001349-D/09-10
(+) VE
93.6%
925.
EZ/WB/KHAGRA/BC/24/1162
001349-D/09-10
(+) VE
93.4%
926.
EZ/AP/SEPPA/V IL/24/422
001349-D/09-10
(+) VE
93.1%
927.
001349-D/09-10
(+) VE
94.8%
928.
001349-D/09-10
(+) VE
96.3%
929.
001349-D/09-10
(+) VE
94.6%
930.
001349-D/09-10
(+) VE
95.6%
931.
EZ/NE/GIRANIA/VIL/24/146
001349-D/09-10
(+) VE
96.0%
932.
001349-D/09-10
(+) VE
93.6%
933.
001349-D/09-10
(+) VE
94.4%
934.
001349-D/09-10
(+) VE
95.9%
935.
EZ/BR/MATHERPUR/VIL/24/840
001349-D/09-10
(+) VE
95.8%
936.
EZ/OR/ANGUL/T/24/672
001349-D/09-10
(+) VE
96.9%
937.
EZ/MIZORAM/CHAUNGTE/DHQ/24/134
001349-D/09-10
(+) VE
94.1%
938.
SZ/KERALA/CHALKUDY/T/24/2923
001349-D/09-10
(+) VE
92.8%
939.
001349-D/09-10
(+) VE
96.7%
940.
001349-D/09-10
(+) VE
93.2%
941.
001349-D/09-10
(+) VE
93.3%
942.
001349-D/09-10
(+) VE
94.4%
943.
001349-D/09-10
(+) VE
93.3%
944.
001349-D/09-10
(+) VE
95.0%
945.
SZ/TN/ARAKKONAM/T/24/3455
001349-D/09-10
(+) VE
93.5%
946.
SZ/TAMILNADU/ULUNDURPET/T/24/3030
001349-D/09-10
(+) VE
95.8%
947.
EZ/OR/BHUVANESHWAR/BC/24/89
001349-D/09-10
(+) VE
96.4%
948.
EZ/WB/MALLICKPUR./T/24/3019
001349-D/09-10
(+) VE
96.4%
949.
001349-D/09-10
(+) VE
95.9%
112
950.
EZ/WB/DHAMUABAZAR/VIL/24/3037
001349-D/09-10
(+) VE
93.1%
951.
001349-D/09-10
(+) VE
94.4%
001799-D/09-10
(+) VE
96.5%
952.
Amlosafe
Amlodipine
Besilate
Tablets 5mg
T/25/2958
CDTL,
Mumbai
953.
001799-D/09-10
(+) VE
92.0%
954.
BC/25/44
001799-D/09-10
(+) VE
97.1%
955.
EZ/OR/JAGATSINGHPUR/VIL/25/96
001799-D/09-10
(+) VE
98.9%
956.
001799-D/09-10
(+) VE
91.9%
957.
SZ/TAMILNADU/JHAHJAUURE/
DHQ/25/311
001799-D/09-10
(+) VE
92.2%
958.
WZ/GUJARAT/DAMAN/VIL/25/1
001799-D/09-10
(+) VE
99.6%
959.
001799-D/09-10
(+) VE
97.6%
960.
001799-D/09-10
(+) VE
94.04%
961.
001799-D/09-10
(+) VE
91.1%
962.
T/25/949
001799-D/09-10
(+) VE
94.4%
963.
001799-D/09-10
(+) VE
91.6%
964.
SZ/KARNATAKA/KOLAR/DHQ/25/4140
001799-D/09-10
(+) VE
98.6%
965.
WZ/GOA/TISWAD/VIL/25/25
001799-D/09-10
(+) VE
94.4%
966.
001799-D/09-10
(+) VE
96.5%
967.
001799-D/09-10
(+) VE
96.6%
968.
001799-D/09-10
(+) VE
101.8%
969.
MC/25/1021
001799-D/09-10
(+) VE
97.4%
970.
001799-D/09-10
(+) VE
91.0%
971.
SZ/TAMILNADU/PORAMBALUR/T/25/3000
001799-D/09-10
(+) VE
90.6%
972.
001799-D/09-10
(+) VE
91.2%
973.
001799-D/09-10
(+) VE
94.3%
974.
001799-D/09-10
(+) VE
94.0%
975.
MC/25/4606
001799-D/09-10
(+) VE
98.7%
976.
001799-D/09-10
(+) VE
94.2%
977.
001799-D/09-10
(+) VE
91.6%
978.
EZ/JHARKHAND/DUMKA/DHQ/25/607
001799-D/09-10
(+) VE
95.9%
979.
EZ/OR/BALASORE/DHQ/25/145
001799-D/09-10
(+) VE
93.9%
980.
001799-D/09-10
(+) VE
91.1%
981.
EZ/OR/DHENKANA/T/25/720
001799-D/09-10
(+) VE
91.0%
982.
SZ/ANDHRAPRADESH/VISAKHAPATNAM/BC/25/3327
001799-D/09-10
(+) VE
95.3%
983.
001799-D/09-10
(+) VE
91.4%
984.
EZ/BR/KISHANGANJ/VIL/25/93
001799-D/09-10
(+) VE
91.2%
985.
001799-D/09-10
(+) VE
104.8%
986.
001799-D/09-10
(+) VE
105.4%
987.
SZ/KERALA./VILLAGE/VIL/25/2440
001799-D/09-10
(+) VE
96.1%
988.
EZ/WB/KOLKATA/MC/25/3114/72
001799-D/09-10
(+) VE
94.4%
989.
001799-D/09-10
(+) VE
99.7%
990.
001799-D/09-10
(+) VE
92.2%
991.
001799-D/09-10
(+) VE
102.3%
992.
EZ/WB/UTTARPARA/T/25/2031
001799-D/09-10
(+) VE
94.4%
993.
001799-D/09-10
(+) VE
99.8%
994.
001799-D/09-10
(+) VE
92.1%
995.
EZ/BR/PURVA/DHQ/25/35
001799-D/09-10
(+) VE
93.4%
996.
EZ/NAGALAND/DIMAPUR/DHQ/25/172
001799-D/09-10
(+) VE
92.6%
997.
001799-D/09-10
(+) VE
92.0%
998.
001799-D/09-10
(+) VE
93.6%
113
999.
EZ/WB/SINGUR/VIL/25/2042
001799-D/09-10
(+) VE
107.3%
1000.
EZ/NE/BELONIA/T/25/65
001799-D/09-10
(+) VE
91.5%
EZ/OR/BALASORE/BC/25/198
001799-D/09-10
(+) VE
91.0%
002049-D/09-10
(+) VE
92.0%
1001.
1002.
Amlopres
Amlodipine
Besilate
Tablets 5 mg
BC/26/4386
CDTL,
Mumbai
1003.
002049-D/09-10
(+) VE
95.1%
1004.
002096-D/09-10
(+) VE
98.2%
92.1%
1005.
002049-D/09-10
(+) VE
92.5%
1006.
002049-D/09-10
(+) VE
92.7%
1007.
SZ/ANDHRA PRADESH/CHITTOR/
T/26/3380
002049-D/09-10
(+) VE
92.6%
1008.
EZ/WB/HARIPAL/VIL/26/3191
002049-D/09-10
(+) VE
91.2%
1009.
002049-D/09-10
(+) VE
92.5%
1010.
002049-D/09-10
(+) VE
92.6%
1011.
002049-D/09-10
(+) VE
98.5%
1012.
SZ/TAMILNADU/THIRUVANNAMALAI/
T/26/2587
002049-D/09-10
(+) VE
92.3%
1013.
002049-D/09-10
(+) VE
95.9%
1014.
NZ/NCT DELHI/ DELHI/MC./26/423
002049-D/09-10
(+) VE
92.3%
1015.
002049-D/09-10
(+) VE
93.6%
1016.
NZ/RAJ/RAWATSAR/T/26/128
002049-D/09-10
(+) VE
98.0%
1017.
002096-D/09-10
(+) VE
101.5%
90.3%
1018.
002049-D/09-10
(+) VE
92.3%
1019.
EZ/JHARKHAND/HATIA/T/26/378
002049-D/09-10
(+) VE
93.5%
1020.
002049-D/09-10
(+) VE
95.2%
1021.
002049-D/09-10
(+) VE
96.0%
1022.
DHQ/26/3781
002049-D/09-10
(+) VE
92.4%
1023.
002049-D/09-10
(+) VE
94.1%
1024.
EZ/JHARKHAND/KARIKE/TOWN/26/505
002049-D/09-10
(+) VE
93.4%
1025.
EZ/WB/NARENDRAPUR/T/26/2768
002049-D/09-10
(+) VE
94.9%
1026.
SZ/ANDHRA PRADESH/RAJAHMUNDRY/
BC/26/3814
002049-D/09-10
(+) VE
91.8%
1027.
EZ/WB/ASANROL/T/26/1062
002049-D/09-10
(+) VE
93.1%
1028.
002049-D/09-10
(+) VE
93.7%
1029.
DHQ/26/355
002049-D/09-10
(+) VE
93.6%
1030.
002049-D/09-10
(+) VE
93.9%
1031.
002049-D/09-10
(+) VE
92.4%
1032.
002049-D/09-10
(+) VE
93.5%
1033.
EZ/ASSAM/TEZPUR/T/26/208
002049-D/09-10
(+) VE
92.4%
1034.
002049-D/09-10
(+) VE
94.4%
1035.
002049-D/09-10
(+) VE
92.6%
1036.
002049-D/09-10
(+) VE
92.9%
1037.
EZ/WB/KRISHNANAGAR/DHQ/26/2576
002049-D/09-10
(+) VE
92.0%
1038.
002049-D/09-10
(+) VE
93.3%
1039.
EZ/OR/SUNDERGARH/DHQ/26/628
002049-D/09-10
(+) VE
97.5%
1040.
002049-D/09-10
(+) VE
92.3%
1041.
002049-D/09-10
(+) VE
93.9%
1042.
002049-D/09-10
(+) VE
93.3%
1043.
002049-D/09-10
(+) VE
92.6%
1044.
002049-D/09-10
(+) VE
92.4%
1045.
002049-D/09-10
(+) VE
92.9%
1046.
002049-D/09-10
(+) VE
92.5%
1047.
EZ/NE/AGARTALAL/BC/26/189
002058-D/0910
(+) VE
92.6%
114
1048.
002096-D/09-10
(+) VE
102.8%
104.6%
1049.
002049-D/09-10
(+) VE
94.1%
1050.
NZ/UP/GOPIGANJ/VILLAGE/26/348
002049-D/09-10
(+) VE
93.5%
002049-D/09-10
(+) VE
94.0%
001709-D/09-10
(+) VE
95.2%
1051.
1052.
EZ/WB/NARENDRAPUR/T/26/2768
Amdepine
Amlodipine
Tablets
CDTL,
Mumbai
1053.
001709-D/09-10
(+) VE
93.3%
1054.
EZ/OR/SAMBALPUR/DHQ/27/258
001709-D/09-10
(+) VE
93.0%
1055.
001709-D/09-10
(+) VE
96.2%
1056.
001709-D/09-10
(+) VE
91.0%
1057.
001709-D/09-10
(+) VE
100.7%
1058.
EZ/JHARKHAND/BOKARO/BC/27/207
001709-D/09-10
(+) VE
93.8%
1059.
001709-D/09-10
(+) VE
92.5%
1060.
001709-D/09-10
(+) VE
90.2%
1061.
DHQ/27/64
001709-D/09-10
(+) VE
91.9%
1062.
001709-D/09-10
(+) VE
92.0%
1063.
WZ/GUJARAT/DAMAN/VIL/27/6
001709-D/09-10
(+) VE
93.0%
1064.
NZ/UTTAR PRADESH/BAROLA/T/27/1116
001709-D/09-10
(+) VE
94.1%
1065.
SZ/TAMILNADU/TIRVNELVELI/BC/27/216
001709-D/09-10
(+) VE
91.5%
1066.
NZ/RAJASTHAN/JAIPUR/BC/27/628
001709-D/09-10
(+) VE
94.5%
1067.
WZ/MADHYA PRADESH/BHOPAL/BC/27/5
001709-D/09-10
(+) VE
95.0%
1068.
001709-D/09-10
(+) VE
92.6%
1069.
001709-D/09-10
(+) VE
100.3%
1070.
EZ/JHARKHAND/DHANBAD/BC/27/256
001709-D/09-10
(+) VE
94.3%
1071.
DHQ/27/28
001709-D/09-10
(+) VE
94.0%
IPC/6007/134 dated 27/10/2009
(+) VE
94.4%
1072.
Tenolol
Atenolol
Tablets
DHQ/28/80
IPC,
Ghaziabad
1073.
IPC/6007/147 dated 27/10/2009
(+) VE
97.0%
1074.
IPC/6007/146 dated 27/10/2009
(+) VE
96.0%
1075.
SZ/TAMILNADU/CHENGAM/T/28/3488
IPC/6007/132 dated 27/10/2009
(+) VE
96.8%
1076.
IPC/6007/119 dated 23/10/2009
(+) VE
104.6%
1077.
DHQ/28/39
IPC/6007/140 dated 27/10/2009
(+) VE
103.8%
1078.
WZ/MAHARASHTRA/AMRAVATI/
DHQ/28/18
IPC/6007/103 dated 23/10/2009
(+) VE
101.0%
1079.
IPC/6007/115 dated 23/10/2009
(+) VE
98.8%
1080.
IPC/6007/128 dated 27/10/2009
(+) VE
93.4%
1081.
NZ/NCT DELHI/DL/MC/28/600
IPC/6007/123 dated 23/10/2009
(+) VE
100.0%
1082.
IPC/6007/142 dated 27/10/2009
(+) VE
98.2%
1083.
NZ/DELHI/DELHI/MC/28/376
IPC/6007/140 dated 27/10/2009
(+) VE
103.8%
1084.
WZ/GUJARAT/MEHSANA/DHQ/28/06
IPC/6007/138 dated 27/10/2009
(+) VE
94.0%
1085.
IPC/6007/107 dated 23/10/2009
(+) VE
103.2%
1086.
NZ/DELHI/DELHI/MC/28/367
IPC/6007/110 dated 23/10/2009
(+) VE
104.4%
1087.
EZ/JHARKHAND/DEOGHART/T/28/527
IPC/6007/106 dated 23/10/2009
(+) VE
97.0%
1088.
IPC/6007/127 dated 23/10/2009
(+) VE
94.4%
1089.
NZ/HIMACHAL PRADESH/BIR/VIL/28/267
IPC/6007/129 dated 27/10/2009
(+) VE
95.8%
1090.
NZ/PUNJAB/ZIRAKAPUR/T/28/545
IPC/6007/117 dated 23/10/2009
(+) VE
100.0%
1091.
IPC/6007/109 dated 23/10/2009
(+) VE
100.0%
1092.
IPC/6007/133 dated 27/10/2009
(+) VE
95.2%
1093.
IPC/6007/104 dated 23/10/2009
(+) VE
100.4%
1094.
NZ/RAJASTHAN/SURATGARHT/T/28/39
IPC/6007/151 dated 27/10/2009
(+) VE
93.0%
1095.
IPC/6007/145 dated 27/10/2009
(+) VE
94.8%
1096.
IPC/6007/121 dated 23/10/2009
(+) VE
104.8%
115
1097.
DHQ/28/112
IPC/6007/122 dated 23/10/2009
(+) VE
94.6%
1098.
BC/28/3933
IPC/6007/144 dated 27/10/2009
(+) VE
93.6%
1099.
SZ/ANDHRA PRADESH/CUDARA/
T/28/3420
IPC/6007/120 dated 23/10/2009
(+) VE
97.2%
1100.
DHQ/28/101
IPC/6007/125 dated 23/10/2009
(+) VE
103.0%
1101.
IPC/6007/150 dated 27/10/2009
(+) VE
99.6%
1102.
IPC/6007/148 dated 27/10/2009
(+) VE
93.6%
1103.
T/28/3849
IPC/6007/111 dated 23/10/2009
(+) VE
93.8%
1104.
IPC/6007/124 dated 23/10/2009
(+) VE
93.6%
1105.
IPC/6007/112 dated 23/10/2009
(+) VE
94.2%
1106.
WZ/MADHYA PRADESH/INDORE/
BC/28/80
IPC/6007/136 dated 27/10/2009
(+) VE
104.2%
1107.
IPC/6007/135 dated 27/10/2009
(+) VE
104.0%
1108.
IPC/6007/113 dated 23/10/2009
(+) VE
100.0%
1109.
IPC/6007/105 dated 23/10/2009
(+) VE
101.4%
1110.
IPC/6007/149 dated 27/10/2009
(+) VE
101.8%
1111.
IPC/6007/137 dated 27/10/2009
(+) VE
98.6%
1112.
IPC/6007/131 dated 27/10/2009
(+) VE
103.2%
1113.
IPC/6007/152 dated 27/10/2009
(+) VE
100.8%
1114.
EZ/ASSAM/LUNDING/VIL/28/376
IPC/6007/114 dated 23/10/2009
(+) VE
101.2%
1115.
IPC/6007/139 dated 27/10/2009
(+) VE
97.8%
1116.
IPC/6007/108 dated 23/10/2009
(+) VE
93.8%
1117.
NZ/RAJASTHAN/BHADRA/T/28/38
IPC/6007/143 dated 27/10/2009
(+) VE
98.2%
1118.
IPC/6007/116 dated 23/10/2009
(+) VE
100.8%
1119.
SZ/TAMILNADU/ULANDURPET/T/28/3031
IPC/6007/130 dated 27/10/2009
(+) VE
99.2%
1120.
IPC/6007/126 dated 23/10/2009
(+) VE
102.0%
1121.
SZ/KARNATAKA/HUBLI/BC/28/4347
IPC/6007/118 dated 23/10/2009
(+) VE
93.4%
IPC/6007/04 dated 12/10/2009
(+) VE
96.8%
1122.
Aten-50
Atenolol
Tablets
IPC,
Ghaziabad
1123.
IPC/6007/18 dated 12/10/2009
(+) VE
95.16%
1124.
IPC/6007/19 dated 12/10/2009
(+) VE
95.4%
1125.
DHQ/29/24
IPC/6007/17 dated 12/10/2009
(+) VE
97.03%
1126.
IPC/6007/25 dated 12/10/2009
(+) VE
95.48%
1127.
IPC/6007/12 dated 12/10/2009
(+) VE
96.53%
1128.
IPC/6007/60 dated 13/10/2009
(+) VE
102.2%
1129.
IPC/6007/67 dated 13/10/2009
(+) VE
103.2%
1130.
IPC/6007/27 dated 12/10/2009
(+) VE
96.7%
1131.
IPC/6007/26 dated 12/10/2009
(+) VE
99.88%
1132.
IPC/6007/05 dated 12/10/2009
(+) VE
94.7%
1133.
NZ/UTTARAKHAND/SRINAGAR/T/29/186
IPC/6007/13 dated 12/10/2009
(+) VE
96.01%
1134.
IPC/6007/61 dated 13/10/2009
(+) VE
103.4%
1135.
EZ/OR/BALIAPAT/VIL/29/177
IPC/6007/09 dated 12/10/2009
(+) VE
97.75%
1136.
EZ/CHHATTISGARH/RAIGARH/VIL/29/40
IPC/6007/14 dated 12/10/2009
(+) VE
94.60%
1137.
IPC/6007/96 dated 23/10/2009
(+) VE
97.8%
1138.
SZ/TAMILNADU/CHENNAI(M)/MC/29/1462
IPC/6007/92 dated 23/10/2009
(+) VE
100.0%
1139.
EZ/GUJARAT/MEHSANA/T/29/11
IPC/6007/23 dated 12/10/2009
(+) VE
96.45%
1140.
IPC/6007/59 dated 13/10/2009
(+) VE
97.6%
1141.
IPC/6007/90 dated 23/10/2009
(+) VE
95.6%
1142.
T/29/3421
IPC/6007/08 dated 12/10/2009
(+) VE
99.79%
1143.
SZ/ANDHRAPRADESH/CHITTOOR/
T/29/3382
IPC/6007/06 dated 12/10/2009
(+) VE
97.7%
116
1144.
IPC/6007/94dated 23/10/2009
(+) VE
98.4%
1145.
DHQ/29/77
IPC/6007/98 dated 23/10/2009
(+) VE
102.0%
1146.
SZ/ANDHRA PRADESH/NARSI PATANAM/T/29/2620
IPC/6007/99 dated 23/10/2009
(+) VE
102.4%
1147.
IPC/6007/62 dated 13/10/2009
(+) VE
102.4%
1148.
IPC/6007/20 dated 12/10/2009
(+) VE
99.36%
1149.
IPC/6007/03 dated 12/10/2009
(+) VE
96.8%
1150.
IPC/6007/102 dated 23/10/2009
(+) VE
94.6%
1151.
NZ/PUNJAB/KAVLI/VILL/29/240
IPC/6007/11 dated 12/10/2009
(+) VE
94.4%
1152.
NZ/HIMACHAL PRADESH/UNA/
DHQ/29/205
IPC/6007/93 dated 23/10/2009
(+) VE
94.6%
1153.
IPC/6007/58 dated 13/10/2009
(+) VE
104.0%
1154.
IPC/6007/21 dated 12/10/2009
(+) VE
101.86%
1155.
IPC/6007/07 dated 12/10/2009
(+) VE
94.9%
1156.
SZ/TN/ ARAKKONAM/T/29/3461
IPC/6007/24 dated 12/10/2009
(+) VE
95.62 %
1157.
IPC/6007/95 dated 23/10/2009
(+) VE
98.4%
1158.
EZ/WB/PANIHATI/MC/29/3743
IPC/6007/88 dated 23/10/2009
(+) VE
102.4%
1159.
IPC/6007/97 dated 23/10/2009
(+) VE
101.0%
1160.
IPC/6007/100 dated 23/10/2009
(+) VE
99.4%
1161.
IPC/6007/89 dated 23/10/2009
(+) VE
102.2%
1162.
IPC/6007/22 dated 12/10/2009
(+) VE
98.03%
1163.
IPC/6007/16 dated 12/10/2009
(+) VE
97.5%
1164.
IPC/6007/15 dated 12/10/2009
(+) VE
96.18%
1165.
DHQ/29/2726
IPC/6007/91 dated 23/10/2009
(+) VE
101.6%
1166.
IPC/6007/10 dated 12/10/2009
(+) VE
100.2%
1167.
NZ/RAJ/JAITPUR/VIL/29/168
IPC/6007/65 dated 13/10/2009
(+) VE
105.6%
1168.
IPC/6007/63 dated 13/10/2009
(+) VE
103.4%
1169.
DHQ/29/2725
IPC/6007/101 datd 23/10/2009
(+) VE
101.2%
1170.
SZ/KERALA/KASARGAD/DHQ/29/2059
IPC/6007/64 dated 13/10/2009
(+) VE
102.8%
1171.
SZ/ANDHRA PRADESH/RAJAHMUNDRY/
BC/29/3816
IPC/6007/66 dated 13/10/2009
(+) VE
102.6%
IPC/6007/40 dated 12/10/2009
(+) VE
100.4%
1172.
Ziblok-50
Atenolol
Tablets
DHQ/30/08
IPC,
Ghaziabad
1173.
IPC/6007/81 dated 13/10/2009
(+) VE
104.5%
1174.
IPC/6007/80 dated 13/10/2009
(+) VE
98.6%
1175.
DHQ/30/3784
IPC/6007/33 dated 12/10/2009
(+) VE
102.2%
1176.
IPC/6007/82 dated 13/10/2009
(+) VE
105.6%
1177.
T/30/2519
IPC/6007/53 dated 12/10/2009
(+) VE
101.6%
1178.
SZ/TAMILNADU/THANJAVURE/
DHQ/30/315
IPC/6007/78 dated 13/10/2009
(+) VE
103.9%
1179.
IPC/60007/50 datd 12/10/2009
(+) VE
100.2%
1180.
SZ/TAMILNADU/CHENNAI-O/MC/30/5096
IPC/6007/39 dated 12/10/2009
(+) VE
98.0%
1181.
BC/30/4091
IPC/6007/51 dated 12/10/2009
(+) VE
100.2%
1182.
IPC/6007/29 dated 12/10/2009
(+) VE
107.2%
1183.
IPC/6007/37 dated 12/10/2009
(+) VE
102.6%
1184.
IPC/6007/85 dated 13/10/2009
(+) VE
104.9%
1185.
DHQ/30/400
IPC/6007/32 dated 12/10/2009
(+) VE
104.0%
1186.
SZ/ANDHRA PRADESH/KAKINAD/
T/30/3282
IPC/6007/43 dated 12/10/2009
(+) VE
101.2%
1187.
IPC/6007/84 dated 13/10/2009
(+) VE
104.4%
117
1188.
DHQ/30/111
IPC/6007/71 dated 13/10/2009
(+) VE
104.60%
1189.
SZ/KARNATKA/VILLAGE/VIL/30/4689
IPC/6007/30 dated 12/10/2009
(+) VE
105.6%
1190.
IPC/6007/57 dated 12/10/2009
(+) VE
105.0%
1191.
IPC/6007/83 dated 13/10/2009
(+) VE
99.0%
1192.
IPC/6007/34 dated 12/10/2009
(+) VE
101.8%
1193.
IPC/6007/52 dated 12/10/2009
(+) VE
96.0%
1194.
WZ/GUJARAT/HIMMATNAGAR/T/30/24
IPC/6007/77 dated 13/10/2009
(+) VE
107.0%
1195.
IPC/6007/68 dated 13/10/2009
(+) VE
106.84%
1196.
IPC/6007/31 dated 12/10/2009
(+) VE
104.8%
1197.
IPC/6007/76 dated 13/10/2009
(+) VE
103.88%
1198.
IPC/6007/47 dated 12/10/2009
(+) VE
104.8%
1199.
IPC/6007/45 dated 12/10/2009
(+) VE
104.2%
1200.
SZ/TAMILNADU/LANCHIPURAM/
DHQ/30/268
IPC/6007/56 dated 12/10/2009
(+) VE
103.2%
1201.
IPC/6007/79 dated 13/10/2009
(+) VE
103.8%
1202.
DHQ/30/62
IPC/6007/86 dated 13/10/2009
(+) VE
104.8%
1203.
IPC/6007/87 dated 13/10/2009
(+) VE
104.2%
1204.
MC/30/9751
IPC/6007/28 dated 12/10/2009
(+) VE
99.4%
1205.
IPC/6007/74 dated 13/10/2009
(+) VE
103.62%
1206.
BC/30/14
IPC/6007/44 dated 12/10/2009
(+) VE
100.6%
1207.
IPC/6007/70 dtaed 13/10/2009
(+) VE
101.20%
1208.
VIL/30/01
IPC/6007/41 dated 12/10/2009
(+) VE
101.2%
1209.
T/30/953
IPC/6007/38 dated 12/10/2009
(+) VE
99.4%
1210.
SZ/ANDHRA PRADESH/CHITTOOT/
T/30/3383
IPC/6007/55 dated 12/10/2009
(+) VE
98.8%
1211.
DHQ/30/122
IPC/6007/36 dated 12/10/2009
(+) VE
102.2%
1212.
SZ/KARNATKA/DHARWAD/BC/30/4036
IPC/6007/49 dated 12/10/2009
(+) VE
97.6%
1213.
SZ/TAMILNADU/CHENNAI(F)/MC/30/1279
IPC/6007/42 dated 12/10/2009
(+) VE
103.2%
1214.
IPC/6007/46 dated 12/10/2009
(+) VE
104.12%
1215.
WZ/GUJARAT/JAMNAGAR/T/30/52
IPC/6007/73 dated 13/10/2009
(+) VE
104.20%
1216.
IPC/6007/54 dated 12/10/2009
(+) VE
101%
102.36%
1217.
IPC/6007/72 dated 13/10/2009
(+) VE
1218.
SZ/KARNATKA/KARWAR/T/30/3986
IPC/6007/75 dated 13/10/2009
(+) VE
103.72%
1219.
SZ/TAMILNADU/CHENNAI(A)/MC/30/1040
IPC/6007/48 dated 12/10/2009
(+) VE
100.0%
1220.
IPC/6007/35 dated 12/10/2009
(+) VE
106.6%
1221.
VIL/30/3523
IPC/6007/69 dated 13/10/2009
(+) VE
103.12%
32-4/2009-SS/SZN-177
(+) VE
98.5%
32-4/2009-SS/SZN-184
(+) VE
100.2%
1224.
32-4/2009-SS/SZN-189
(+) VE
93.2%
1225.
DHQ/31/995
32-4/2009-SS/SZN-169
(+) VE
104.79%
1226.
32-4/2009-SS/SZN-201
(+) VE
103.77%
1227.
SZ/TAMILNADU/VRUDHACHALAM/
T/31/3170
32-4/2009-SS/SZN-158
(+) VE
98.33%
1228.
WZ/MADHYA PRADESH/CHHINDWARA/
DHQ/31/ 121
32-4/2009-SS/SZN-180
(+) VE
101.8%
1222.
1223.
118
ZIVAST-10
Atorvastatin
Tablets
BC/31/30
CDL,
Kolkata
1229.
32-4/2009-SS/SZN-171
(+) VE
98.75%
1230.
T/31/2964
32-4/2009-SS/SZN-176
(+) VE
100.83%
1231.
32-4/2009-SS/SZN-186
(+) VE
100.4%
1232.
32-4/2009-SS/SZN-192
(+) VE
93%
1233.
SZ/TAMILNADU/NAGARCOIL/T/31/680
32-4/2009-SS/SZN-166
(+) VE
101.9%
1234.
32-4/2009-SS/SZN-202
(+) VE
99.79%
1235.
WZ/GUJARAT/ANAND/DHQ/31/31
32-4/2009-SS/SZN-188
(+) VE
100.8%
1236.
WZ/CHHATTISGARH/RAJNANDGAON/
DHQ/31/01
32-4/2009-SS/SZN-194
(+) VE
90.1%
1237.
MC/31/1011
32-4/2009-SS/SZN-179
(+) VE
101.6%
1238.
32-4/2009-SS/SZN-174
(+) VE
98.33%
1239.
SZ/TAMILNADU/THANTAUURE/
DHQ/31/316
32-4/2009-SS/SZN-159
(+) VE
97.7%
1240.
NZ/UTTAR PRADESH/MEERUT/
BC/31/1246
32-4/2009-SS/SZN-196
(+) VE
96.6%
1241.
DHQ/31/ 43
32-4/2009-SS/SZN-185
(+) VE
96.2%
1242.
DHQ/31/45
32-4/2009-SS/SZN-178
(+) VE
99.7%
1243.
32-4/2009-SS/SZN-157
(+) VE
98.96%
1244.
32-4/2009-SS/SZN-173
(+) VE
102.71%
1245.
DHQ/31/03
32-4/2009-SS/SZN-191
(+) VE
90.1%
1246.
32-4/2009-SS/SZN-195
(+) VE
93.29%
1247.
32-4/2009-SS/SZN-163
(+) VE
97.50%
1248.
32-4/2009-SS/SZN-160
(+) VE
97.92%
1249.
NZ/UP/HARTHALA/TOWN/31/418
32-4/2009-SS/SZN-200
(+) VE
91%
1250.
32-4/2009-SS/SZN-206
(+) VE
98.53%
1251.
32-4/2009-SS/SZN-162
(+) VE
96.88%
1252.
32-4/2009-SS/SZN-181
(+) VE
98.5%
1253.
32-4/2009-SS/SZN-161
(+) VE
98.54%
1254.
SZ/TAMILNADU/CHENNAI/T/31/3491
32-4/2009-SS/SZN-168
(+) VE
104.38%
1255.
BC/31/4199
32-4/2009-SS/SZN-172
(+) VE
97.5%
1256.
NZ/RAJ./JODHPUR/BC/31/92
32-4/2009-SS/SZN-205
(+) VE
98.74%
1257.
DHQ/31/401
32-4/2009-SS/SZN-167
(+) VE
102.08%
1258.
32-4/2009-SS/SZN-203
(+) VE
101.46%
1259.
32-4/2009-SS/SZN-193
(+) VE
93.5%
1260.
BC/31/40
32-4/2009-SS/SZN-187
(+) VE
101%
1261.
NZ/RAJ/SURATGARH/DHQ/31/86
32-4/2009-SS/SZN-204
(+) VE
97.27%
1262.
32-4/2009-SS/SZN-190
(+) VE
91.1%
1263.
NZ/UP/MEJA ROAD/TOWN/31/403
32-4/2009-SS/SZN-197
(+) VE
97%
1264.
32-4/2009-SS/SZN-165
(+) VE
97.08%
1265.
32-4/2009-SS/SZN-182
(+) VE
99.30%
1266.
32-4/2009-SS/SZN-164
(+) VE
96.66%
1267.
32-4/2009-SS/SZN-175
(+) VE
104.79%
1268.
32-4/2009-SS/SZN-170
(+) VE
100.83%
1269.
NZ/UP/PURANA MUMPHAND GANJ/

BC/31/407
32-4/2009-SS/SZN-198
(+) VE
96.85%
1270.
MC/31/9861
32-4/2009-SS/SZN-183
(+) VE
101%
1271.
NZ/UP/ASHARFI VILLA/TOWN/31/405
32-4/2009-SS/SZN-199
(+) VE
93.9%
119
1272.
Atherochek
Atorvastatin
Tablets
DHQ/32/105
CDL,
Kolkata
32-4/2009-SS/SZN-214
(+) VE
101.8%
1273.
32-4/2009-SS/SZN-215
(+) VE
105.9%
1274.
32-4/2009-SS/SZN-211
(+) VE
99%
1275.
DHQ/32/13
32-4/2009-SS/SZN-213
(+) VE
106.1%
1276.
32-4/2009-SS/SZN-208
(+) VE
104%
1277.
DHQ/32/05
32-4/2009-SS/SZN-219
(+) VE
90.4%
1278.
DHQ/32/123
32-4/2009-SS/SZN-212
(+) VE
100.6%
1279.
T/32/954
32-4/2009-SS/SZN-207
(+) VE
93%
1280.
32-4/2009-SS/SZN-221
(+) VE
98.4%
1281.
32-4/2009-SS/SZN-209
(+) VE
98%
1282.
32-4/2009-SS/SZN-218
(+) VE
95%
1283.
32-4/2009-SS/SZN-223
(+) VE
90%
1284.
32-4/2009-SS/SZN-220
(+) VE
93.4%
1285.
32-4/2009-SS/SZN-226
(+) VE
94.5%
1286.
32-4/2009-SS/SZN-216
(+) VE
109.5%
1287.
BC/32/3937
32-4/2009-SS/SZN-210
(+) VE
107.18%
1288.
DHQ/32/08
32-4/2009-SS/SZN-217
(+) VE
104.3%
1289.
NZ/UTTARAKHAND/DEHRADUN/
BC/32/371
32-4/2009-SS/SZN-222
(+) VE
92.7%
1290.
32-4/2009-SS/SZN-224
(+) VE
95.7%
1291.
32-4/2009-SS/SZN-225
(+) VE
94.5%
32-4/2009-SS/SZN-251
(+) VE
96.9%
1292.
STORVAS
Atorvastatin
Calcium
Tablets
CDL,
Kolkata
1293.
32-4/2009-SS/SZN-227
(+) VE
105%
1294.
DHQ/33/4937
32-4/2009-SS/SZN-238
(+) VE
94.7%
1295.
32-4/2009-SS/SZN-254
(+) VE
94.4%
1296.
SZ/KARNATAKA/TUMKUR/DHQ/33/4282
32-4/2009-SS/SZN-230
(+) VE
96.9%
1297.
32-4/2009-SS/SZN-252
(+) VE
97.7%
1298.
NZ/RAJ/JAIPUR/BC/33/125
32-4/2009-SS/SZN-261
(+) VE
94.5%
1299.
DHQ/33/14
32-4/2009-SS/SZN-268
(+) VE
98.8%
1300.
BC/33/4392
32-4/2009-SS/SZN-229
(+) VE
108%
1301.
32-4/2009-SS/SZN-236
(+) VE
95.8%
1302.
32-4/2009-SS/SZN-240
(+) VE
98.3%
1303.
NZ/PUNJAB/LOHAR MARKET/T/33/537
32-4/2009-SS/SZN-265
(+) VE
98.5%
1304.
32-4/2009-SS/SZN-237
(+) VE
91.8%
1305.
32-4/2009-SS/SZN-247
(+) VE
96%
1306.
32-4/2009-SS/SZN-239
(+) VE
90%
1307.
32-4/2009-SS/SZN-243
(+) VE
100.9%
1308.
32-4/2009-SS/SZN-256
(+) VE
95.2%
1309.
T/33/3285
32-4/2009-SS/SZN-235
(+) VE
100%
1310.
NZ/UTTARAKHAND/KASHIPUR/T/33/221
32-4/2009-SS/SZN-264
(+) VE
94.5%
1311.
NZ/HARYANA/ROHTAK/BC/33/330
32-4/2009-SS/SZN-260
(+) VE
94.4%
1312.
NZ/RAJ/LOOKRANSAR/T/33/121
32-4/2009-SS/SZN-262
(+) VE
98.7%
1313.
EZ/BR/PURVA/DHQ/33/99
32-4/2009-SS/SZN-253
(+) VE
97.6%
1314.
BC/33/38
32-4/2009-SS/SZN-266
(+) VE
95.4%
120
SZ/TAMILNADU/LANCHIPURAY/
DHQ/33/270
1315.
32-4/2009-SS/SZN-245
(+) VE
99%
1316.
32-4/2009-SS/SZN-271
(+) VE
96.2%
1317.
32-4/2009-SS/SZN-272
(+) VE
93.2%
1318.
32-4/2009-SS/SZN-270
(+) VE
91.0%
1319.
32-4/2009-SS/SZN-248
(+) VE
94.7%
1320.
32-4/2009-SS/SZN-267
(+) VE
98.8%
1321.
SZ/TAMILNADU/PATTUKOTTAI DHANNARGUDI /T/33/ 5249
32-4/2009-SS/SZN-242
(+) VE
110%
1322.
32-4/2009-SS/SZN-276
(+) VE
91.7%
1323.
NZ/UTTARAKHAND/ALMORA/BC/33/482
32-4/2009-SS/SZN-263
(+) VE
95.6%
1324.
32-4/2009-SS/SZN-241
(+) VE
107%
1325.
32-4/2009-SS/SZN-246
(+) VE
100%
1326.
SZ/ANDHRA PRADESH/VISAKHAPATNAM/BC/33/ 3333
32-4/2009-SS/SZN-231
(+) VE
92.1%
1327.
VIL/33/3887
32-4/2009-SS/SZN-234
(+) VE
101%
1328.
32-4/2009-SS/SZN-273
(+) VE
95.1%
1329.
SZ/ANDHRA PRADESH/SECUNDERABAD/BC/33/ 3679
32-4/2009-SS/SZN-232
(+) VE
93.8%
1330.
T/33/3423
32-4/2009-SS/SZN-233
(+) VE
90%
1331.
EZ/WB/HABRA/T/33/2311
32-4/2009-SS/SZN-255
(+) VE
96.7%
1332.
SZ/TAMILNADU/NAGERCOIL/T/33/681
32-4/2009-SS/SZN-249
(+) VE
90.7%
1333.
32-4/2009-SS/SZN-259
(+) VE
96.3%
1334.
EZ/NE/UDAIPUR/DHQ/33/111
32-4/2009-SS/SZN-257
(+) VE
92.6%
1335.
EZ/ASSAM/DIPHU/VIL/33/391
32-4/2009-SS/SZN-250
(+) VE
99.9%
1336.
32-4/2009-SS/SZN-244
(+) VE
98.8%
1337.
32-4/2009-SS/SZN-274
(+) VE
97.4%
1338.
32-4/2009-SS/SZN-228
(+) VE
100%
1339.
WZ/GUJARAT/GODHRA/VIL/33/35
32-4/2009-SS/SZN-269
(+) VE
93.9%
1340.
32-4/2009-SS/SZN-258
(+) VE
95.8%
1341.
32-4/2009-SS/SZN-275
(+) VE
95.3%
RDTL/SS/760/09
(+) VE
95.95%
1342.
Glyciphage
Metformin
Tablets
SZ/TAMILNADU/NAGAPATTNAM/
DHQ/34/404
RDTL,
Chandigarh
1343.
DHQ/34/08
RDTL/SS/790/09
(+) VE
103.12%
1344.
WZ/GOA/PERNEM/DHQ/34/13
RDTL/SS/759/09
(+) VE
104.55%
1345.
SZ/TAMILNADU/ARIYALORE/T/34/2849
RDTL/SS/755/09
(+) VE
104.64%
1346.
RDTL/SS/776/09
(+) VE
104.11%
1347.
RDTL/SS/758/09
(+) VE
98.23%
1348.
RDTL/SS/781/09
(+) VE
103.66%
1349.
SZ/TN/TAMBAGAM/T/34/2337
RDTL/SS/765/09
(+) VE
101.30%
1350.
RDTL/SS/784/09
(+) VE
96.05%
1351.
RDTL/SS/780/09
(+) VE
102.61%
1352.
RDTL/SS/742/09
(+) VE
98.44%
1353.
WZ/GUJARAT/AMRELI/DHQ/34/24
RDTL/SS/767/09
(+) VE
96.02%
1354.
DHQ/34/29
RDTL/SS/779/09
(+) VE
104.27%
1355.
RDTL/SS/782/09
(+) VE
98.84%
1356.
RDTL/SS/771/09
(+) VE
103.49%
1357.
SZ/ANDHRA PRADESH/LUDAPA/
T/34/3136
RDTL/SS/761/09
(+) VE
96.74%
1358.
RDTL/SS/749/09
(+) VE
103.83%
1359.
RDTL/SS/752/09
(+) VE
102.80%
121
1360.
DHQ/34/04
RDTL/SS/773/09
(+) VE
100.45%
1361.
RDTL/SS/743/09
(+) VE
102.65%
1362.
WZ/MAHARASHTRA/NANDED/
DHQ/34/09
RDTL/SS/777/09
(+) VE
100.27%
1363.
DHQ/34/30
RDTL/SS/751/09
(+) VE
103.47%
1364.
VIL/34/34
RDTL/SS/772/09
(+) VE
102.86%
1365.
NZ/UP/CHIKLANA/TOWN/34/761
RDTL/SS/768/09
(+) VE
98.41%
1366.
RDTL/SS/741/09
(+) VE
99.27%
1367.
WZ/MAHARASHTRA/NANDED/VIL/34/07
RDTL/SS/754/09
(+) VE
104.06%
1368.
RDTL/SS/787/09
(+) VE
102.75%
1369.
NZ/HIMACHAL PRADESH/UNA/
DHQ/34/219
RDTL/SS/744/09
(+) VE
99.95%
1370.
RDTL/SS/763/09
(+) VE
98.81%
1371.
RDTL/SS/766/09
(+) VE
100.26%
1372.
BC/34/102
RDTL/SS/748/09
(+) VE
98.75%
1373.
RDTL/SS/757/09
(+) VE
99.72%
1374.
RDTL/SS/786/09
(+) VE
99.86%
1375.
MC/34/1035
RDTL/SS/778/09
(+) VE
103.27%
1376.
RDTL/SS/750/09
(+) VE
103.66%
1377.
RDTL/SS/745/09
(+) VE
99.99%
1378.
RDTL/SS/789/09
(+) VE
104.29%
1379.
SZ/KERALA/ATTINGAL/T/34/2271
RDTL/SS/774/09
(+) VE
101.58%
1380.
NZ/UTTARAKHAND/HARIDWAR/
DHQ/34/05
RDTL/SS/762/09
(+) VE
95.55%
1381.
RDTL/SS/747/09
(+) VE
99.68%
1382.
SZ/ANDHRA PRADESH/CHITTOOT/
T/34/3385
RDTL/SS/785/09
(+) VE
104.60%
1383.
RDTL/SS/788/09
(+) VE
104.18%
1384.
RDTL/SS/775/09
(+) VE
101.52%
1385.
RDTL/SS/783/09
(+) VE
104.50%
1386.
RDTL/SS/770/09
(+) VE
104.9%
1387.
RDTL/SS/769/09
(+) VE
102.00%
1388.
RDTL/SS/764/09
(+) VE
96.35%
1389.
RDTL/SS/753/09
(+) VE
101.32%
1390.
RDTL/SS/746/09
(+) VE
102.37%
RDTL/SS/756/09
(+) VE
103.03%
RDTL/SS/648/09
(+) VE
96.06%
1391.
1392.
Glycomet
Metformin
Tablets
NZ/RAJASTHAN/LOOKRANSAR/T/35/565
RDTL,
Chandigarh
1393.
EZ/OR/SURDARGARH/T/35/606
RDTL/SS/647/09
(+) VE
100.89%
1394.
RDTL/SS/645/09
(+) VE
95.03%
1395.
RDTL/SS/664/09
(+) VE
99.52%
1396.
RDTL/SS/659/09
(+) VE
101.46%
1397.
RDTL/SS/655/09
(+) VE
100.98%
1398.
RDTL/SS/ 681/09
(+) VE
99.13%
1399.
BC/35/34
RDTL/SS/678/09
(+) VE
98.36%
1400.
EZ/OR/CUTTAK/BC/35/282
RDTL/SS/654/09
(+) VE
97.91%
1401.
RDTL/SS/685/09
(+) VE
103.16%
1402.
RDTL/SS/665/09
(+) VE
103.25%
1403.
RDTL/SS/673/09
(+) VE
101.7%
1404.
RDTL/SS/669/09
(+) VE
102.50%
1405.
EZ/WB/DEOPUR/MC/35/3751
RDTL/SS/642/09
(+) VE
98.00%
122
1406.
RDTL/SS/668/09
(+) VE
103.10%
1407.
RDTL/SS/657/09
(+) VE
96.29%
1408.
EZ/WB/RISHROL/T/35/3297
RDTL/SS/646/09
(+) VE
104.71%
1409.
RDTL/SS/677/09
(+) VE
101.14%
1410.
EZ/WB/DIARA/VIL/35/3277
RDTL/SS/649/09
(+) VE
103.30%
1411.
RDTL/SS/650/09
(+) VE
98.23%
1412.
RDTL/SS/661/09
(+) VE
102.59%
1413.
NZ/RAJASTHAN/SRIGANGANAGAR/
DHQ/35/572
RDTL/SS/663/09
(+) VE
100.39%
1414.
RDTL/SS/641/09
(+) VE
97.45%
1415.
RDTL/SS/660/09
(+) VE
100.70%
1416.
WZ/GUJARAT/SILVASSA/VIL/35/04
RDTL/SS/684/09
(+) VE
103.23%
1417.
RDTL/SS/653/09
(+) VE
98.99%
1418.
RDTL/SS/688/09
(+) VE
99.88%
1419.
RDTL/SS/675/09
(+) VE
103.07%
1420.
DHQ/35/84
RDTL/SS/676/09
(+) VE
98.55%
1421.
RDTL/SS/680/09
(+) VE
103.71%
1422.
BC/35/531
RDTL/SS/671/09
(+) VE
102.38%
1423.
EZ/BR/KATIHAR/DHQ/35/26
RDTL/SS/652/09
(+) VE
104.44%
1424.
DHQ/35/4939
RDTL/SS/651/09
(+) VE
98.72%
1425.
RDTL/SS/689/09
(+) VE
104.28%
1426.
RDTL/SS/672/09
(+) VE
98.20%
1427.
T/35/07
RDTL/SS/683/09
(+) VE
102.91%
1428.
DHQ/35/50
RDTL/SS/643/09
(+) VE
99.26%
1429.
SZ/ANDHRAPRADESH/RAJAHMUNDRY/
BC/35/3818
RDTL/SS/656/09
(+) VE
97.48%
1430.
RDTL/SS/670/09
(+) VE
96.45%
1431.
RDTL/SS/682/09
(+) VE
100.91%
1432.
DHQ/35/12
RDTL/SS/640/09
(+) VE
97.11%
1433.
WZ/CHHATTISGARH/DURG/DHQ/35/35
RDTL/SS/658/09
(+) VE
98.49%
1434.
RDTL/SS/644/09
(+) VE
97.07%
1435.
RDTL/SS/686/09
(+) VE
103.31%
1436.
EZ/TRIPURA/DHARMANAGAR/T/35/241
RDTL/SS/662/09
(+) VE
100.95%
1437.
VIL/35/05
RDTL/SS/666/09
(+) VE
99.20%
1438.
RDTL/SS/687/09
(+) VE
100.16%
1439.
WZ/GUJARAT/BHUJ/DHQ/35/09
RDTL/SS/679/09
(+) VE
98.21%
1440.
RDTL/SS/667/09
(+) VE
102.21%
1441.
RDTL/SS/674/09
(+) VE
103.89%
RDTL/SS/704/09
(+) VE
102.26%
1442.
Gluformin
Metformin
Tablets
RDTL,
Chandigarh
1443.
BC/36/128
RDTL/SS/690/09
(+) VE
100.66%
1444.
T/36/3288
RDTL/SS/701/09
(+) VE
98.66%
1445.
RDTL/SS/715/09
(+) VE
103.93%
1446.
RDTL/SS/723/09
(+) VE
102.93%
1447.
RDTL/SS/707/09
(+) VE
104.06%
1448.
RDTL/SS/703/09
(+) VE
103.90%
1449.
NZ/RAJASTHAN/RATANPURA/VIL/36/614
RDTL/SS/716/09
(+) VE
104.12%
123
1450.
EZ/WB/KADAMTALA/T/36/3319
RDTL/SS/713/09
(+) VE
103.49%
1451.
RDTL/SS/708/09
(+) VE
102.97%
1452.
RDTL/SS/739/09
(+) VE
103.97%
1453.
SZ/ANDHRAPRADESH/VIZIANASARAH/
T/36/4514
RDTL/SS/728/09
(+) VE
104.35%
1454.
RDTL/SS/732/09
(+) VE
104.64%
1455.
RDTL/SS/693/09
(+) VE
97.19%
1456.
RDTL/SS/721/09
(+) VE
104.08%
1457.
RDTL/SS/700/09
(+) VE
97.28%
1458.
RDTL/SS/706/09
(+) VE
103.55%
1459.
RDTL/SS/695/09
(+) VE
99.54%
1460.
RDTL/SS/694/09
(+) VE
98.17%
1461.
SZ/TAMILNADU/NAGAPTTIAM/
DHQ/36/406
RDTL/SS/696/09
(+) VE
97.10%
1462.
DHQ/36/24
RDTL/SS/711/09
(+) VE
104.18%
1463.
RDTL/SS/727/09
(+) VE
104.57%
1464.
NZ/RAJASTHAN/CHURU/DHQ/36/619
RDTL/SS/737/09
(+) VE
104.15%
1465.
EZ/OR/SUNDERGARH/BC/36/623
RDTL/SS/697/09
(+) VE
99.35%
1466.
BC/36/1845
RDTL/SS/733/09
(+) VE
103.77%
1467.
RDTL/SS/709/09
(+) VE
104.35%
1468.
RDTL/SS/720/09
(+) VE
104.18%
1469.
RDTL/SS/736/09
(+) VE
104.62%
1470.
EZ/OR/MUDIPUDI/VIL/36/242
RDTL/SS/699/09
(+) VE
100.93%
1471.
RDTL/SS/724/09
(+) VE
104.59%
1472.
NZ/PUNJAB/PATIALA/BC/36/68
RDTL/SS/698/09
(+) VE
101.03%
1473.
RDTL/SS/738/09
(+) VE
102.68%
1474.
RDTL/SS/718/09
(+) VE
103.94%
1475.
NZ/PUNJAB/PHILLAUR/T/36/63
RDTL/SS/731/09
(+) VE
102.30%
1476.
RDTL/SS/726/09
(+) VE
104.21%
1477.
RDTL/SS/734/09
(+) VE
104.29%
1478.
NZ/RAJASTHAN/DURGAGARH/T/36/612
RDTL/SS/719/09
(+) VE
104.42%
1479.
DHQ/36/62
RDTL/SS/710/09
(+) VE
104.56%
1480.
DHQ/36/134
RDTL/SS/722/09
(+) VE
102.65%
1481.
RDTL/SS/691/09
(+) VE
96.75%
1482.
SZ/TAMILNADU/CHENNAI/(B)/MC/36/1093
RDTL/SS/717/09
(+) VE
103.87%
1483.
WZ/GOA/MARGAO/VIL/36/16
RDTL/SS/714/09
(+) VE
104.68%
1484.
RDTL/SS/692/09
(+) VE
100.32%
1485.
NZ/UP/SAHIBABAD/T/36/946
RDTL/SS/735/09
(+) VE
104.04%
1486.
EZ/WB/SHANTIPUR/T/36/2790
RDTL/SS/730/09
(+) VE
102.55%
1487.
RDTL/SS/725/09
(+) VE
104.25%
1488.
SZ/KERALA/THALASERN/T/36/2699
RDTL/SS/729/09
(+) VE
104.79%
1489.
SZ/TAMILNADU/PATTUKOTTAI & MANNARGUDI/ T/36/ 5252
RDTL/SS/712/09
(+) VE
103.36%
1490.
RDTL/SS/702/09
(+) VE
96.17%
1491.
NZ/UP/MOHAN NAGAR/VIL/36/824
RDTL/SS/705/09
(+) VE
103.01%
RDTL/SS/799/09
(+) VE
103.02%
1492.
Glizid-80
Gliclazide
Tablets
RDTL,
Chandigarh
1493.
NZ/HARYANA/SICARI/VIL/37/93
RDTL/SS/797/09
(+) VE
102.36%
1494.
RDTL/SS/814/09
(+) VE
96.93%
1495.
EZ/WB/SODEPUR/MC/37/3752
RDTL/SS/805/09
(+) VE
95.25%
1496.
EZ/OR/BHUVANESHWAR/BC/37/46
RDTL/SS/827/09
(+) VE
95.87%
1497.
NZ/HARYANA/BALLABGARH/T/37/84
RDTL/SS/ 828/09
(+) VE
96.23%
124
1498.
RDTL/SS/831/09
(+) VE
101.55%
1499.
RDTL/SS/792/09
(+) VE
96.56%
1500.
RDTL/SS/835/09
(+) VE
101.44%
1501.
DHQ/37/144
RDTL/SS/822/09
(+) VE
98.75%
1502.
RDTL/SS/829/09
(+) VE
98.89%
1503.
NZ/UP/MORADABAD/BC/37/334
RDTL/SS/808/09
(+) VE
100.67%
1504.
BC/37/52
RDTL/SS/823/09
(+) VE
95.33%
1505.
RDTL/SS/832/09
(+) VE
96.63%
1506.
EZ/WB/RISHRA/T/37/3133
RDTL/SS/810/09
(+) VE
97.53%
1507.
RDTL/SS/801/09
(+) VE
97.40%
1508.
NZ/UP/BARABANKI/DHQ/37/325
RDTL/SS/794/09
(+) VE
100.75%
1509.
RDTL/SS/819/09
(+) VE
98.84%
1510.
RDTL/SS/834/09
(+) VE
95.33%
1511.
RDTL/SS/838/09
(+) VE
99.39%
1512.
NZ/PUNJAB/AMRITSAR/BC/37/119
RDTL/SS/806/09
(+) VE
97.44%
1513.
RDTL/SS/833/09
(+) VE
95.88%
1514.
WZ/GUJARAT/JUNAGARH/DHQ/37/10
RDTL/SS/826/09
(+) VE
98.02%
1515.
RDTL/SS/813/09
(+) VE
98.90%
1516.
WZ/GUJARAT/BHUJ/DHQ/37/02
RDTL/SS/830/09
(+) VE
96.96%
1517.
RDTL/SS/817/09
(+) VE
96.94%
1518.
RDTL/SS/837/09
(+) VE
95.39%
1519.
RDTL/SS/820/09
(+) VE
103.79%
1520.
RDTL/SS/795/09
(+) VE
96.54%
1521.
RDTL/SS/839/09
(+) VE
99.94%
1522.
NZ/HIMACHAL PRADESH/SOLAN/
DHQ/37/188
RDTL/SS/812/09
(+) VE
102.11%
1523.
DHQ/37/01
RDTL/SS/825/09
(+) VE
96.48%
1524.
NZ/J&K/TRIKUTA NAGAR/T/37/149
RDTL/SS/840/09
(+) VE
98.18%
1525.
RDTL/SS/803/09
(+) VE
97.73%
1526.
WZ/GUJARAT/PORBANDAR/T/37/18
RDTL/SS/818/09
(+) VE
100.21%
1527.
RDTL/SS/800/09
(+) VE
99.81%
1528.
RDTL/SS/809/09
(+) VE
98.46%
1529.
BC/37/3572
RDTL/SS/804/09
(+) VE
99.36%
1530.
RDTL/SS/816/09
(+) VE
99.60%
1531.
NZ/RAJASTHAN/RIMOULI/VIL/37/659
RDTL/SS/798/09
(+) VE
101.11%
1532.
RDTL/SS/821/09
(+) VE
95.53%
1533.
RDTL/SS/824/09
(+) VE
97.49%
1534.
NZ/PUNJAB/JHIC/VIL/37/121
RDTL/SS/791/09
(+) VE
97.45%
1535.
EZ/WB/JAYNAGAR/T/37/3406
RDTL/SS/793/09
(+) VE
96.51%
1536.
RDTL/SS/796/09
(+) VE
100.10%
1537.
BC/37/4099
RDTL/SS/802/09
(+) VE
95.67%
1538.
RDTL/SS/815/09
(+) VE
99.91%
1539.
RDTL/SS/836/09
(+) VE
99.74%
1540.
NZ/HIMACHAL PRADESH/AMB/T/37/191
RDTL/SS/811/09
(+) VE
97.24%
1541.
RDTL/SS/807/09
(+) VE
99.73%
RDTL/SS/908/09
(+) VE
98.39%
1542.
Glycigon-80
Gliclazide
Tablets
RDTL,
Chandigarh
1543.
RDTL/SS/917/09
(+) VE
97.95%
1544.
DHQ/38/4942
RDTL/SS/900/09
(+) VE
96.83%
1545.
DHQ/38/30
RDTL/SS/910/09
(+) VE
97.72%
1546.
RDTL/SS/921/09
(+) VE
95.70%
125
1547.
RDTL/SS/902/09
(+) VE
100.31%
1548.
RDTL/SS/935/09
(+) VE
98.18%
1549.
RDTL/SS/892/09
(+) VE
97.53%
1550.
RDTL/SS/894/09
(+) VE
98.06%
1551.
RDTL/SS/918/09
(+) VE
101.41%
1552.
WZ/GOA/MORUMGAO/VIL/38/13
RDTL/SS/903/09
(+) VE
98.75%
1553.
RDTL/SS/924/09
(+) VE
100.97%
1554.
RDTL/SS/931/09
(+) VE
99.56%
1555.
T/38/2969
RDTL/SS/929/09
(+) VE
99.51%
1556.
RDTL/SS/912/09
(+) VE
98.94%
1557.
RDTL/SS/906/09
(+) VE
99.93%
1558.
RDTL/SS/915/09
(+) VE
98.63%
1559.
RDTL/SS/928/09
(+) VE
97.06%
1560.
RDTL/SS/911/09
(+) VE
101.40%
1561.
RDTL/SS/901/09
(+) VE
96.57%
1562.
MC/38/6017
RDTL/SS/895/09
(+) VE
101.56%
1563.
DHQ/38/276
RDTL/SS/898/09
(+) VE
97.12%
1564.
RDTL/SS/927/09
(+) VE
98.78%
1565.
RDTL/SS/920/09
(+) VE
96.80%
1566.
EZ/WB/JONARPUR/MC/38/2369
RDTL/SS/939/09
(+) VE
98.01%
1567.
RDTL/SS/916/09
(+) VE
96.38%
1568.
RDTL/SS/933/09
(+) VE
100.62%
1569.
MC/38/1032
RDTL/SS/907/09
(+) VE
100.09%
1570.
RDTL/SS/904/09
(+) VE
100.47%
1571.
RDTL/SS/934/09
(+) VE
97.88%
1572.
RDTL/SS/893/09
(+) VE
98.87%
1573.
RDTL/SS/938/09
(+) VE
97.84%
1574.
EZ/WB/TALPUKUR/MC/38/3649
RDTL/SS/930/09
(+) VE
100.58%
1575.
RDTL/SS/932/09
(+) VE
100.82%
1576.
RDTL/SS/936/09
(+) VE
100.17%
1577.
RDTL/SS/919/09
(+) VE
97.36%
1578.
EZ/WB/MASLANDAPUR/VIL/38/2287
RDTL/SS/926/09
(+) VE
98.50%
1579.
RDTL/SS/891/09
(+) VE
99.91%
1580.
RDTL/SS/925/09
(+) VE
96.21%
1581.
RDTL/SS/940/09
(+) VE
98.22%
1582.
RDTL/SS/905/09
(+) VE
96.86%
1583.
RDTL/SS/899/09
(+) VE
98.79%
1584.
RDTL/SS/896/09
(+) VE
98.80%
1585.
RDTL/SS/922/09
(+) VE
98.74%
1586.
RDTL/SS/909/09
(+) VE
97.70%
1587.
RDTL/SS/914/09
(+) VE
99.12%
1588.
RDTL/SS/937/09
(+) VE
100.71%
1589.
RDTL/SS/923/09
(+) VE
99.35%
1590.
EZ/ASSAM/NAGAON/T/38/333
RDTL/SS/913/09
(+) VE
98.48%
RDTL/SS/897/09
(+) VE
102.12%
RDTL/SS/879/09
(+) VE
100.05%
1591.
1592.
Reclide-80
Gliclazide
Tablets
RDTL,
Chandigarh
1593.
WZ/GOA/MARGAO/VIL/39/26
RDTL/SS/881/09
(+) VE
101.39%
1594.
SZ/KARNATAKA/KARWAR/T/39/399
RDTL/SS/849/09
(+) VE
101.17%
1595.
RDTL/SS/862/09
(+) VE
102.60%
1596.
RDTL/SS/871/09
(+) VE
99.52%
1597.
WZ/MADHYA
DHQ/39/10
RDTL/SS/857/09
(+) VE
99.95%
1598.
RDTL/SS/886/09
(+) VE
97.67%
126
PRADESH/
SATNA/
1599.
RDTL/SS/878/09
(+) VE
102.03%
1600.
RDTL/SS/848/09
(+) VE
95.80%
1601.
RDTL/SS/842/09
(+) VE
103.91%
1602.
DHQ/39/10
RDTL/SS/861/09
(+) VE
99.14%
1603.
RDTL/SS/854/09
(+) VE
98.31%
1604.
RDTL/SS/890/09
(+) VE
101.49%
1605.
RDTL/SS/870/09
(+) VE
96.82%
1606.
RDTL/SS/850/09
(+) VE
97.22%
1607.
SZ/TAMILNADU/KUMBAKONAM/T/39/960
RDTL/SS/858/09
(+) VE
97.24%
1608.
SZ/TAMILNADU/CHENNAI(J)/MC/39/1521
RDTL/SS/873/09
(+) VE
102.08%
1609.
SZ/ANDHRA
BC/39/2662
RDTL/SS/860/09
(+) VE
99.23%
PRADESH/HYDERABAD/
1610.
RDTL/SS/882/09
(+) VE
103.82%
1611.
BC/30/4100
RDTL/SS/867/09
(+) VE
100.32%
1612.
RDTL/SS/866/09
(+) VE
102.12%
1613.
RDTL/SS/865/09
(+) VE
100.75%
1614.
RDTL/SS/864/09
(+) VE
102.45%
1615.
WZ/MADHYA
BC/39/21
RDTL/SS/883/09
(+) VE
95.42%
PRADESH/INDORE/
1616.
RDTL/SS/841/09
(+) VE
102.72%
1617.
RDTL/SS/887/09
(+) VE
104.02%
1618.
EZ/BR/MAHABIRTOLA/T/39/425
RDTL/SS/863/09
(+) VE
102.50%
1619.
DHQ/39/02
RDTL/SS/872/09
(+) VE
95.37%
1620.
RDTL/SS/869/09
(+) VE
96.57%
1621.
RDTL/SS/854/09
(+) VE
103.20%
1622.
RDTL/SS/844/09
(+) VE
99.35%
1623.
RDTL/SS/875/09
(+) VE
103.92%
1624.
WZ/MAHARASHTRA/SOLAPUR/
DHQ/39/45
RDTL/SS/847/09
(+) VE
102.86%
1625.
VIL/39/05
RDTL/SS/868/09
(+) VE
96.86%
1626.
RDTL/SS/888/09
(+) VE
103.67%
1627.
T/39/4316
RDTL/SS/846/09
(+) VE
98.54%
1628.
T/39/3858
RDTL/SS/889/09
(+) VE
101.0%
1629.
RDTL/SS/851/09
(+) VE
99.82%
1630.
RDTL/SS/874/09
(+) VE
97.40%
1631.
RDTL/SS/884/09
(+) VE
100.86%
1632.
NZ/UP/MIJAROAD/T/39/521
RDTL/SS/885/09
(+) VE
99.87%
1633.
RDTL/SS/845/09
(+) VE
100.68%
1634.
EZ/OR/GOLE BAZAR/T/39/220
RDTL/SS/855/09
(+) VE
98.36%
1635.
WZ/MADHYA
BC/39/65
RDTL/SS/877/09
(+) VE
102.06%
PRADESH/INDORE/
1636.
EZ/OR/MODU BAZAR/T/39/149
RDTL/SS/876/09
(+) VE
101.94%
1637.
RDTL/SS/880/09
(+) VE
96.10%
1638.
RDTL/SS/843/09
(+) VE
99.64%
1639.
NZ/HARYANA/HASSI/T/39/344
RDTL/SS/856/09
(+) VE
101.74%
1640.
RDTL/SS/859/09
(+) VE
95.62%
1641.
MC/39/4617
RDTL/SS/853/09
(+) VE
95.53%
127
1642.
Glimiprex-2
Glimepiride
Tablets
CDL,
Kolkata
32-4/2009-SS/SZN-284
(+) VE
92.5%
1643.
BC/40/3945
32-4/2009-SS/SZN-286
(+) VE
92%
1644.
NZ/UP/MORADABAD/BC/40/286
32-4/2009-SS/SZN-304
(+) VE
91.81%
1645.
NZ/RAJASTHAN/SIKAR/DHQ/40/634
32-4/2009-SS/SZN-303
(+) VE
89.15%
1646.
32-4/2009-SS/SZN-285
(+) VE
93%
1647.
32-4/2009-SS/SZN-289
(+) VE
99.47%
1648.
32-4/2009-SS/SZN-277
(+) VE
97.4%
1649.
32-4/2009-SS/SZN-281
(+) VE
92.15%
1650.
32-4/2009-SS/SZN-278
(+) VE
93.9%
1651.
32-4/2009-SS/SZN-294
(+) VE
98.36%
1652.
32-4/2009-SS/SZN-301
(+) VE
95.75%
1653.
32-4/2009-SS/SZN-295
(+) VE
96.43%
1654.
32-4/2009-SS/SZN-296
(+) VE
111.5%
1655.
NZ/UTTARAKHAND/CHANODA/
VIL/40/132
32-4/2009-SS/SZN-305
(+) VE
90.65%
1656.
NZ/HARYANA/BADHASHAPUR/
VIL/40/179
32-4/2009-SS/SZN-300
(+) VE
96.25%
1657.
32-4/2009-SS/SZN-299
(+) VE
95.54%
1658.
32-4/2009-SS/SZN-302
(+) VE
94%
1659.
DHQ/40/133
32-4/2009-SS/SZN-306
(+) VE
90%
1660.
32-4/2009-SS/SZN-292
(+) VE
98.13%
1661.
MC/40/8721
32-4/2009-SS/SZN-297
(+) VE
98.8%
1662.
32-4/2009-SS/SZN-291
(+) VE
99.47%
1663.
32-4/2009-SS/SZN-293
(+) VE
107.68%
1664.
DHQ/40/33
32-4/2009-SS/SZN-290
(+) VE
91.25%
1665.
MC/40/1010
32-4/2009-SS/SZN-298
(+) VE
100.3%
1666.
32-4/2009-SS/SZN-280
(+) VE
90.5%
1667.
32-4/2009-SS/SZN-279
(+) VE
90.5%
1668.
32-4/2009-SS/SZN-282
(+) VE
93.5%
1669.
32-4/2009-SS/SZN-288
(+) VE
94.78%
1670.
T/40/3391
32-4/2009-SS/SZN-283
(+) VE
93%
32-4/2009-SS/SZN-287
(+) VE
95.81%
32-4/2009-SS/SZN-344
(+) VE
95.15%
1671.
1672.
Amaryl-2
Glimepiride
Tablets
CDL,
Kolkata
1673.
32-4/2009-SS/SZN-351
(+) VE
92.15%
1674.
SZ/ANDHRA PRADESH/VISAKHAPATNAM/BC/41/ 3341
32-4/2009-SS/SZN-346
(+) VE
94.25%
1675.
32-4/2009-SS/SZN-335
(+) VE
94.9%
1676.
32-4/2009-SS/SZN-353
(+) VE
92.15%
1677.
EZ/WB/GOBARDANGA/VIL/41/2257
32-4/2009-SS/SZN-317
(+) VE
91.5%
1678.
32-4/2009-SS/SZN-327
(+) VE
94.65%
1679.
32-4/2009-SS/SZN-333
(+) VE
90.9%
1680.
32-4/2009-SS/SZN-315
(+) VE
94.15%
1681.
32-4/2009-SS/SZN-332
(+) VE
92.3%
1682.
WZ/GUJARAT/PORBANDAR/T/41/17
32-4/2009-SS/SZN-331
(+) VE
91.2%
1683.
BC/41/2664
32-4/2009-SS/SZN-347
(+) VE
93.9%
1684.
32-4/2009-SS/SZN-352
(+) VE
93.7%
128
1685.
32-4/2009-SS/SZN-319
(+) VE
90.05%
1686.
32-4/2009-SS/SZN-339
(+) VE
94.7%
1687.
32-4/2009-SS/SZN-330
(+) VE
92.05%
1688.
32-4/2009-SS/SZN-323
(+) VE
92.6%
1689.
32-4/2009-SS/SZN-340
(+) VE
93.9%
1690.
NZ/UTTARAKHAND/KAHSNA/VIL/41/270
32-4/2009-SS/SZN-341
(+) VE
95.3%
1691.
32-4/2009-SS/SZN-322
(+) VE
92.8%
1692.
DHQ/41/4318
32-4/2009-SS/SZN-345
(+) VE
94.05%
1693.
EZ/OR/BALANGA/VIL/41/530
32-4/2009-SS/SZN-326
(+) VE
92.8%
1694.
DHQ/41/20
32-4/2009-SS/SZN-328
(+) VE
96.9%
1695.
SZ/TAMILNADU/TIRUNELVEH/BC/41/229
32-4/2009-SS/SZN-350
(+) VE
94.45%
1696.
32-4/2009-SS/SZN-324
(+) VE
92.2%
1697.
32-4/2009-SS/SZN-312
(+) VE
93.95%
1698.
32-4/2009-SS/SZN-310
(+) VE
91.7%
1699.
32-4/2009-SS/SZN-349
(+) VE
92.9%
1700.
32-4/2009-SS/SZN-354
(+) VE
92.9%
1701.
32-4/2009-SS/SZN-311
(+) VE
90.25%
1702.
32-4/2009-SS/SZN-316
(+) VE
93.9%
1703.
32-4/2009-SS/SZN-308
(+) VE
90.1%
1704.
DHQ/41/37
32-4/2009-SS/SZN-329
(+) VE
92.55%
1705.
DHQ/41/41
32-4/2009-SS/SZN-337
(+) VE
95.05%
1706.
EZ/NE/SILCHAR/DHQ/41/29
32-4/2009-SS/SZN-325
(+) VE
91.85%
1707.
WZ/GUJARAT/GODHRA/DHQ/41/12
32-4/2009-SS/SZN-334
(+) VE
98.1%
1708.
32-4/2009-SS/SZN-321
(+) VE
93.05%
1709.
32-4/2009-SS/SZN-307
(+) VE
92.7%
1710.
EZ/WB/KOLKATA/BC/41/312
32-4/2009-SS/SZN-309
(+) VE
91.1%
1711.
32-4/2009-SS/SZN-343
(+) VE
90.55%
1712.
EZ/WB/KOLKATA/BC/41/310
32-4/2009-SS/SZN-313
(+) VE
93.25%
1713.
DHQ/41/ 55
32-4/2009-SS/SZN-336
(+) VE
97.15%
1714.
32-4/2009-SS/SZN-338
(+) VE
95.65%
1715.
32-4/2009-SS/SZN-342
(+) VE
94.7%
1716.
SZ/TAMILNADU/CHENNAI (N)/
MC/41/1713
32-4/2009-SS/SZN-356
(+) VE
91.5%
1717.
MC/41/4619
32-4/2009-SS/SZN-355
(+) VE
91.55%
1718.
32-4/2009-SS/SZN-320
(+) VE
91.5%
1719.
EZ/WB/BUDGE BUDGE/T/41/3351
32-4/2009-SS/SZN-318
(+) VE
91.0%
1720.
32-4/2009-SS/SZN-314
(+) VE
91.65%
1721.
SZ/ANDHRA PRADESH/NAGUDUPET/
T/41/2041
32-4/2009-SS/SZN-348
(+) VE
93.0%
32-4/2009-SS/SZN-386
(+) VE
109.66%
1722.
Glyree-2
Glimepiride
Tablets
CDL,
Kolkata
1723.
EZ/OR/GUNA/VIL/42/27
32-4/2009-SS/SZN-368
(+) VE
96.3%
1724.
BC/42/15
32-4/2009-SS/SZN-360
(+) VE
93.62%
1725.
NZ/HARYANA/THAJJAR/DHQ/42/102
32-4/2009-SS/SZN-381
(+) VE
89.98%
1726.
32-4/2009-SS/SZN-373
(+) VE
107.53%
1727.
32-4/2009-SS/SZN-370
(+) VE
91.1%
1728.
BC/42/3947
32-4/2009-SS/SZN-379
(+) VE
88.5%
1729.
32-4/2009-SS/SZN-364
(+) VE
106.22%
1730.
32-4/2009-SS/SZN-357
(+) VE
110.5%
1731.
32-4/2009-SS/SZN-384
(+) VE
97.61%
129
1732.
EZ/WB/KHARDAH/MC/42/3650
32-4/2009-SS/SZN-372
(+) VE
92.94%
1733.
32-4/2009-SS/SZN-377
(+) VE
103.14%
1734.
32-4/2009-SS/SZN-374
(+) VE
100.7%
1735.
32-4/2009-SS/SZN-385
(+) VE
101.11%
1736.
DHQ/42/ 127
32-4/2009-SS/SZN-359
(+) VE
105.14%
1737.
32-4/2009-SS/SZN-378
(+) VE
100.88%
1738.
NZ/RAJASTHAN/SRI NAGAR/DHQ/42/277
32-4/2009-SS/SZN-383
(+) VE
102.72%
1739.
32-4/2009-SS/SZN-376
(+) VE
110.04%
1740.
32-4/2009-SS/SZN-367
(+) VE
93.2%
1741.
32-4/2009-SS/SZN-375
(+) VE
89.0%
1742.
32-4/2009-SS/SZN-358
(+) VE
96.8%
1743.
32-4/2009-SS/SZN-361
(+) VE
105.08%
1744.
32-4/2009-SS/SZN-365
(+) VE
97.84%
1745.
EZ/OR/BAMIPADA/VIL/42/336
32-4/2009-SS/SZN-369
(+) VE
108.9%
1746.
32-4/2009-SS/SZN-363
(+) VE
105.08%
1747.
32-4/2009-SS/SZN-366
(+) VE
100.36%
1748.
32-4/2009-SS/SZN-380
(+) VE
94.75%
1749.
32-4/2009-SS/SZN-362
(+) VE
104.4%
1750.
EZ/WB/SANTOSHR/T/42/3361
32-4/2009-SS/SZN-371
(+) VE
90.67%
1751.
32-4/2009-SS/SZN-382
(+) VE
108.9%
001249-D/09-10
(+) VE
100.7%
1752.
Lariago
Chloroquine
Phosphate
Tablets
SZ/TAMIL NADU/CHENGAM/T/43/3499
CDTL,
Mumbai
1753.
EZ/WB/HIND MOTOR/T/43/2108
001249-D/09-10
(+) VE
100.1%
1754.
001249-D/09-10
(+) VE
102.1%
1755.
NZ/HIMACHAL PRADESH/SOLAN/
DHQ/43/221
001249-D/09-10
(+) VE
95.3%
1756.
001249-D/09-10
(+) VE
103.7%
1757.
001249-D/09-10
(+) VE
103.5%
1758.
001249-D/09-10
(+) VE
103.4%
1759.
NZ/UP/DADRI/T/43/1079
001249-D/09-10
(+) VE
102.3%
1760.
001249-D/09-10
(+) VE
103.2%
1761.
001249-D/09-10
(+) VE
102.4%
1762.
001249-D/09-10
(+) VE
104.7%
1763.
001249-D/09-10
(+) VE
102.4%
1764.
SZ/TAMILNADU/PATTUKOTTAIMANNARGUDI/T/43/5257
001249-D/09-10
(+) VE
101.3%
1765.
001249-D/09-10
(+) VE
100.7%
1766.
001249-D/09-10
(+) VE
99.2%
1767.
001249-D/09-10
(+) VE
100.5%
1768.
SZ/ANDRA PRADESH/UIZIANAGARAM/
T/43/4517
001249-D/09-10
(+) VE
103.6%
1769.
SZ/TAMILNADU/PANRATI/T/43/1899
001249-D/09-10
(+) VE
103.4%
1770.
001249-D/09-10
(+) VE
101.3%
1771.
001249-D/09-10
(+) VE
100.5%
1772.
WZ/GUJARAT/DALANPUR/DHQ/43/04
001249-D/09-10
(+) VE
100.5%
1773.
001249-D/09-10
(+) VE
102.6%
1774.
001249-D/09-10
(+) VE
103.2%
1775.
001249-D/09-10
(+) VE
100.9%
1776.
001249-D/09-10
(+) VE
101.3%
1777.
001249-D/09-10
(+) VE
102.8%
1778.
SZ/TN/SRIPURAMBUDUR/T/43/1742
001249-D/09-10
(+) VE
103.3%
1779.
001249-D/09-10
(+) VE
102.1%
1780.
001249-D/09-10
(+) VE
102.6%
1781.
001249-D/09-10
(+) VE
103.0%
1782.
001249-D/09-10
(+) VE
102.5%
1783.
001249-D/09-10
(+) VE
103.1%
1784.
EZ/JHARKHAND/BOKARO/BC/43/201
001249-D/09-10
(+) VE
101.4%
130
1785.
001249-D/09-10
(+) VE
102.3%
1786.
001249-D/09-10
(+) VE
102.0%
1787.
EZ/JHARKHAND/DHANBAD/BC/43/237
001249-D/09-10
(+) VE
102.6%
1788.
001249-D/09-10
(+) VE
104.5%
1789.
EZ/WB/CHANDARNAGAR/T/43/2982
001249-D/09-10
(+) VE
100.1%
1790.
EZ/WB/CANNING/T/43/1982
001249-D/09-10
(+) VE
103.0%
1791.
001249-D/09-10
(+) VE
102.3%
1792.
NZ/PUNJAB/TEHANG/T/43/326
001249-D/09-10
(+) VE
101.1%
1793.
WZ/MADHYA PRADESH/SAGAR/DHQ/43/72
001249-D/09-10
(+) VE
103.4%
1794.
WZ/MAHARASHTRA/NANDED/DHQ/43/17
001249-D/09-10
(+) VE
103.6%
1795.
001249-D/09-10
(+) VE
104.8%
1796.
001249-D/09-10
(+) VE
104.5%
1797.
WZ/GUJARAT/MEHSANA/DHQ/43/08
001249-D/09-10
(+) VE
102.2%
1798.
001249-D/09-10
(+) VE
100.8%
1799.
001249-D/09-10
(+) VE
103.1%
1800.
WZ/GUJARAT/HIMMATNAGAR/VIL/43/09
001249-D/09-10
(+) VE
103.0%
EZ/WB/HINDMOTOR/T/43/2108
001249-D/09-10
(+) VE
101.5%
001299-D/09-10
(+) VE
102.8%
99.5%
1801.
1802.
REZIZ
Pyrimethamine
& Sulphadoxine
Tablets
CDTL,
Mumbai
1803.
EZ/OR/SAMBALPUR/VIL/44/240
001299-D/09-10
(+) VE
1804.
001299-D/09-10
(+) VE
1805.
001299-D/09-10
(+) VE
1806.
001299-D/09-10
(+) VE
1807.
VIL/44/23
001299-D/09-10
(+) VE
1808.
001299-D/09-10
(+) VE
1809.
001299-D/09-10
(+) VE
1810.
DHQ/44/85
001299-D/09-10
(+) VE
1811.
001299-D/09-10
(+) VE
1812.
NZ/UP/MURAD NAGAR/T/44/1234
001299-D/09-10
(+) VE
1813.
001299-D/09-10
(+) VE
1814.
NZ/UTTAR PRADESH/SIKANDRABAD/
T/44/1281
001299-D/09-10
(+) VE
1815.
001299-D/09-10
(+) VE
1816.
DHQ/44/111
001299-D/09-10
(+) VE
1817.
NZ/UP/KAWAL NAGAR/VIL/44/658
001299-D/09-10
(+) VE
1818.
001299-D/09-10
(+) VE
1819.
WZ/JHARKHAND/HAZARIBAG/BC/44/482
001299-D/09-10
(+) VE
1820.
001299-D/09-10
(+) VE
1821.
EZ/BR/BUREMAIKERTAN/VIL/44/846
001299-D/09-10
(+) VE
1822.
DHQ/44/36
001299-D/09-10
(+) VE
1823.
001299-D/09-10
(+) VE
1824.
NZ/UTTAR PRADESH/GHAZIABAD/
DHQ/44/1511
001299-D/09-10
(+) VE
1825.
NZ/UP/MURAD NAGAR/T/44/1041
001299-D/09-10
(+) VE
1826.
NZ/PUNJAB/THEANG/T/44/357
001299-D/09-10
(+) VE
1827.
001299-D/09-10
(+) VE
98.5%
104.7%
98.8%
108.0%
91.1%
98.7%
98.1%
108.9%
100.2%
105.7%
103.3%
104.6%
92.7%
99.4%
93.8%
101.1%
92.2%
99.9%
92.3%
106.0%
92.6%
99.7%
95.0%
99.1%
97.0%
104.7%
94.2%
101.9%
98.1%
103.8%
93.1%
108.1%
96.9%
100.5%
94.1%
101.0%
95.9%
100.9%
98.9%
104.5%
103.6%
101.1%
91.8%
105.3%
91.3%
108.7%
96.8%
99.5%
98.1%
101.3%
131
1828.
NZ/UP/DADRI/T/44/1065
001299-D/09-10
(+) VE
1829.
DHQ/44/03
001299-D/09-10
(+) VE
1830.
001299-D/09-10
(+) VE
1831.
001299-D/09-10
(+) VE
1832.
NZ/UP/PILKHUWA/T/44/1447
001299-D/09-10
(+) VE
1833.
NZ/UTTAR PRADESH/DADRI/T/44/1093
001299-D/09-10
(+) VE
1834.
WZ/JHARKHAND/DEOGHAR/T/44/533
001299-D/09-10
(+) VE
1835.
001299-D/09-10
(+) VE
1836.
001299-D/09-10
(+) VE
1837.
NZ/UP/DASNA/VIL/44/1621
001299-D/09-10
(+) VE
1838.
NZ/UP/SIKRIKALA/VIL/44/1254
001299-D/09-10
(+) VE
1839.
001299-D/09-10
(+) VE
1840.
001299-D/09-10
(+) VE
1841.
EZ/JHARKHAND/KANKE/TOWN/44/503
001299-D/09-10
(+) VE
1842.
001299-D/09-10
(+) VE
1843.
EZ/OR/DHENKONAL/VIL/44/697
001299-D/09-10
(+) VE
1844.
001299-D/09-10
(+) VE
1845.
001299-D/09-10
(+) VE
1846.
001299-D/09-10
(+) VE
1847.
DHQ/44/42
001299-D/09-10
(+) VE
1848.
NZ/UTTAR PRADESH/BHANGEL/
T/44/1095
001299-D/09-10
(+) VE
1849.
DHQ/44/11
001299-D/09-10
(+) VE
1850.
001299-D/09-10
(+) VE
001299-D/09-10
(+) VE
32-4/2009-SS/SZN-421
(+) VE
NZ/UP/MODI NAGAR/T/44/1228
1851.
1852.
Nimulid
Nimesulide
Tablets
CDL,
Kolkata
97.0%
101.0%
91.7%
98.8%
93.0%
101.2%
91.6%
108.4%
97.5%
105.4%
97.3%
105.6%
93.7%
100.8%
95.2%
102.8%
96.7%
101.3%
92.7%
107.9%
94.1%
101.6%
92.8%
100.5%
93.0%
100.6%
91.4%
100.5%
91.7%
94.1%
92.3%
101.3%
92.0%
102.6%
92.8%
100.6%
93.9%
101.6%
90.4%
98.3%
99.3%
105.7%
92.1%
98.9%
97.5%
104.6%
91.8%
103.0%
101.09%
1853
32-4/2009-SS/SZN-429
(+) VE
96.31%
1854.
EZ/ASSAM/DIBRUGARH/DHQ/45/60
32-4/2009-SS/SZN-422
(+) VE
92.54%
1855.
EZ/OR/CUTTAK/DHQ/45/301
32-4/2009-SS/SZN-431
(+) VE
95.22%
1856.
NZ/UTTARAKHAND/KASHIPUR/T/45/301
32-4/2009-SS/SZN-394
(+) VE
97.58%
1857.
32-4/2009-SS/SZN-401
(+) VE
97.80%
1858.
32-4/2009-SS/SZN-403
(+) VE
101.69%
1859.
32-4/2009-SS/SZN-405
(+) VE
101.90%
1860.
32-4/2009-SS/SZN-392
(+) VE
99.38%
1861.
32-4/2009-SS/SZN-424
(+) VE
105.06%
1862.
32-4/2009-SS/SZN-415
(+) VE
98.55%
1863.
SZ/TAMILNADU/JHANJAURE/DHQ/45/329
32-4/2009-SS/SZN-404
(+) VE
101.29%
1864.
EZ/JH/RATU ROAD/T/45/29
32-4/2009-SS/SZN-433
(+) VE
103.51%
1865.
VIL/45/3532
32-4/2009-SS/SZN-418
(+) VE
105.26%
1866.
EZ/ASSAM/GOLAGHAT/45/352
32-4/2009-SS/SZN-423
(+) VE
98.24%
1867.
T/45/3178
32-4/2009-SS/SZN-408
(+) VE
99.04%
1868.
EZ/WB/BARHAMPUR/BC/45/1145
32-4/2009-SS/SZN-428
(+) VE
90.88%
1869.
32-4/2009-SS/SZN-407
(+) VE
98.82%
1870.
32-4/2009-SS/SZN-409
(+) VE
98.49%
132
1871.
SZ/KERALA/THALASERRY/T/45/2701
32-4/2009-SS/SZN-412
(+) VE
98.59%
1872.
32-4/2009-SS/SZN-426
(+) VE
92.76%
1873.
32-4/2009-SS/SZN-425
(+) VE
93.20%
1874.
SZ/TAMILNADU/SATAM/BC/45/41
32-4/2009-SS/SZN-419
(+) VE
104.61%
1875.
NZ/UP/AGRA/BC/45/1337
32-4/2009-SS/SZN-398
(+) VE
99.90%
1876.
32-4/2009-SS/SZN-411
(+) VE
98.51%
1877.
EZ/JH/RACHI/BC/45/103
32-4/2009-SS/SZN-434
(+) VE
99.56%
1878.
32-4/2009-SS/SZN-420
(+) VE
104.38%
1879.
NZ/J&K/SAMBA/DHQ/45/138
32-4/2009-SS/SZN-397
(+) VE
102.34%
1880.
32-4/2009-SS/SZN-413
(+) VE
96.88%
1881.
NZ/RAJASTHAN/AJMER/BC/45/513
32-4/2009-SS/SZN-388
(+) VE
102.05%
1882.
SZ/ANDHRA PRADESH/ANKAPALLE/
VIL/45/2568
32-4/2009-SS/SZN-417
(+) VE
106.35%
1883.
32-4/2009-SS/SZN-427
(+) VE
106.35%
1884.
32-4/2009-SS/SZN-396
(+) VE
101.03%
1885.
T/45/2974
32-4/2009-SS/SZN-416
(+) VE
99.86%
1886.
32-4/2009-SS/SZN-402
(+) VE
101.29%
1887.
32-4/2009-SS/SZN-390
(+) VE
99.86%
1888.
EZ/JH/ORUMEJHI/T/45/01
32-4/2009-SS/SZN-432
(+) VE
95.17%
1889.
NZ/HIMACHAL PRADESH/MANDI/
DHQ/45/144
32-4/2009-SS/SZN-393
(+) VE
100.39%
1890.
32-4/2009-SS/SZN-414
(+) VE
99.26%
1891.
32-4/2009-SS/SZN-399
(+) VE
99.91%
1892.
32-4/2009-SS/SZN-430
(+) VE
105.04%
1893.
32-4/2009-SS/SZN-400
(+) VE
101.61%
1894.
32-4/2009-SS/SZN-410
(+) VE
100.20%
1895.
NZ/RAJASTHAN/SRIGANGANAGAR/
DHQ/45/511
32-4/2009-SS/SZN-389
(+) VE
101.33%
1896.
BC/45/493
32-4/2009-SS/SZN-395
(+) VE
98.03%
1897.
EZ/MANIPUR/IMPHAL/BC/45/11
32-4/2009-SS/SZN-435
(+) VE
95.66%
1898.
NZ/RAJASTHAN/DUJOD/VIL/45/508
32-4/2009-SS/SZN-387
(+) VE
99.01%
1999.
32-4/2009-SS/SZN-391
(+) VE
100.06%
1900.
BC/45/1852
32-4/2009-SS/SZN-436
(+) VE
95.83%
32-4/2009-SS/SZN-406
(+) VE
100.84%
32-4/2009-SS/SZN-486
(+) VE
91.15%
1901.
1903.
SZ/TAMILNADU/CHENNAI(K)/MC/45/1568
DHQ/46/4322
NZ/UP/SAHARANPUR/DHQ/46/1674
1904.
1902.
NICIP
Nimesulide
Tablets
CDL,
Kolkata
32-4/2009-SS/SZN-465
(+) VE
94.1%
32-4/2009-SS/SZN-466
(+) VE
90.12%
1905.
32-4/2009-SS/SZN-469
(+) VE
94.8%
1906.
32-4/2009-SS/SZN-463
(+) VE
96.79%
1907.
32-4/2009-SS/SZN-476
(+) VE
98.21%
1908.
32-4/2009-SS/SZN-472
(+) VE
95.33%
1909.
32-4/2009-SS/SZN-451
(+) VE
99.34%
1910.
NZ/UP/LONI/T/46/916
32-4/2009-SS/SZN-462
(+) VE
96.38%
1911.
DHQ/46/14
32-4/2009-SS/SZN-459
(+) VE
97.25%
1912.
32-4/2009-SS/SZN-481
(+) VE
98.0%
1913.
32-4/2009-SS/SZN-478
(+) VE
96.76%
1914.
32-4/2009-SS/SZN-442
(+) VE
98.68%
1915.
T/46/3396
32-4/2009-SS/SZN-483
(+) VE
97.0%
1916.
32-4/2009-SS/SZN-447
(+) VE
95.6%
1917.
32-4/2009-SS/SZN-468
(+) VE
96.62%
1918.
32-4/2009-SS/SZN-471
(+) VE
95.16%
1919.
32-4/2009-SS/SZN-467
(+) VE
96.14%
1920.
EZ/BR/HAJIPUR/VIL/46/636
32-4/2009-SS/SZN-446
(+) VE
94.61%
133
WZ/MAHARASHTARA/MUMBAI/
MC/46/765
32-4/2009-SS/SZN-461
(+) VE
92.52%
1922.
32-4/2009-SS/SZN-437
(+) VE
91.75%
1923.
SZ/ANDHRA PRADESH/ANAKAPALLE/
VIL/46/2569
32-4/2009-SS/SZN-485
(+) VE
93.20%
1921.
1924.
32-4/2009-SS/SZN-445
(+) VE
100.0%
1925.
32-4/2009-SS/SZN-479
(+) VE
92.13%
1926.
32-4/2009-SS/SZN-440
(+) VE
92.96%
1927.
32-4/2009-SS/SZN-453
(+) VE
95.71%
1928.
BC/46/1853
32-4/2009-SS/SZN-480
(+) VE
95.02%
1929.
NZ/RAJASTHAN/NOHAR/T/46/248
32-4/2009-SS/SZN-475
(+) VE
96.5%
1930.
EZ/ASSAM/GOLAGHAT/VIL/46/361
32-4/2009-SS/SZN-438
(+) VE
92.96%
1931.
WZ/CHHATTISGARH/RAIGAD/VIL/46/21
32-4/2009-SS/SZN-449
(+) VE
100.32%
1932.
VIL/46/03
32-4/2009-SS/SZN-454
(+) VE
94.18%
1933.
MC/46/1071
32-4/2009-SS/SZN-460
(+) VE
95.38%
1934.
32-4/2009-SS/SZN-482
(+) VE
95.38%
1935.
VIL/46/08
32-4/2009-SS/SZN-455
(+) VE
98.68%
1936.
32-4/2009-SS/SZN-448
(+) VE
94.50%
1937.
EZ/BR/BHOJPUR/DHQ/46/611
32-4/2009-SS/SZN-444
(+) VE
98.68%
1938.
32-4/2009-SS/SZN-452
(+) VE
96.37%
1939.
NZ/UP/MODI NAGAR/T/46/1616
32-4/2009-SS/SZN-464
(+) VE
98.09%
1940.
NZ/RAJASTHAN/KUNKRANSHAR/
T/46/1247
32-4/2009-SS/SZN-474
(+) VE
97.63%
1941.
32-4/2009-SS/SZN-470
(+) VE
96.65%
1942.
32-4/2009-SS/SZN-457
(+) VE
95.82%
1943.
32-4/2009-SS/SZN-439
(+) VE
99.56%
1944.
32-4/2009-SS/SZN-456
(+) VE
98.57%
1945.
EZ/WB/BELGHARIA/MC/46/3616
32-4/2009-SS/SZN-443
(+) VE
94.61%
1946.
32-4/2009-SS/SZN-441
(+) VE
100.1%
1947.
32-4/2009-SS/SZN-477
(+) VE
94.09%
1948.
NZ/RAJASTHAN/PALLU/T/46/251
32-4/2009-SS/SZN-473
(+) VE
93.9%
1949.
T/46/3863
32-4/2009-SS/SZN-484
(+) VE
95.65%
1950.
32-4/2009-SS/SZN-450
(+) VE
99.45%
1951.
WZ/MAHARASHTRA/MUMBAI/46/230
32-4/2009-SS/SZN-458
(+) VE
94.83%
32-4/2009-SS/SZN-517
(+) VE
99.75%
1952.
Nise
Nimesulide
Tablets
CDL,
Kolkata
1953.
EZ/JHARKHAND/JASIDIH/T/47/572
32-4/2009-SS/SZN-516
(+) VE
98.11%
1954.
32-4/2009-SS/SZN-497
(+) VE
96.87%
1955.
EZ/WB/RAHARA/MC/47/3633
32-4/2009-SS/SZN-520
(+) VE
99.64%
1956.
32-4/2009-SS/SZN-488
(+) VE
99.43%
1957.
32-4/2009-SS/SZN-499
(+) VE
101.29%
1958.
T/47/3864
32-4/2009-SS/SZN-501
(+) VE
97.49%
1959.
EZ/WB/CHAMPDANI/T/47/2071
32-4/2009-SS/SZN-521
(+) VE
97.96%
1960.
32-4/2009-SS/SZN-523
(+) VE
99.27%
1961.
NZ/RAJASTHAN/SARDARSHAHR/
T/47/588
32-4/2009-SS/SZN-531
(+) VE
99.45%
1962.
SZ/ANDHRA PRADESH/NAGUDUPET/
T/47/2043
32-4/2009-SS/SZN-500
(+) VE
98.2%
1963.
SZ/TAMILNADU/JHANJAUR/DHQ/47/331
32-4/2009-SS/SZN-496
(+) VE
98.39%
1964.
32-4/2009-SS/SZN-491
(+) VE
99.39%
1965.
EZ/OR/CUTTACK/DHQ/47/278
32-4/2009-SS/SZN-514
(+) VE
103.03%
1966.
32-4/2009-SS/SZN-495
(+) VE
99.65%
1967.
DHQ/47/279
32-4/2009-SS/SZN-489
(+) VE
98.91%
134
1968.
32-4/2009-SS/SZN-493
(+) VE
95.45%
1969.
32-4/2009-SS/SZN-518
(+) VE
100.18%
1970.
EZ/JHARKHAND/KURU/VIL/47/286
32-4/2009-SS/SZN-515
(+) VE
101.26%
1971.
32-4/2009-SS/SZN-524
(+) VE
96.06%
1972.
32-4/2009-SS/SZN-519
(+) VE
103.81%
1973.
32-4/2009-SS/SZN-522
(+) VE
103.5%
1974.
32-4/2009-SS/SZN-513
(+) VE
102.33%
1975.
32-4/2009-SS/SZN-492
(+) VE
104.43%
1976.
NZ/UP/FARAH/A/T/47/1348
32-4/2009-SS/SZN-534
(+) VE
103.22%
1977.
32-4/2009-SS/SZN-490
(+) VE
99.42%
1978.
DHQ/47/102
32-4/2009-SS/SZN-511
(+) VE
97.67%
1979.
32-4/2009-SS/SZN-507
(+) VE
96.65%
1980.
32-4/2009-SS/SZN-526
(+) VE
104.17%
1981.
32-4/2009-SS/SZN-530
(+) VE
98.03%
1982.
NZ/UP/AJAMGARH/DHQ/47/792
32-4/2009-SS/SZN-533
(+) VE
100.38%
1983.
WZ/GUJARAT/BHAVNAGAR/T/47/32
32-4/2009-SS/SZN-504
(+) VE
98.15%
1984.
DHQ/47/3794
32-4/2009-SS/SZN-487
(+) VE
97.78%
1985.
NZ/UP/DEOBAND/T/47/798
32-4/2009-SS/SZN-535
(+) VE
96.41%
1986.
32-4/2009-SS/SZN-532
(+) VE
100.13%
1987.
32-4/2009-SS/SZN-494
(+) VE
99.88%
1988.
32-4/2009-SS/SZN-510
(+) VE
94.98%
1989.
DHQ/47/36
32-4/2009-SS/SZN-506
(+) VE
96.44%
1990.
32-4/2009-SS/SZN-509
(+) VE
94.01%
1991.
NZ/UTTARAKHAND/NEW TEHRI/
DHQ/47/463
32-4/2009-SS/SZN-536
(+) VE
99.87%
1992.
DHQ/47/22
32-4/2009-SS/SZN-505
(+) VE
98.15%
1993.
32-4/2009-SS/SZN-508
(+) VE
96.73%
1994.
32-4/2009-SS/SZN-502
(+) VE
102.27%
1995.
DHQ/47/29
32-4/2009-SS/SZN-512
(+) VE
99.14%
1996.
WZ/GUJARAT/BARODA/BC/47/44
32-4/2009-SS/SZN-503
(+) VE
98.88%
1997.
32-4/2009-SS/SZN-529
(+) VE
98.59%
1998.
BC/47/4207
32-4/2009-SS/SZN-498
(+) VE
98.33%
1999.
32-4/2009-SS/SZN-527
(+) VE
94.85%
2000.
32-4/2009-SS/SZN-525
(+) VE
101.77%
2001.
NZ/J&K/UDHAMPUR/DHQ/47/23
32-4/2009-SS/SZN-528
(+) VE
90.05%
001570-D/09-10
(+) VE
102.7%
2002.
Crocin
Paracetamol
Tablets
WZ/ GUJARAT/SURAT/BC/48/11
CDTL,
Mumbai
2003.
001570-D/09-10
(+) VE
100.6%
2004.
EZ/OR/RAURKELA/DHQ/48/431
001570-D/09-10
(+) VE
96.7%
2005.
WZ/MP/ UJJAIN/VIL/48/21
001570-D/09-10
(+) VE
99.5%
2006.
WZ/ GUJARAT/SILVASSA/DHQ/48/4
001570-D/09-10
(+) VE
96.2%
2007.
EZ/OR/ KOKATPUR/VIL/48/520
001570-D/09-10
(+) VE
98.3%
2008.
NZ/PUNJAB/JALANDHAR./BC/48/302
001570-D/09-10
(+) VE
96.9%
2009.
001570-D/09-10
(+) VE
96.8%
2010.
EZ/BR/KISHANGANJ/VIL/48/146
001570-D/09-10
(+) VE
98.3%
2011.
NZ/J&K/ KATRA/T/48/282
001570-D/09-10
(+) VE
98.4%
2012.
WZ/MH/ NANDURBAR/DHQ/48/19
001570-D/09-10
(+) VE
103.9%
2013.
EZ/NE/AGURLA/VIL/48/297
001570-D/09-10
(+) VE
98.6%
2014.
001570-D/09-10
(+) VE
103.4%
2015.
001570-D/09-10
(+) VE
100.0%
2016.
EZ/OR/BALASORE/BC/48/195
001570-D/09-10
(+) VE
104.1%
2017.
001570-D/09-10
(+) VE
95.6%
135
2018.
NZ/UP/BULANDSHAHAR/DHQ/48/1300
001570-D/09-10
(+) VE
98.8%
2019.
001570-D/09-10
(+) VE
103.1%
2020.
SZ/TN/ VILLAGE/ VIL/48/828
001570-D/09-10
(+) VE
97.6%
2021.
NZ/UP/HAPUR/ T/ 48/462
001570-D/09-10
(+) VE
99.0%
2022.
001570-D/09-10
(+) VE
99.2%
2023.
001570-D/09-10
(+) VE
98.8%
2024.
WZ/GUJARAT/ PORBANDAR/ DHQ/48/18
001570-D/09-10
(+) VE
101.6%
2025.
WZ/ MH/ SOLAPUR/ DHQ/ 48/40
001570-D/09-10
(+) VE
99.6%
2026.
WZ/ CHHATTISGARH/BILASPUR/
BC/48/37
001570-D/09-10
(+) VE
103.5%
2027.
SZ/TN/VILLAGE/ VIL/48/4753
001570-D/09-10
(+) VE
100.9%
2028.
WZ/GUJARAT/ PALANPUR/ DHQ/ 48/ 17
001570-D/09-10
(+) VE
99.4%
2029.
NZ/NCTDELHI/DELHI/ MC/48/ 195
001570-D/09-10
(+) VE
102.1%
2030.
EZ/ BR/ KATIHAR/DHQ/ 48/ 54
001570-D/09-10
(+) VE
98.2%
2031.
NZ/UP/ HASUNPURKALA/ VIL/ 48/993
001570-D/09-10
(+) VE
95.5%
2032.
EZ/ BR/ MUZAFFARPUR/ DHQ/ 48/ 322
001570-D/09-10
(+) VE
98.5%
2033.
WZ/MH/ MUMBAI/ MC/ 48/ 685
001570-D/09-10
(+) VE
98.6%
2034.
WZ/ CHHATTISGARH/ RAIGAD/ VIL/

48/ 8
001570-D/09-10
(+) VE
97.5%
2035.
WZ/ MH/ MUMBAI/ MC/ 48/ 257
001570-D/09-10
(+) VE
96.6%
2036.
EZ/ OR/ ANGUL/ VIL/ 48/ 657
001570-D/09-10
(+) VE
101.3%
2037.
001570-D/09-10
(+) VE
101.3%
2038.
001570-D/09-10
(+) VE
95.5%
2039.
SZ/ TAMILNADU/ T/ 51/ 2002
001570-D/09-10
(+) VE
96.9%
2040.
NZ/HARYANA/ PALWAL/ DHQ/ 48/ 243
001570-D/09-10
(+) VE
100.7%
2041.
SZ/ TN/ MADURAI/ BC/ 48/ 4810
001570-D/09-10
(+) VE
96.2%
2042.
NZ/ RAJASTHAN/ CHURU/ DHQ/ 48/ 314
001570-D/09-10
(+) VE
95.8%
2043.
WZ/ GUJARAT/ BHAVNAGAR/ DHQ/ 48/

30
001570-D/09-10
(+) VE
96.1%
2044.
SZ/ KARNATAKA/ VILLAGE/ VIL/ 48/ 3911
001570-D/09-10
(+) VE
97.3%
2045.
EZ/ BR/ CHAPRA/ DHQ/ 48/ 531
001570-D/09-10
(+) VE
99.3%
2046.
EZ/ OR/ BHULSAM/ VIL/ 48/ 710
001570-D/09-10
(+) VE
97.5%
2047.
EZ/ OR/ SAMBALPUR/ VIL/ 48/ 217
001570-D/09-10
(+) VE
100.2%
2048.
NZ/ UP/ LONI/ T/ 48/ 958
001570-D/09-10
(+) VE
98.6%
2049.
NZ/ UP/ GHAZIABAD/ DHQ/ 48/ 1643
001570-D/09-10
(+) VE
100.9%
2050.
NZ/ HARYANA/ ROHTAK/ BC/ 48/ 247
001570-D/09-10
(+) VE
96.9%
2051.
EZ/NE/ HIRANEA/VIL/ 48/163
001570-D/09-10
(+) VE
98.0%
102.1%
Paracetamol
Tablets
CDTL,
Mumbai
001749-D/09-10
(+) VE
2053.
EZ/BR/ SIWAN/ DHQ/ 49/ 725
001749-D/09-10
(+) VE
102.4%
2054.
SZ/ TN/ CHENNAI/ MC/ 49/ 5162
001749-D/09-10
(+) VE
100.4%
2052.
Pacimol
EZ/BR/ BHAGALPUR/ DHQ/ 49/ 248
2055.
EZ/ WB/ KOL/ MC/ 49/ 1998
001749-D/09-10
(+) VE
95.4%
2056.
EZ/ MANIPUR/ IMPHAL/ BC/ 49/ 29
001749-D/09-10
(+) VE
98.0%
2057.
NZ/ RAJASTHAN/ JODHPUR/ BC/ 49/ 525
001749-D/09-10
(+) VE
98.5%
2058.
SZ/ AP/ CHITTOOR/ T/ 49/ 3399
001749-D/09-10
(+) VE
95.8%
2059.
NZ/ UP/ FATEHABAD/ T/ 49/ 1354
001749-D/09-10
(+) VE
96.2%
2060.
SZ/ PONDICHERRY/ T/ 49/ 4448
001749-D/09-10
(+) VE
96.4%
2061.
EZ/ WB/ BARRACKPORE/ MC/ 49/ 3510
001749-D/09-10
(+) VE
97.5%
2062.
EZ/ WB/ KOL/ MC/ 49/ 1961
001749-D/09-10
(+) VE
104.2%
2063.
WZ/ MH/ NASHIK/ VIL/ 49/ 26
001749-D/09-10
(+) VE
100.2%
2064.
EZ/BR/LOHRIASARIA/T/49/280
001749-D/09-10
(+) VE
95.3%
2065.
WZ/MH/MUMBAI/MC/ 49/606
001749-D/09-10
(+) VE
104.6%
2066.
NZ/ PUNJAB/ KHANNA NAGAR/T/ 49/ 233
001749-D/09-10
(+) VE
99.4%
2067.
WZ/MH/SOLAPUR /T/ 49/16
001749-D/09-10
(+) VE
99.2%
2068.
WZ/MH/PUNE/BC / 49/6
001749-D/09-10
(+) VE
100.4%
2069.
EZ/WB/ AMTALA/VIL/ 49/ 3451
001749-D/09-10
(+) VE
102.0%
2070.
EZ/ WB/ NABAWIP/ VIL/ 49/3745
001749-D/09-10
(+) VE
99.2%
2071.
WZ/ GUJARAT/ JAMNAGAR/ VIL/ 49/ 36
001749-D/09-10
(+) VE
100.4%
136
2072.
001749-D/09-10
(+) VE
97.8%
2073.
SZ/ KERALA/ THRISSUR/ BC/ 49/ 1962
001749-D/09-10
(+) VE
101.6%
2074.
EZ/ WB/ KOLKATA/ MC/ 49/ 358
001749-D/09-10
(+) VE
96.0%
2075.
NZ/ UP/ VARANASI/ BC/ 49/ 104
001749-D/09-10
(+) VE
96.6%
2076.
SZ/ KERALA/ KASARGOD/ DHQ/ 49/ 2065
001749-D/09-10
(+) VE
98.2%
2077.
EZ/ WB/ GODHRAN/ VIL/ 49/ 3030
001749-D/09-10
(+) VE
100.2%
2078.
NZ/UTTARAKHAND/BHEMTALL / VIL /
49/ 101
001749-D/09-10
(+) VE
103.8%
2079.
SZ/ KERALA/ THIRUVANANTHAPURAM/ BC/ 49/ 1858
001749-D/09-10
(+) VE
102.4%
2080.
SZ/TN/ VILLAGE/ VIL/ 49/ 5349
001749-D/09-10
(+) VE
96.9%
2081.
EZ/ ASSAM/ JORHAT/ T/ 49/ 42
001749-D/09-10
(+) VE
104.4%
2082.
EZ/ WB/ SANARPUR/ MC/ 49/ 2362
001749-D/09-10
(+) VE
96.8%
2083.
001749-D/09-10
(+) VE
97.1%
2084.
001749-D/09-10
(+) VE
104.2%
2085.
001749-D/09-10
(+) VE
99.6%
2086.
WZ/MH/THANE /BC/ 49/83
001749-D/09-10
(+) VE
99.2%
2087.
WZ/GUJARAT/JAMNAGAR/ T/ 49/ 53
001749-D/09-10
(+) VE
95.2%
2088.
WZ/MH/THANE /BC/ 49/24
001749-D/09-10
(+) VE
103.8%
2089.
WZ/GUJARAT/ BHAVNAGAR/DHQ/49/ 31
001749-D/09-10
(+) VE
97.0%
2090.
EZ/ WB/ GOCHAVAN/ VIL/ 49/ 3030
001749-D/09-10
(+) VE
98.1%
2091.
SZ/ TN/ TIRUNELVELI/ BC/ 49/ 236
001749-D/09-10
(+) VE
101.5%
2092.
001749-D/09-10
(+) VE
94.5%
2093.
NZ/ UP/ MEERUT/ BC/ 49/101
001749-D/09-10
(+) VE
103.4%
2094.
SZ/ AP/ GUNTUR/ T/ 49/ 2978
001749-D/09-10
(+) VE
100.0%
2095.
SZ/ TN/ VILLAGE / VIL/ 49/ 871
001749-D/09-10
(+) VE
104.2%
2096.
SZ/ KERALA/ THALASERY/ T/ 49/ 2703
001749-D/09-10
(+) VE
104.0%
2097.
SZ/ TN/ KANCHIPURAM/ DHQ/ 49/ 281
001749-D/09-10
(+) VE
98.7%
2098.
EZ/ BR/ BHAGALPUR/ DHQ/ 49/ 193
001749-D/09-10
(+) VE
104.4%
2099.
EZ/ WB/ SURJAYAPUR/ VIL/ 49/ 2389
001749-D/09-10
(+) VE
99.8%
2100.
SZ/ TN/ TRICHY/ BC/ 49/91
001749-D/09-10
(+) VE
100.2%
001749-D/09-10
(+) VE
95.6%
001119-D/09-10
(+) VE
97.5%
2101.
2102.
NZ/UP/GHAZIABAD/ DHQ/ 49/1050

Paracip
Paracetamol
Tablets
SZ/ KERALA/ VILLAGE/ VIL/ 50/ 6026
CDTL,
Mumbai
2103.
001119-D/09-10
(+) VE
103.3%
2104.
001119-D/09-10
(+) VE
100.1%
2105.
001119-D/09-10
(+) VE
104.2%
2106.
NZ/ UP/ GZB/ DHQ/ 50/ 1188
001119-D/09-10
(+) VE
100.2%
2107.
SZ/ AP/ KAKINADA/ T/ 50/ 3300
001119-D/09-10
(+) VE
99.1%
2108.
SZ/ KERALA/ ALUVA/ T/ 50/2242
001119-D/09-10
(+) VE
103.5%
96.1%
2109.
SZ/ KARNATAKA/ BANGALORE/ BC/ 50/ 4109
001119-D/09-10
(+) VE
2110.
SZ/ TN/ TIRRAGUDI/ T/ 50/ 3259
001119-D/09-10
(+) VE
103.2%
2111.
SZ/ AP/ RAJAMUNDRY/ T/ 50/ 6089
001119-D/09-10
(+) VE
101.5%
2112.
EZ/ AP/ PASIGHAT/ DHQ/ 50/ 307
001119-D/09-10
(+) VE
98.8%
2113.
WZ/ GUJARAT/ AHMEDABAD/ BC/ 50/ 180
001119-D/09-10
(+) VE
97.1%
2114.
SZ/ KERALA/ THIRUVANANTHAPURAM

/ BC/ 50/ 1859
001119-D/09-10
(+) VE
96.6%
102.2%
2115.
001119-D/09-10
(+) VE
2116.
001119-D/09-10
(+) VE
103.0%
2117.
SZ/ TN/ VILLAGE/ VIL/ 50/ 646
001119-D/09-10
(+) VE
97.0%
2118.
EZ/ NE/ JURANIA/ VIL/ 50/ 164
001119-D/09-10
(+) VE
102.8%
2119.
WZ/ MP/ SATNA/ DHQ/ 50/ 29
001119-D/09-10
(+) VE
103.5%
2120.
EZ/ JH/ RANCHI/ BC/ 50/ 121
001119-D/09-10
(+) VE
98.8%
2121.
SZ/ TN/ NAMAKKAL/ T/ 50/ 600
001119-D/09-10
(+) VE
103.2%
2122.
WZ/ MP/ INDORE/ BC/ 50/ 47
001119-D/09-10
(+) VE
102.7%
2123.
001119-D/09-10
(+) VE
103.6%
96.8%
2124.
NZ/ UTTARAKHAND/ KASIPUR/ T/ 50/ 691
001119-D/09-10
(+) VE
2125.
NZ/ PUNJAB/ MOHALI/ T/ 50/ 558
001119-D/09-10
(+) VE
102.1%
2126.
EZ/ WB/ RANAGHAT/ T/ 50/ 2546
001119-D/09-10
(+) VE
104.0%
137
2127.
SZ/ TN/ TANJORE/ DHQ/50/ 921
001119-D/09-10
(+) VE
103.0%
2128.
EZ/ AP/ PASIGHAT/ DHQ/ 50/ 307
001119-D/09-10
(+) VE
99.3%
2129.
SZ/ TN/ PANRUTI/ T/ 50/ 1903
001119-D/09-10
(+) VE
103.3%
2130.
WZ/ CHHATTISGARH/ BILASPUR/ BC/ 50/ 76
001119-D/09-10
(+) VE
100.1%
2131.
WZ/ GUJARAT/ AHMEDABAD/ BC/ 50/ 86
001119-D/09-10
(+) VE
98.4%
001609-D/09-10
(+) VE
98.2%
2132.
Calpol
Paracetamol
Tablets
SZ/ TN/ PUDURKOTTAI/ T/ 51/ 534
CDTL,
Mumbai
2133.
SZ/ KERALA/ VILLLAGE/ VIL/ 51/ 6034
001609-D/09-10
(+) VE
103.1%
2134.
NZ/ UTTARAKHAND/ MAHOD/ VIL/ 51/ 176
001609-D/09-10
(+) VE
100.4%
2135.
WZ/ GUJARAT/ JAMNAGAR/ DHQ/ 51/ 47
001609-D/09-10
(+) VE
97.2%
2136.
001609-D/09-10
(+) VE
97.4%
2137.
SZ/ TN/ PANRUFI/ T/ 51/ 1904
001609-D/09-10
(+) VE
95.2%
2138.
001609-D/09-10
(+) VE
96.3%
2139.
SZ/ TAMIL NADU/ T/ 51/ 2002
001609-D/09-10
(+) VE
96.7%
2140.
SZ/ TN / CHENNAI/ MC/ 51/ 5545
001609-D/09-10
(+) VE
99.3%
2141.
001609-D/09-10
(+) VE
100.0%
2142.
NZ/ J&K/ JAMMU/BC/ 51/ 36
001609-D/09-10
(+) VE
97.6%
2143.
SZ/ TN/ CUDDALORE/ DHQ/ 51/ 370
001609-D/09-10
(+) VE
95.4%
2144.
SZ/ TN/ SALEM/ BC/ 51/ 47
001609-D/09-10
(+) VE
98.0%
2145.
001609-D/09-10
(+) VE
95.5%
2146.
001609-D/09-10
(+) VE
97.1%
96.4%
2147.
001609-D/09-10
(+) VE
2148.
SZ/ TN/ PARAMAKODI/ T/ 51/ 5006
001609-D/09-10
(+) VE
95.6%
2149.
WZ/ GUJARAT/ JAMNAGAR/ T/ 51/ 46
001609-D/09-10
(+) VE
96.6%
2150.
SZ/ KERALA/ KOLLAM/ BC/ 51/ 2839
001609-D/09-10
(+) VE
99.6%
2151.
NZ/ RAJASTHAN/ DUJOD/ VIL/ 51/ 532
001609-D/09-10
(+) VE
96.9%
2152.
WZ/ MP/ TIKAMGARH/ DHQ/ 51/ 84
001609-D/09-10
(+) VE
96.6%
2153.
001609-D/09-10
(+) VE
96.4%
2154.
SZ/ KERALA/ ATTINGAL/ T/ 51/ 2282
001609-D/09-10
(+) VE
99.3%
2155.
SZ/ TN/ VADALOR/ T/ 51/ 2361
001609-D/09-10
(+) VE
99.1%
2156.
001609-D/09-10
(+) VE
99.4%
2157.
001609-D/09-10
(+) VE
97.9%
2158.
NZ/ UP/ BALUAGHAT/ T/ 51/ 438
001609-D/09-10
(+) VE
97.0%
2159.
001609-D/09-10
(+) VE
98.1%
2160.
SZ/ TN/ DHARMAPURI/ T/ 51/ 567
001609-D/09-10
(+) VE
96.0%
2161.
EZ/ WB/ HOW/ DHQ/51/ 3100
001609-D/09-10
(+) VE
99.3%
2162.
001609-D/09-10
(+) VE
101.1%
2163.
EZ/ BR/ SAMASTIPUR/ DHQ/ 51/ 223
001609-D/09-10
(+) VE
99.5%
2164.
WZ/ MH/ NANDURBAR/ DHQ/ 51/ 6
001609-D/09-10
(+) VE
99.5%
2165.
NZ/ UP/ BHADOHI/ DHQ/ 51/ 432
001609-D/09-10
(+) VE
100.4%
2166.
001609-D/09-10
(+) VE
99.9%
2167.
001609-D/09-10
(+) VE
95.2%
2168.
WZ/ MH/ NASHIK/ T/ 51/ 40
001609-D/09-10
(+) VE
97.4%
2169.
SZ/ KERALA/ KOCHI/ BC/ 51/ 3112
001609-D/09-10
(+) VE
103.4%
2170.
WZ/ MP/ CHHINDWARA/ DHQ/ 51/ 47
001609-D/09-10
(+) VE
98.0%
2171.
SZ/ TN/ THENI/ DHQ/ 51/ 445
001609-D/09-10
(+) VE
96.3%
2172.
001609-D/09-10
(+) VE
102.5%
2173.
SZ/ TN/ KANCHIPURAM/ DHQ/ 51/ 5844
001609-D/09-10
(+) VE
99.2%
2174.
001609-D/09-10
(+) VE
99.7%
2175.
SZ/ TN/ ARIYALORE/ T/ 51/ 2854
001609-D/09-10
(+) VE
95.8%
2176.
001609-D/09-10
(+) VE
97.0%
2177.
SZ/ TN/ MADURAI/ BC/ 51/ 4812
001609-D/09-10
(+) VE
96.9%
2178.
001609-D/09-10
(+) VE
99.5%
2179.
SZ/ KERALA/ VILLAGE/ VIL/ 51/6031
001609-D/09-10
(+) VE
96.4%
2180.
EZ/ WB/KOL/ MC/ 51/ 1630
001609-D/09-10
(+) VE
98.9%
001609-D/09-10
(+) VE
97.3%
001849-D/09-10
(+) VE
101.3%
001849-D/09-10
(+) VE
100.2%
2181.
2182.
2183.
138
NZ/ HP/ MANDI/ DHQ/ 51/ 164

Brufen
Ibuprofen
Tablets
NZ/UP/ BIJNOR/ DHQ/ 52/ 512

CDTL,
Mumbai
2184.
001849-D/09-10
(+) VE
103.5%
2185.
WZ/ MP/INDORE / BC/ 52/ 51
001894-D/09-10
(+) VE
104.9%
2186.
NZ/ UP/ LONI/ T/ 52/ 504
001849-D/09-10
(+) VE
103.3%
2187.
NZ/ UP/ DADRI/ T/ 52/ 1083
001849-D/09-10
(+) VE
101.0%
2188.
EZ/ WB/ KOL/ 52/ 1583
001849-D/09-10
(+) VE
99.3%
2189.
001849-D/09-10
(+) VE
103.9%
2190.
NZ/ PUNJAB/ RAJPURA/ T/ 52/ 452
001849-D/09-10
(+) VE
102.5%
2191.
NZ/ UP/ SHAHJAHANPUR/ T/ 52/ 972
001894-D/09-10
(+) VE
101.6%
2192.
SZ/AP/ SECUNDERABAD/ BC/ 52/ 3698
001849-D/09-10
(+) VE
100.1%
2193.
WZ/ GUJARAT/ MEHSANA/ DHQ/ 52/ 2
001849-D/09-10
(+) VE
101.7%
2194.
NZ/ UP/ PILKHUWA/ T/ 52/ 1462
001894-D/09-10
(+) VE
98.1%
2195.
001849-D/09-10
(+) VE
102.1%
2196.
SZ/ KERALA/ CALICUT/ T/ 52/ 5608
001894-D/09-10
(+) VE
100.9%
2197.
001849-D/09-10
(+) VE
101.1%
2198.
001849-D/09-10
(+) VE
103.3%
2199.
001849-D/09-10
(+) VE
98.0%
2200.
001849-D/09-10
(+) VE
97.7%
2201.
001849-D/09-10
(+) VE
103.7%
2202.
WZ/WB/ KOL/ MC/ 52/ 1701
001894-D/09-10
(+) VE
103.8%
2203.
WZ/ WB/ KOLKATA/ MC/ 52/ 1359
001849-D/09-10
(+) VE
103.0%
102.2%
2204.
001849-D/09-10
(+) VE
2205.
SZ/ AP/ ANAKAPALLE/ VIL/ 52/ 2574
001849-D/09-10
(+) VE
103.5%
2206.
SZ/ TN/ KUMBAKONAM/ T/ 52/ 970
001849-D/09-10
(+) VE
105.0%
99.6%
2207.
SZ/ KARNATAKA/ DHARWAD/ BC/ 52/ 4056
001849-D/09-10
(+) VE
2208.
NZ/UP/DADRI/ T/ 52/ 1066
001894-D/09-10
(+) VE
102.4%
2209.
SZ/ KARNATAKA/ HUBLI/ BC/ 52/ 4365
001894-D/09-10
(+) VE
102.0%
2210.
SZ/ AP/ RAJAMUNDRY/T/52/ 6091
001849-D/09-10
(+) VE
102.8%
2211.
EZ/WB/KAMARKUNDU/VIL/ 52/ 2084
001849-D/09-10
(+) VE
98.8%
2212.
SZ/ KARNATAKA/ TUMKUR/ DHQ/ 52/ 4295
001849-D/09-10
(+) VE
98.3%
2213.
WZ/ CHHATTISGARH/ RAIGARH/VIL/ 52/31
001849-D/09-10
(+) VE
102.6%
2214.
NZ/ J&K/ JAMMU/ BC/ 52/ 06
001849-D/09-10
(+) VE
101.0%
2215.
001849-D/09-10
(+) VE
99.8%
2216.
WZ/ MP/ JABALPUR/ BC/ 52/ 19
001849-D/09-10
(+) VE
102.0%
2217.
001849-D/09-10
(+) VE
103.4%
2218.
SZ/ AP/ HYDERABAD/ BC/ 52/ 2674
001849-D/09-10
(+) VE
97.8%
2219.
NZ/ HARYANA/ FARIDABAD/ DHQ/ 52/ 367
001849-D/09-10
(+) VE
99.9%
2220.
SZ/ KERALA/ KOCHI/ BC/52/ 3113
001849-D/09-10
(+) VE
104.7%
2221.
EZ/ WB/ KAMARKUNDU/ VIL/ 52/ 2084
001849-D/09-10
(+) VE
102.6%
2222.
SZ/ KERALA/ KIAYANAD/ DHQ/ 52/ 2198
001849-D/09-10
(+) VE
103.2%
2223.
SZ/ AP/ GUDUR/ T/ 52/ 2312
001849-D/09-10
(+) VE
104.5%
2224.
EZ/ WB/ BALARMABATI/ VIL 52/ 3183
001849-D/09-10
(+) VE
102.3%
2225.
SZ/ TN/ CHENGALPATTU/ T/ 52/ 3745
001849-D/09-10
(+) VE
102.4%
2226.
SZ/AP/ VILLAGE/ VIL/ 52/ 3537
001849-D/09-10
(+) VE
98.4%
2227.
SZ/ TN/ VILLAGE/ VIL/ 52/741
001856-D/09-10
(+) VE
101.9%
2228.
001856-D/09-10
(+) VE
100.0%
2229.
SZ/ KARNATAKA/ BANGALORE/ BC/ 52/

4111
001849-D/09-10
(+) VE
99.6%
2230.
WZ/ GOA/ MARGAO/ VIL/ 52/ 22
001849-D/09-10
(+) VE
101.3%
001849-D/09-10
(+) VE
99.5%
001199-D/09-10
(+) VE
96.2%
2231.
2232.

Ibugesic
Ibuprofen
Tablets
SZ/KERALA/ VILLAGE/VIL / 53/ 2492
CDTL,
Mumbai
2233.
SZ/ANDHRAPRADESH/SECUNDERABAD/
BC/53/3699
001199-D/09-10
(+) VE
96.3%
2234.
001199-D/09-10
(+) VE
100.0%
2235.
DHQ/53/120
001202-D/09-10
(+) VE
103.5%
93.9%
2236.
001199-D/09-10
(+) VE
102.8%
2237.
001199-D/09-10
(+) VE
98.0%
2238.
001199-D/09-10
(+) VE
98.7%
139
2239.
EZ/WB/D. BARASAT/53/3387
001199-D/09-10
(+) VE
102.5%
2240.
001202-D/09-10
(+) VE
106.7%
95.1%
2241.
DHQ/53/01
001199-D/09-10
(+) VE
100.0%
2242.
SZ/TAMILNADU/CHENNAI(K)/MC/53/1575
001199-D/09-10
(+) VE
101.1%
2243.
001199-D/09-10
(+) VE
102.4%
2244.
001199-D/09-10
(+) VE
101.1%
2245.
001199-D/09-10
(+) VE
101.6%
2246.
SZ/KERALA/ VILLAGE/ VIL/ 53/ 6040
001199-D/09-10
(+) VE
100.4%
2247.
EZ/WB/ KOLKATA/ MC/ 53/ 2867
001199-D/09-10
(+) VE
101.7%
2248.
NZ/ HARYANA/ FARIDABAD/ DHQ/ 53/ 590
001199-D/09-10
(+) VE
101.2%
2249.
001199-D/09-10
(+) VE
104.0%
2250.
EZ/ WB/ KOL/ MC/ 53/ 1957
001199-D/09-10
(+) VE
101.5%
2251.
001199-D/09-10
(+) VE
99.7%
2252.
SZ/TN/ PANRUTI/ T/ 53/ 1906
001199-D/09-10
(+) VE
100.6%
2253.
SZ/ KARNATAKA/VILLAGE/VIL/ 53/ 4713
001199-D/09-10
(+) VE
97.8%
2254.
NZ/ J&K/ SAMBA/ DHQ/ 53/ 346
001202-D/09-10
(+) VE
105.9%
90.4%
2255.
EZ/ WB/ KOL/ MC/ 53/ 3333
001199-D/09-10
(+) VE
98.4%
2256.
WZ/ CHHATTISGARH/ BILASPUR/ BC/

53/ 10
001202-D/09-10
(+) VE
103.7%
94.8%
2257.
SZ/ TN/ CHENNAI(C)/MC/ 53/ 1157
001199-D/09-10
(+) VE
102.6%
104.4%
93.1%
2258.
SZ/ TN/ PUDUKOTTAI/ T/ 53/ 447
001202-D/09-10
(+) VE
2259.
001199-D/09-10
(+) VE
102.0%
2260.
NZ/ HP/ CHOTASHIMLA/ BC/ 53/ 132
001202-D/09-10
(+) VE
106.7%
96.8%
2261.
WZ/GUJARAT/ MEHSANA/ T/ 53/ 467
001202-D/09-10
(+) VE
105.2%
93.3%
2262.
EZ/ WB/ SILIGURI/ DHQ/ 53/ 446
001199-D/09-10
(+) VE
103.8%
2263.
001199-D/09-10
(+) VE
97.8%
2264.
001199-D/09-10
(+) VE
101.0%
2265.
EZ/ WB/ RANAGHAT/ T/ 53/ 2532
001199-D/09-10
(+) VE
100.7%
2266.
001199-D/09-10
(+) VE
99.6%
2267.
NZ/ UTTARAKHAND/ PITHORAGARH/

BC/ 53/ 484
001199-D/09-10
(+) VE
102.7%
2268.
001199-D/09-10
(+) VE
100.3%
2269.
EZ/ MEGHALYA/ SHILLONG/ BC/53/ 239
001199-D/09-10
(+) VE
102.2%
2270.
NZ/ UP/ MEERUT/ BC/ 53/ 877
001199-D/09-10
(+) VE
101.8%
2271.
SZ/TN/ VILLLAGE/ VIL/ 53/ 5220
001199-D/09-10
(+) VE
100.9%
2272.
EZ/WB/BANGAOLE/ T/ 53/2176
001199-D/09-10
(+) VE
103.3%
2273.
EZ/JHARKHAND/ GUMLA/ DHQ/ 53/ 413
001199-D/09-10
(+) VE
102.9%
2274.
SZ/KERALA/ CHALAKUDY/T/ 53/ 2938
001199-D/09-10
(+) VE
101.4%
2275.
EZ/ WB/ CHENGAIL/ VIL/ 53/1367
001199-D/09-10
(+) VE
100.0%
2276.
EZ/WB/ D. BARASAT/ 53/ 3387
001199-D/09-10
(+) VE
98.3%
2277.
WZ/MP/SAGAR/ DHQ/ 53/ 16
001199-D/09-10
(+) VE
103.2%
2278.
SZ/ KERALA/ KOLLAM/ BC/ 53/2842
001199-D/09-10
(+) VE
102.5%
2279.
EZ/ WB/ KOL/ MC/ 53/ 1686
001199-D/09-10
(+) VE
100.0%
2280.
SZ/KERALA/ THIRUVANANTHAPURAM
/ BC/ 53/1863
001199-D/09-10
(+) VE
101.2%
EZ/JH/ RANCHI/ BC/ 53/ 125
001199-D/09-10
(+) VE
103.8%
001899-D/09-10
(+) VE
99.6%
103.8%
2281.
2282.
R-Cinex
Rifampin &
Isoniazid
Capsules
EZ/OR/BANKANAGAR/VIL/54/458
CDTL,
Mumbai
2283.
001899-D/09-10
(+) VE
97.9%
106.2%
2284.
BC/54/3585
001899-D/09-10
(+) VE
101.3%
101.5%
140
2285.
001899-D/09-10
(+) VE
97.1%
105.7%
2286.
NZ/UP/PHULPUR/VIL/54/738
001899-D/09-10
(+) VE
96.5%
101.3%
2287.
EZ/TRIPURA/DHARMANAGAR/T/54/253
001899-D/09-10
(+) VE
101.7%
102.8%
2288.
NZ/RAJASTHAN/NAHAR/T/54/445
001899-D/09-10
(+) VE
93.5%
107.2%
2289.
001899-D/09-10
(+) VE
101.6%
102.0%
2290.
001899-D/09-10
(+) VE
100.8%
101.3%
2291.
EZ/BR/MAIRWA/T/54/813
001899-D/09-10
(+) VE
94.1%
105.6%
2292.
001899-D/09-10
(+) VE
96.7%
102.0%
2293.
001899-D/09-10
(+) VE
97.8%
106.0%
2294.
001899-D/09-10
(+) VE
93.4%
107.5%
2295.
001899-D/09-10
(+) VE
93.6%
105.9%
2296.
001899-D/09-10
(+) VE
99.9%
106.0%
2297.
001899-D/09-10
(+) VE
93.1%
107.4%
2298.
EZ/WB/MAGRAHAT/VIL/54/2771
001899-D/09-10
(+) VE
102.1%
103.2%
2299.
EZ/WB/JAYNAGAR/T/54/3399
001899-D/09-10
(+) VE
93.5%
106.6%
2300.
EZ/BR/ARA/DHQ/54/420
001899-D/09-10
(+) VE
93.7%
107.3%
2301.
001899-D/09-10
(+) VE
93.9%
103.2%
2302.
001899-D/09-10
(+) VE
93.8%
106.7%
2303.
001899-D/09-10
(+) VE
94.2%
107.1%
2304.
001899-D/09-10
(+) VE
98.6%
102.7%
2305.
001899-D/09-10
(+) VE
103.3%
102.7%
2306.
001899-D/09-10
(+) VE
100.7%
101.8%
2307.
001899-D/09-10
(+) VE
93.5%
106.7%
2308.
NZ/UP/KHETA SARAI/VILLAGE/54/754
001899-D/09-10
(+) VE
95.8%
103.6%
2309.
SZ/TAMILNADU/KALLAKURUDHI/
T/54/3220
001899-D/09-10
(+) VE
93.5%
106.9%
2310.
001899-D/09-10
(+) VE
97.2%
106.6%
2311.
NZ/UP/KHETA SARAI/VILLAGE/54/755
001899-D/09-10
(+) VE
98.4%
106.2%
2312.
001899-D/09-10
(+) VE
93.4%
107.5%
2313.
001899-D/09-10
(+) VE
98.2%
105.1%
2314.
001899-D/09-10
(+) VE
93.1%
107.0%
2315.
DHQ/54/89
001899-D/09-10
(+) VE
94.9%
106.6%
2316.
SZ/KARNATAKA/MANGALOR/BC/54/4644
001899-D/09-10
(+) VE
101.7%
100.0%
2317.
001899-D/09-10
(+) VE
94.8%
101.2%
141
2318.
DHQ/54/264
001899-D/09-10
(+) VE
93.2%
107.1%
2319.
001899-D/09-10
(+) VE
96.2%
106.8%
2320.
EZ/BR/KISHANGANJ/T/54/147
001899-D/09-10
(+) VE
94.9%
102.8%
2321.
001899-D/09-10
(+) VE
95.1%
106.9%
2322.
001899-D/09-10
(+) VE
96.4%
107.3%
2323.
001899-D/09-10
(+) VE
101.7%
101.7%
2324.
001899-D/09-10
(+) VE
93.5%
106.6%
001899-D/09-10
(+) VE
94.4%
107.2%
2325.
2326.
BC/54/267
001899-D/09-10
(+) VE
100.0%
106.7%
2327.
WZ/GUJARAT/SILVASSA/DHQ/54/8
001899-D/09-10
(+) VE
96.5%
103.2%
2328.
001899-D/09-10
(+) VE
100.9%
105.2%
2329.
EZ/MANIPUR/IMPHAL./BC/54/26
001899-D/09-10
(+) VE
102.5%
100.2%
2330.
001899-D/09-10
(+) VE
104.1%
102.1%
2331.
001899-D/09-10
(+) VE
99.5%
102.5%
001949-D/09-10
(+) VE
102.9%
93.3%
2332.
Rimactazid
Rifampicin
and Isoniazid
Tablets
CDTL,
Mumbai
2333.
NZ/UP/BARABANKI/DHQ/55/837
001949-D/09-10
(+) VE
103.7%
98.9%
2334.
SZ/ANDHRA PRADESH/CUDAPAH/
T/55/3145
001949-D/09-10
(+) VE
103.9%
92.8%
2335.
SZ/ANDHRA PRADESH/RAJAMUNDRY/
T/55/6093
001949-D/09-10
(+) VE
107.9%
92.5%
2336.
BC/55/42
001949-D/09-10
(+) VE
94.7%
106.7%
2337.
001949-D/09-10
(+) VE
97.5%
97.2%
2338.
001949-D/09-10
(+) VE
96.3%
103.8%
2339.
001949-D/09-10
(+) VE
106.1%
95.1%
2340.
001949-D/09-10
(+) VE
101.5%
92.0%
2341.
001949-D/09-10
(+) VE
106.0%
96.8%
2342.
DHQ/55/286
001949-D/09-10
(+) VE
103.2%
96.3%
2343.
001949-D/09-10
(+) VE
108.4%
92.1%
2344.
BC/55/2677
001949-D/09-10
(+) VE
105.2%
96.2%
2345.
001949-D/09-10
(+) VE
101.6%
100.6%
2346.
001949-D/09-10
(+) VE
107.7%
91.9%
2347.
DHQ/55/4957
001949-D/09-10
(+) VE
106.8%
105.8%
2348.
001949-D/09-10
(+) VE
107.7%
92.8%
2349.
001949-D/09-10
(+) VE
106.0%
98.3%
142
2350.
001949-D/09-10
(+) VE
99.8%
93.5%
2351.
SZ/KARNATAKA/MYSORE/BC/55/4662
001949-D/09-10
(+) VE
106.2%
94.1%
2352.
001949-D/09-10
(+) VE
95.2%
106.5%
2353.
001949-D/09-10
(+) VE
107.3%
100.7%
2354.
001949-D/09-10
(+) VE
92.6%
100.2%
2355.
001949-D/09-10
(+) VE
100.6%
94.2%
2356.
001949-D/09-10
(+) VE
106.4%
97.8%
2357.
001949-D/09-10
(+) VE
107.4%
92.8%
2358.
001949-D/09-10
(+) VE
103.7%
96.6%
2359.
001949-D/09-10
(+) VE
92.3%
97.3%
2360.
001949-D/09-10
(+) VE
107.8%
94.7%
2361.
001949-D/09-10
(+) VE
106.9%
93.7%
2362.
001949-D/09-10
(+) VE
105.2%
92.9%
2363.
001949-D/09-10
(+) VE
98.5%
97.4%
2364.
EZ/OR/BARIPADA/VIL/55/351
001949-D/09-10
(+) VE
107.2%
94.0%
2365.
001949-D/09-10
(+) VE
97.7%
97.0%
2366.
SZ/TAMILNADU/CHENNAI-M/MC/5/1485
001949-D/09-10
(+) VE
106.2%
92.6%
2367.
001949-D/09-10
(+) VE
106.6%
97.6%
2368.
SZ/TAMILNADU/CHENNAI-W/MC/55/4630
001949-D/09-10
(+) VE
107.4%
94.4%
2369.
001949-D/09-10
(+) VE
105.5%
99.6%
2370.
SZ/ANDRAPRADESH/NTUORT/
DHQ/55/4480
001949-D/09-10
(+) VE
101.0%
100.3%
2371.
DHQ/55/2744
001949-D/09-10
(+) VE
103.6%
95.2%
2372.
DHQ/55/4335
001949-D/09-10
(+) VE
107.4%
103.6%
2373.
SZ/ANDHRA PRADESH/CHITTOR/
T/55/3405
001949-D/09-10
(+) VE
106.5%
95.2%
2374.
001949-D/09-10
(+) VE
107.5%
92.4%
2375.
SZ/TAMILNADU/KALLQKURUCHI/
T/55/3221
001949-D/09-10
(+) VE
97.5%
99.3%
2376.
T/55/2982
001949-D/09-10
(+) VE
103.7%
94.8%
2377.
NZ/NCT DELHI/ DELHI/MC/55/67
001949-D/09-10
(+) VE
104.7%
99.4%
2378.
EZ/WB/KOLKATA/T/55/341
001949-D/09-10
(+) VE
105.7%
93.5%
2379.
001949-D/09-10
(+) VE
104.1%
103.0%
2380.
001949-D/09-10
(+) VE
107.7%
101.9%
2381.
001949-D/09-10
(+) VE
107.7%
93.1%
143
2382.
AKT-4
A. Ethambutol
Hydrochloride
and Isoniazid
Tablets
B. Pyrazinamide
Tablets
C. Rifampicin
Capsule
CDTL,
Mumbai
001999-D/09-10
(+) VE
99.7%
96.8%
98.7%
98.5%
2383.
EZ/NE/BELONIA/DHQ/56/87
001999-D/09-10
(+) VE
99.0%
95.6%
98.5%
99.6%
2384.
EZ/WB/HINDMOTOR/T/56/2110
001999-D/09-10
(+) VE
102.8%
94.6%
98.2%
99.8%
2385.
001999-D/09-10
(+) VE
99.9%
96.2%
99.6%
104.2%
2386.
001999-D/09-10
(+) VE
99.1%
96.2%
98.8%
95.8%
2387.
001999-D/09-10
(+) VE
99.6%
95.7%
101.3%
99.7%
2388.
SZ/TAMILNADU/CHENNAI-CS/MC/56/5550
001999-D/09-10
(+) VE
99.7%
97.8%
99.9%
98.3%
2389.
DHQ/56/107
(+) VE
96.8%
95.0%
99.5%
96.2%
001999-D/09-10
2390.
001999-D/09-10
(+) VE
97.8%
96.7%
98.7%
99.2%
2391.
001999-D/09-10
(+) VE
100.1%
95.5 %
97.4%
100.3%
2392.
001999-D/09-10
(+) VE
92.9%
94.7%
98.9%
94.1%
2393.
NZ/UTTARAKHAND/BARINAG/T/56/253
001999-D/09-10
(+) VE
101.5%
96.7%
101.9%
97.0%
2394.
NZ/UP/BIJNOR/DHQ/56/305
001999-D/09-10
(+) VE
98.1%
97.5%
101.3%
99.7%
2395.
NZ/PUNJAB/PHILLAUR/T/56/268
001999-D/09-10
(+) VE
96.5%
95.5%
100.6%
96.3%
2396.
001999-D/09-10
(+) VE
93.2%
96.3%
99.5%
102.5%
2397.
001999-D/09-10
(+) VE
101.5%
97.4%
101.0%
104.4%
2398.
001999-D/09-10
(+) VE
101.7%
95.4%
100.0%
100.6%
144
2399.
DHQ/56/11
001999-D/09-10
(+) VE
100.8%
96.7%
98.6%
100.3%
2400.
001999-D/09-10
(+) VE
101.8%
94.7%
99.2%
99.1 %
2401.
001999-D/09-10
(+) VE
98.1%
95.2%
101.0%
98.5%
2402.
001999-D/09-10
(+) VE
100.5%
94.8%
100.8%
98.9%
2403.
001999-D/09-10
(+) VE
96.1%
94.3%
101.5%
96.4%
2404.
001999-D/09-10
(+) VE
97.6%
97.0%
100.4%
101.8%
(+) VE
96.9%
96.4%
98.4%
96.6%
2405.
EZ/WB/MASLANDPUR/VIL/56/2284
2406.
BC/56/3959
001999-D/09-10
(+) VE
98.3%
95.6%
99.5%
96.1%
2407.
001999-D/09-10
(+) VE
105.2%
94.0%
101.3%
97.0%
2408.
001999-D/09-10
(+) VE
99.0%
94.8%
98.1%
96.4%
2409.
001999-D/09-10
(+) VE
100.0%
95.1%
98.9%
100.3%
2410.
001999-D/09-10
(+) VE
95.9%
95.9%
97.8%
99.9%
2411.
EZ/WB/DHAMUA BAZAR/VIL/56/3025
001999-D/09-10
(+) VE
99.4%
97.9%
99.1%
98.1%
2412.
001999-D/09-10
(+) VE
102.1%
95.7%
99.1%
100.3%
2413.
001999-D/09-10
(+) VE
97.3%
96.8%
98.7%
99.8%
(+) VE
99.6%
95.7%
99.4%
105.0%
2414.
EZ/OR/BERAMPUR/DHQ/56/36
001999-D/09-10
001999-D/09-10
2415.
001999-D/09-10
(+) VE
100.4%
96.2%
98.8%
102.0%
2416.
001999-D/09-10
(+) VE
103.7%
94.7%
98.4%
96.6%
145
2417.
001999-D/09-10
(+) VE
100.0%
96.6%
99.0%
101.4%
2418.
DHQ/56/20
001999-D/09-10
(+) VE
90.5%
96.9%
99.2%
97.7%
2419.
001999-D/09-10
(+) VE
99.4%
94.1%
98.5%
100.4%
2420.
VIL/56/3891
001999-D/09-10
(+) VE
99.7%
96.9%
97.6%
101.8%
2421.
001999-D/09-10
(+) VE
100.1%
94.4%
99.0%
102.5%
2422.
SZ/ANDHRA PRADESH/SECUNDERABAD/BC/56/3702
001999-D/09-10
(+) VE
101.5%
95.6%
99.8%
101.2%
(+) VE
101.9%
95.9%
100.0%
94.7%
2423.
001999-D/09-10
2424.
001999-D/09-10
(+) VE
94.7%
96.4%
101.7%
102.4%
2425.
001999-D/09-10
(+) VE
99.2%
96.8%
96.9%
98.9%
2426.
001999-D/09-10
(+) VE
103.0%
97.7%
97.6%
100.6%
2427.
001999-D/09-10
(+) VE
104.0%
95.7%
98.6%
98.3%
2428.
EZ/BR/BHAGALPUR/DHQ/56/200
001999-D/09-10
(+) VE
97.6%
95.8%
98.3
98.9
2429.
001999-D/09-10
(+) VE
99.6
97.3
101.3
96.8
2430.
001999-D/09-10
(+) VE
101.0
95.2
97.7
97.3
001999-D/09-10
(+) VE
94.5
96.3
97.7
100.1
(+) VE
98.1%
2431.
2432.
PZA-CIBA
Pyrazinamide
Tablets
RDTL,
Guwahati
2433.
BC/57/70
(+) VE
99.4%
2434.
(+) VE
96.0%
2435.
(+) VE
99.0%
2436.
(+) VE
99.2%
2437.
T/57/3189
(+) VE
98.7%
146
2438.
SZ/TAMILNADU/MANNARGUDI/
T/57/2872
(+) VE
99.5%
2439.
SZ/TAMILNADU/CHENNAI/(H)/
MC/57/1388
(+) VE
102.0%
2440.
DHQ/57/56
(+) VE
95.0%
2441.
EZ/WB/SURI/BC/57/412
(+) VE
98.9%
2442.
(+) VE
99.2%
2443.
(+) VE
98.2%
2444.
DHQ/57/1013
(+) VE
96.8%
2445.
(+) VE
99.3%
2446.
(+) VE
100.0%
2447.
SZ/TAMILNADU/CHENNAI-E/MC/57/1256
(+) VE
98.55
2448.
DHQ/57/30
(+) VE
101.3%
2449.
WZ/MAHRASHTRA/AMRAVATI/
DHQ/57/37
(+) VE
99.7%
2450.
SZ/TAMILNADU/CHENNAI-J/MC/57/1534
(+) VE
98.2%
2451.
(+) VE
98.9%
2452.
EZ/WB/SILIGURI/DHQ/57/458
(+) VE
97.9%
2453.
WZ/MADHYA PRADESH/GWALIOR/57/52
(+) VE
100.4%
2454.
(+) VE
98.4%
2455.
(+) VE
98.5%
2456.
NZ/UP/FATEHABAD/T/57/1352
(+) VE
99.6%
2457.
(+) VE
96.0%
2458.
WZ/MAHARASHTRA/SOLAPUR/
DHQ/57/2
(+) VE
96.0%
2459.
T/57/3307
(+) VE
96.4%
2460.
(+) VE
100.8%
2461.
WZ/MAHRASHTRA/THANE/BC./57/61
(+) VE
97.4%
2462.
(+) VE
99.8%
2463.
DHQ/57/18
(+) VE
97.3%
2464.
(+) VE
99.2%
2465.
(+) VE
99.1%
2466.
(+) VE
99.0%
2467.
NZ/J&K/VIJAYPUR/T/57/106
(+) VE
98.7%
2468.
SZ/TAMILNADU/CHENNAI-B/MC/57/1111
(+) VE
98.5%
2469.
BC/57/16
(+) VE
95.6%
2470.
(+) VE
96.7%
2471.
(+) VE
95.0%
2472.
SZ/TAMILNADU/CHENNAI-G/MC/57/1337
(+) VE
100.7%
2473.
(+) VE
99.7%
2474.
SZ/ANDHRAPRADESH/VILLAGE/
VIL/57/3540
(+) VE
95.0%
2475.
SZ/ANDHRA PRADESH/UDUDAPAH/
T/57/3146
(+) VE
96.0%
2476.
(+) VE
96.0%
2477.
(+) VE
100.2%
2478.
(+) VE
98.0%
2479.
DHQ/57/375
(+) VE
98.7%
2480.
(+) VE
99.1%
147
2481.
2482.
P-zide 750
Pyrazinamide
Tablets
EZ/JHARKHAND/KHUNTI/DHQ/58/177
RDTL,
Guwahati
(+) VE
95.8%
(+) VE
96.9%
2483.
DHQ/58/41
(+) VE
95.9%
2484.
(+) VE
102.0%
2485.
NZ/UP/UNNAO/DHQ/58/48
(+) VE
99.6%
2486.
(+) VE
97.4%
2487.
(+) VE
96.4%
2488.
(+) VE
97.6%
2489.
NZ/RAJASTHAN/AJMER/BC/58/34
(+) VE
99.0%
2490.
EZ/JHARKHAND/KHUNTI/DHQ/58/177
(+) VE
101.3%
2491.
DHQ/58/5
(+) VE
97.8%
2492.
NZ/UP/PHAPHAMAU/VILLAGE/58/885
(+) VE
96.1%
2493.
(+) VE
95.9%
2494.
DHQ/58/43
(+) VE
95.0%
2495.
BC/58/4214
(+) VE
103.1%
2496.
DHQ/58 /4960
(+) VE
96.36%
2497.
(+) VE
Passes
2498.
(+) VE
100.0%
2499.
(+) VE
95.2%
2500.
SZ/ANDHRAPRADESH/VISAKHAPATNAM/BC /58/3356
(+) VE
102.3%
(+) VE
001459-D/09-10
(+) VE
95.07%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
2501.
2502.
Revital
Vitamins and
Minerals
VIL/59/42
CDTL,
Mumbai
2503.
001459-D/09-10
(+) VE
2504.
SZ/TAMILNADU/PUDUKUTTAI/T/59/540
001459-D/09-10
(+) VE
2505.
WZ/BR/MUZAFFARPUR/DHQ/59/319
001459-D/09-10
(+) VE
2506.
EZ/JHARKHAND/LOHARDAGE/
DHQ/59/151
001459-D/09-10
(+) VE
2507.
001459-D/09-10
(+) VE
2508.
EZ/BR/LALGANGEROAD/T/59/871
001459-D/09-10
(+) VE
2509.
EZ/OR/KALIBAD/T/59/183
001459-D/09-10
(+) VE
2510.
NZ/NCT DELHI/DELHI./MC/59/471
001459-D/09-10
(+) VE
2511.
001459-D/09-10
(+) VE
2512.
EZ/WB/HASNABAD/VIL/59/2340
001459-D/09-10
(+) VE
2513.
001459-D/09-10
(+) VE
2514.
EZ/WB/B.T.ROAD/MC/59/3594
001459-D/09-10
(+) VE
2515.
001459-D/09-10
(+) VE
2516.
001459-D/09-10
(+) VE
2517.
001459-D/09-10
(+) VE
2518.
001459-D/09-10
(+) VE
2519.
SZ/TAMILNADU/VILLUPURAM/VIL/59/745
001459-D/09-10
(+) VE
2520.
BC/59/50
001459-D/09-10
(+) VE
148
2521.
001459-D/09-10
(+) VE
2522.
NZ/UTTARAKHAND/RUDRAPUR/
DHQ/59/96
001459-D/09-10
(+) VE
2523.
WZ/GUJARAT/AWREB/DHQ/59/41
001459-D/09-10
(+) VE
2524.
001459-D/09-10
(+) VE
2525.
001459-D/09-10
(+) VE
2526.
001459-D/09-10
(+) VE
2527.
001459-D/09-10
(+) VE
2528.
001459-D/09-10
(+) VE
2529.
DHQ/59/19
001459-D/09-10
(+) VE
2530.
EZ/OR/SUNDERGARH/T/59/615
001459-D/09-10
(+) VE
2531.
001459-D/09-10
(+) VE
2532.
001459-D/09-10
(+) VE
2533.
VIL/59/3892
001459-D/09-10
(+) VE
2534.
WZ/GUJARAT/JUNAGARH/DHQ/59/1
001459-D/09-10
(+) VE
2535.
NZ/UP/BARAUT/T/59/1357
001459-D/09-10
(+) VE
2536.
SZ/ANDHRAPRADESH/VIJAYWADA/
BC/59/3589
001459-D/09-10
(+) VE
2537.
NZ/J&K/AKHNOOR/T/59/139
001459-D/09-10
(+) VE
2538.
001459-D/09-10
(+) VE
2539.
EZ/OR/RKY/DHQ/59/402
001459-D/09-10
(+) VE
2540.
NZ/NCT DELHI/ DELHI/MC/59/462
001459-D/09-10
(+) VE
2541.
001459-D/09-10
(+) VE
2542.
001459-D/09-10
(+) VE
2543.
001459-D/09-10
(+) VE
2544.
001459-D/09-10
(+) VE
2545.
001459-D/09-10
(+) VE
2546.
001459-D/09-10
(+) VE
2547.
NZ/UP/HAPUR/DHQ/59/1473
001459-D/09-10
(+) VE
2548.
001459-D/09-10
(+) VE
2549.
SZ/ANDHRA PRADESH/VIZIANAGARN/
T/59/4525
001459-D/09-10
(+) VE
2550.
001459-D/09-10
(+) VE
001459-D/09-10
(+) VE
001509-D/09-10
(+) VE
2551.
2552.
Becadexamine
Vitamins and
Minerals
CDTL,
Mumbai
2553.
SZ/TAMILNADU/CHENNAI-NC/
MC/60/1729
001509-D/09-10
(+) VE
2554.
001509-D/09-10
(+) VE
2555.
EZ/WB/HELENCHA/VIL/60/2195
001509-D/09-10
(+) VE
2556.
001509-D/09-10
(+) VE
2557.
001509-D/09-10
(+) VE
2558.
MC/60/4634
001509-D/09-10
(+) VE
2559.
001509-D/09-10
(+) VE
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
149
2560.
001509-D/09-10
(+) VE
2561.
001509-D/09-10
(+) VE
2562.
001509-D/09-10
(+) VE
2563.
EZ/WB/BELGHARIA/MC/60/3590
001509-D/09-10
(+) VE
2564.
EZ/WB/NABADRIP/T/60/3721
001509-D/09-10
(+) VE
2565.
001509-D/09-10
(+) VE
2566.
001509-D/09-10
(+) VE
2567.
001509-D/09-10
(+) VE
2568.
001509-D/09-10
(+) VE
2569.
001509-D/09-10
(+) VE
2570.
001509-D/09-10
(+) VE
2571.
001509-D/09-10
(+) VE
2572.
EZ/WB/VLUBERIA/VIL/60/1403
001509-D/09-10
(+) VE
2573.
001509-D/09-10
(+) VE
2574.
001509-D/09-10
(+) VE
001509-D/09-10
(+) VE
001509-D/09-10
(+) VE
001509-D/09-10
(+) VE
001509-D/09-10
(+) VE
001509-D/09-10
(+) VE
2580.
001509-D/09-10
(+) VE
2581.
DHQ/60/164
001509-D/09-10
(+) VE
2582.
EZ/BR/BHOJPUR/DHQ/60/697
001509-D/09-10
(+) VE
2583.
001509-D/09-10
(+) VE
2584.
DHQ/60/39
001509-D/09-10
(+) VE
EZ/WB/BUDGE BUDGE/T/60/3413
001509-D/09-10
(+) VE
001509-D/09-10
(+) VE
001509-D/09-10
(+) VE
2575.
2576.
2577.
2578.
2579.
2585.
2586.
2587.
MC/60/1092
MC/60/1089
BC/60/3590
BC/60/4216
SZ/TAMILNADU/KUMBOKONAM/
T/60/2913
2588.
001509-D/09-10
(+) VE
2589.
001509-D/09-10
(+) VE
001509-D/09-10
(+) VE
001509-D/09-10
(+) VE
001509-D/09-10
(+) VE
2590.
2591.
2592.
DHQ/60/110
SZ/TAMILNADU/MANNARGUDI/
T/60/2873
MC/60/1098
2593.
001509-D/09-10
(+) VE
2594.
001509-D/09-10
(+) VE
2595.
001509-D/09-10
(+) VE
2596.
DHQ/60/151
001509-D/09-10
(+) VE
2597.
NZ/UP/SAHIBABAD/T/60/943
001509-D/09-10
(+) VE
2598.
SZ/AP/CHITTOOR/T/60/3409
001509-D/09-10
(+) VE
150
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
2599.
001509-D/09-10
(+) VE
2600.
NZ/UP/SALARPUR/VIL/60/1097
001509-D/09-10
(+) VE
001509-D/09-10
(+) VE
001659-D/09-10
(+) VE
2601.
2602.
SZ/ANDHRA PRADESH/KAUAL/T/60/4503
DSN
Vitamins and
Minerals
DHQ/61/2751
CDTL,
Mumbai
2603.
001659-D/09-10
(+) VE
2604.
EZ/OR/KANAKHYA NAGAR/T/61/702
001659-D/09-10
(+) VE
2605.
001659-D/09-10
(+) VE
2606.
001659-D/09-10
(+) VE
2607.
001659-D/09-10
(+) VE
2608.
001659-D/09-10
(+) VE
2609.
DHQ/61/153
001659-D/09-10
(+) VE
2610.
001659-D/09-10
(+) VE
2611.
DHQ/61/42
001659-D/09-10
(+) VE
2612.
001659-D/09-10
(+) VE
2613.
001659-D/09-10
(+) VE
2614.
BC/61/44
001659-D/09-10
(+) VE
2615.
NZ/HARYANA/HANSI/VIL/61/518
001659-D/09-10
(+) VE
2616.
DHQ/61/94
001659-D/09-10
(+) VE
2617.
EZ/BR/SAMASTIPUR/BC/61/210
001659-D/09-10
(+) VE
2618.
DHQ/61/60
001659-D/09-10
(+) VE
2619.
001659-D/09-10
(+) VE
2620.
NZ/UTTAR PRADESH/GHAZIBAD/
DHQ/61/1509
001659-D/09-10
(+) VE
2621.
NZ/UP/DAURALA/VIL/61/134
001659-D/09-10
(+) VE
2622.
DHQ/61/317
001659-D/09-10
(+) VE
2623.
NZ/RAJ/CHURU/DHQ/61/384
001659-D/09-10
(+) VE
2624.
T/61/3877
001659-D/09-10
(+) VE
2625.
001659-D/09-10
(+) VE
2626.
001659-D/09-10
(+) VE
2627.
001659-D/09-10
(+) VE
2628.
EZ/OR/ALLMAPURA/VIL/61/535
001659-D/09-10
(+) VE
2629.
EZ/OR/BEHAMPUR/T/61/40
001659-D/09-10
(+) VE
2630.
SZ/KARNATAKA/TIMKUR/DHQ/61/4300
001659-D/09-10
(+) VE
2631.
EZ/OR/RKL-04/DHQ/61/413
001659-D/09-10
(+) VE
2632.
001659-D/09-10
(+) VE
2633.
001659-D/09-10
(+) VE
2634.
WZ/MAHARASHTRA/MC/61/619
001659-D/09-10
(+) VE
2635.
001659-D/09-10
(+) VE
2636.
001659-D/09-10
(+) VE
2637.
EZ/OR/JATNI/VIL/61/602
001659-D/09-10
(+) VE
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
151
WZ/CHHATTISGARH/DHAMTARI/
DHQ/61/1
2638.
2639.
2640.
BC/61/4120
DHQ/61/66
DHQ/61/17
BC/61/3964
2641.
2642.
2643.
2644.
001659-D/09-10
(+) VE
001659-D/09-10
(+) VE
001659-D/09-10
(+) VE
001659-D/09-10
(+) VE
001659-D/09-10
(+) VE
001659-D/09-10
(+) VE
001659-D/09-10
(+) VE
2645.
001659-D/09-10
(+) VE
2646.
DHQ/61/2750
001659-D/09-10
(+) VE
2647.
001659-D/09-10
(+) VE
2648.
001659-D/09-10
(+) VE
2649.
001659-D/09-10
(+) VE
2650.
EZ/BR/KATIHAR/DHQ/61/53
001659-D/09-10
(+) VE
2651.
NZ/UP/MURADNAGAR/T/61/140
001659-D/09-10
(+) VE
001729-D/09-10
(+) VE
2652.
Zeva
Tablets
Zeva Tablets
CDTL,
Mumbai
2653.
001729-D/09-10
(+) VE
2654.
EZ/WB/CHAKDAI/T/62/2441
001729-D/09-10
(+) VE
2655.
001729-D/09-10
(+) VE
2656.
001729-D/09-10
(+) VE
2657.
001729-D/09-10
(+) VE
2658.
001729-D/09-10
(+) VE
2659.
NZ/J&K/GANDHI NAGAR/T/62/122
001729-D/09-10
(+) VE
2660.
001729-D/09-10
(+) VE
2661.
001729-D/09-10
(+) VE
2662.
001729-D/09-10
(+) VE
2663.
001729-D/09-10
(+) VE
2664.
001729-D/09-10
(+) VE
2665.
EZ/WB/GARULIA/TOWN/62/3748
001729-D/09-10
(+) VE
2666.
001729-D/09-10
(+) VE
2667.
001729-D/09-10
(+) VE
2668.
001729-D/09-10
(+) VE
2669.
DHQ/62/22
001729-D/09-10
(+) VE
2670.
001729-D/09-10
(+) VE
2671.
001729-D/09-10
(+) VE
152
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
More
than 90%
ACKNOWLEDGEMENTS
i)
Ministry of Health & Family Welfare, Govt. of India.
ii)
Directorate General of Health Services.
iii)
Indian Statistical Institute, Hyderabad.
iv)
All NGOs & Consumers Association as listed in Annexure-III
v)
Shri Prafull D. Sheth, Professional Secretary, SEAR Pharm Forum.
vi)
Office of Drugs Controller General (India), FDA Bhawan,

Kotla Road, New Delhi.
vii)
All Zonal Offices of Central Drugs Standard Control Organisation.
viii)
Indian Pharmacopoeia Commission, Ghaziabad.
ix)
Central Drugs Laboratory, Kolkata.
x)
Central Drugs Testing Laboratory, Mumbai.
xi)
Central Drugs Testing Laboratory, Chennai.
xii)
Regional Drugs Testing Laboratory, Guwahati.
xiii)
Regional Drugs Testing Laboratory, Chandigarh.
153
Samples Collected
from all over India
NORTH ZONE
SOUTH ZONE
WEST ZONE
EAST ZONE
Total Sample Collected - 24136

Report Cdsco Spurious Drugs

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Report Cdsco Spurious Drugs

Uploaded by

Copyright:

Available Formats

Samples Collected from all over India

Details of Sampling (Table 3)

Further processing after collection

Photographs of Spurious Products

Further Sampling from the residual stock

Recent studies on Spurious Drugs

Comparison of present study with the study conducted by SEARPharm

Future Study Design

Future Administrative Control

Annexure-I (Copy of Gazette Notification)

Annexure-II (Determination of Sample Size and Samples for Estimation of

Annexure-IV (Format for recording the details of samples drawn)

Annexure-V (Format for recording the details of samples drawn) - CDSCO

Funding: Ministry of Health & FW, Govt. of India

Manufacture and sale of spurious drugs is primarily a

Under the provisions of Drugs and Cosmetics Act and Rules

The media had been projecting the problem of spurious

Sale and manufacture of spurious drugs, which are not

likely to cause consequences as stated in (i) above, be made

Authorization of the police to file prosecution.

vi) Constitution of special courts for trial of offence under

The following therapeutic categories of drugs will be

Sixty one (61) popular brands of drugs belonging

The drug samples from each brand under this survey

The drug samples under this survey would be

The drugs would be collected without prescription.

The drugs would be collected by the members of

All CDSCO zonal officers were directed by the Drugs

3.0 Detail of sampling

No. of samples collected

All samples are

Glaxo Smith Kline

Nax Par Lab (p)

Sun Pharma Ltd

All samples are stated

Sulphamethoxazole & Trimethoprim Tablets

IPCA Lab. Ltd

Dr. Reddys Lab.

IPCA Lab. Ltd.

IPCA Lab Ltd

Dr. Reddys Labs

All samples are

IPCA Lab. Ltd.

Briocia Pharma (I)

Novartis India Ltd

GSK Pharma Ltd.

Pamax Labs (P)

Detail of sampling Zone wise:

4.0 Further Processing after Collection:

Name & Addr

M/s Dr. Reddys Laboratories Limited,

Spurious. Foil not matching (not coated with

M/s Dr. Reddys Laboratories Limited,

M/s Dr. Reddys Laboratories Limited,

M/s Dr. Reddys Laboratories Limited,

1. Covert feature dot after Mfg. is missing

1. Covert feature dot after Mfg. is missing

1. Covert feature dot after Mfg. is missing

1. Covert feature dot after batch number

M/s Life Line

1. Covert feature dot after batch number

1. Covert feature dot after batch number

M/s Sree Ram

1. Covert feature dot after Mfg. is missing